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Abstract 
 
Flavonoids are a class of natural products derived from plants which are incorporated 
into honeys through propolis, nectar and pollen.  Research has shown that many 
honeys possess characteristic flavonoid profiles which can be used as markers for the 
geographical and floral origin of honey.  The objective of this study has been to 
determine the flavonoid profile of New Zealand manuka (Leptospermum scoparium) 
honey, a honey which is internationally recognised for its unique medicinal 
properties.  While all honeys are antibacterial due to the production of peroxides, 
manuka is unique because it exhibits an additional non-peroxide antibacterial activity 
due to high levels of methylglyoxal. 
 
The established extraction method, which utilises Amberlite XAD-2 resin to extract 
phenolics from honey, has been modified to permit extraction of phenolics from 
samples as small as five grams, with no measurable loss of extraction reproducibility.  
This development opens up a much larger collection of honey samples to flavonoid 
profiling. 
 
Measurement of the recovery rates for this extraction method has been further 
developed in this study in an attempt to account for the matrix effects of the high 
carbohydrate and phenolic acid content, relative to the flavonoids, of honey.  This was 
achieved by extraction of flavonoid standards from an artificial honey matrix.  The 
recovery rates of 10 ± 6%, 16 ± 7% and 19 ± 9% for quercetin, chrysin and 
kaempferol respectively, were significantly lower than rates (28-60%) measured using 
the accepted procedure of extracting flavonoids from a simple solution.  However, it 
should be noted that the recovery rates measured for extraction from solution were 
lower than those reported by other research groups.  This has been partly attributed to 
an additional filtration step using a sacrificial HPLC column which was implemented 
to protect the analytical HPLC system from an unknown contaminant in the phenolic 
extracts. 
 
Having evaluated the reproducibility and reliability of the modified extraction 
method, it was then applied to the analysis of 31 manuka honeys and 8 other non-
iii 
 
manuka honeys from New Zealand.  The results have shown that the honeys studied 
have a common flavonoid profile consisting mainly of the flavanone pinocembrin and 
the dihydroflavonol pinobanksin.  These flavonoids are derived from propolis and are 
a common feature of honeys from temperate regions of the Northern Hemisphere. 
 
The manuka honeys analysed had total flavonoid content ranging between 0.59-
2.24mg/100g of honey, with an average level of 1.16 ± 0.16mg per 100g of honey.  
The flavonoid profile of these samples consisted mainly of pinobanksin (0.27 ± 
0.04mg/100g honey), pinocembrin (0.17 ± 0.02mg/100g honey), luteolin (0.14 ± 
0.02mg/100g honey) and chrysin (0.13 ± 0.02mg/100g honey), together accounting 
for 61% of the total flavonoid content.   
 
Manuka honey was distinguishable from the other honeys studied by its high total 
flavonoid content, high luteolin content (greater than 0.05mg/100g honey) and high 
levels of an unidentified (unknown compound 01) which was found to elute with the 
flavonoids on HPLC but did not appear to be a flavonoid from its UV spectrum. 
 
Statistical analysis showed that a positive correlation existed between the levels of 
unknown compound 01 in manuka honeys and their non-peroxide antibacterial 
activity.  A similar correlation was also observed for luteolin. 
 
The progress of this research has been hampered by the limited range of flavonoid 
standards available for comparison with HPLC chromatogram peaks.  A total of eight 
flavonoids were found in manuka honey, and a further seven in the non-manuka 
honeys, which did not coincide with any of the flavonoid standards available.  Two of 
unknown flavonoids were subsequently extracted from fifteen kilograms of manuka 
honey using Amberlite XAD-2 resin and liquid-liquid extraction, and isolated by a 
combination of Sephadex-LH20 column chromatography and HPLC.   
 
Characterisation of these flavonoids was achieved using a combination of UV 
absorption spectroscopy, 
1
H, 
13
C and HMBC NMR spectroscopy, and LDI-TOF mass 
spectrometry.  The isolated flavonoids were identified as pinobanksin and 8-
methoxykaempferol, both flavonoids which have been previously found in honeys. 
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 1 
Chapter 1: Introduction 
1.1 Honey 
Honey is a natural substance produced by honey bees, usually from the nectar of 
flowers and honeydew excreted by scale insects.
1
  Honeybees make honey to use 
as a food store during the winter and this has been exploited by humans since 
ancient times.  Beekeeping has been documented at least as far back as the 
Ancient Egyptians (2000-5000 years ago) who used honey as a medicine, as a 
food source and in embalming.
2, 3
 
 
Honey is the only known natural food which will never spoil and the only 
sweetening material which requires no processing to render it ready for 
consumption.  Raw honey can be eaten straight out of the comb taken from the 
beehive.
2
 
1.1.1 Manuka Honey 
Manuka honey is derived from the nectar of the manuka tree, Leptospermum 
scoparium, a native of New Zealand.  This nectar is produced in the flowers of the 
manuka tree, which are generally white in the wild and 10 to 12 mm across in 
diameter.
4
  Flowering takes place between September and February.
5
 
 
The manuka plant is often colonised by scale insects which feed off the phloem of 
the tree and excrete honeydew.  This encourages black sooty mould to grow on 
the bark, giving it a dark colouring.
4
  Honeybees can use this honeydew as a raw 
material for the production of honey and indeed, honeybees have been observed 
harvesting honeydew from scale insects on manuka trees.
6
  However, it is unclear 
as to whether this honeydew is incorporated into manuka honey.  Honeydew 
honeys have a very complex oligosaccharide composition due to 
transglucosylation of the sugars by enzymes in the scale insects gut.  It has been 
shown that while manuka honey does have higher levels of complex sugars (10%) 
than most floral honeys (1.5%), it clearly lacks the variety of oligosaccharides 
found in honeydew honeys such as Beech honeydew honey.  This suggests that 
the sugars used to produce manuka honey are predominantly floral in origin rather 
than from honeydew.
7, 8
 
 2 
 
Manuka honey has a strong and distinctive flavour with a herby and woody 
character.
9
  It is also dark in colour and exhibits thixotropic behaviour similar to 
that found in Australian bush jelly honey and European heather honey.
10, 11
 
1.1.2 Composition of Honey 
The chemical composition of honey varies depending on the floral origin, 
seasonal and climatic variations, and geographical origin.
3, 12
 
1.1.2.1 Water 
The average water content of honey is 17.2% but it has been shown to vary 
between 13.4% and 22.9%.
13
  The water content of honey needs to be below 17% 
to prevent fermentation from occurring.
12
  Nectar contains higher levels of water 
but evaporation of the water in honey is enhanced in the hive by bees fanning 
their wings to create a draft across the honeycomb.
14
 
1.1.2.2  Carbohydrates 
Over 95% of the dry weight of honey can be attributed to its sugar content.  The 
monosaccharides glucose and fructose together make up 85-95% of the total sugar 
content.
3
  The ratio of fructose to glucose found in a honey is mostly determined 
by its floral source.  The average ratio found in honey is 1.2:1 fructose to 
glucose.
15, 16
  Sucrose is also present in honey and makes up about 1% of the dry 
weight.
12
  The remainder of the sugar content of honey is comprised of 
oligosaccharides, of which at least 22 have been identified in honeys.
17
 
 
The oligosaccharides in honey are the result of trans-glycosylation and trans-
fructosylation reactions which are assisted by enzymes in bee secretions.  These 
reactions build up more complex sugars from the glucose and fructose 
monosaccharides present.  These processes occur as the honey ripens and ages in 
the hive and even continue when the honey is stored leading to increased 
oligosaccharide content and decreased monosaccharide content over time.
18, 19
 
 
The oligosaccharides of manuka honey make up 10% of the sugar content.  
Significant levels of maltulose, kojibiose, turanose, nigerose, maltose, trehalose, 
palatinose, sucrose, erlose, panose, melezitose and maltotriose have all been 
identified in manuka honey.
7, 20
  
 3 
 
A comprehensive study of 490 American floral honeys gave the average sugar 
composition and ranges shown in Table 1.1.
13
 
 
Table 1.1: Average sugar composition of American floral honeys.
13
 
 Average Range Standard 
Deviation 
Fructose (%) 38.38 27.25-44.26 2.07 
Glucose (%) 31.28 22.03-40.75 3.03 
Sucrose (%) 1.31 0.25-7.57 0.95 
Reducing 
Disaccharides (%) 
7.31 2.74-15.98 2.09 
Higher Sugars (%) 1.5 0.13-8.49 1.03 
Undetermined (%) 3.1 0.00-13.20 1.97 
 
1.1.2.3  Organics 
In addition to the carbohydrates, there are a large number of other organic 
compounds present in honey.  Mono- and dibasic acids, phenolic acids, 
hydrocarbons and flavonoids have all been identified in honeys and in some cases 
can be characteristic of the floral or geographic origin.
12, 21
 
 
All honeys contain high levels of gluconic acid, produced via the enzymatic 
oxidation of glucose by glucose oxidase contained in bee secretions.  This 
reaction also produces hydrogen peroxide.  The reduced pH and hydrogen 
peroxide help stabilise honey against spoilage while it ripens.
3
 
 
A study by Tan et al.
21
 found that manuka honey contained hydrocarbons (C21-
C33), straight chain fatty acids (C8-C28), dibasic acids and aromatic acids.  
Unifloral manuka honey can be characterised by its high levels of several 
aromatic acids which are largely unaffected by season or geographical origin.  
Phenyllactic acid (1) and 2-hydroxy-3-(4-methoxyphenyl)propionic acid (2) have 
an average combined concentration of 893 mg/kg and levels over 700mg/kg are 
considered a characteristic of manuka honey.  Similarly, syringic acid (3) and 
 4 
3,4,5-trimethoxybenzoic acid (4) have an average combined concentration of 64 
mg/kg and levels over 35 mg/kg are characteristic.  Combined acetophenone (5) 
and 2-methoxy acetophenone (6) levels over 20 mg/kg are also characteristic of 
manuka honey.
22
 
 
Cinnamic acid (7) and its derivatives; caffeic (8), coumaric (9) and ferulic acid 
(10) have all been found in manuka honey.
23, 24
  Yao et al
24
 also observed high 
levels of gallic acid (11) (7.05 mg/100g) and abscisic acid (12) (32.8 mg/100g) in 
two manuka honey samples and has suggested that with further study they could 
be used as a floral marker for manuka honey.  The same study also found the 
cinnamic acid derivatives mentioned previously and ellagic acid (13).  Structures 
of the most significant aromatic acids in manuka honey are shown in Figure 1.1. 
 
Honey also contains a number of flavonoids in their aglycone form.  Some floral 
honeys have been shown to exhibit unique flavonoid profiles making flavonoid 
patterns a useful tool for the determining the floral and geographical origin of 
honeys.
12
  Flavonoids, their biochemistry and their potential use in determining 
floral origin will be covered in Section 1.3.   
 
1.1.2.4 Minor Components 
The free amino acid content of honey is low and variable (0.26-59.65 mg/100g).
25
  
Proline is the most significant of the amino acids present, accounting for 50-85% 
of the total amino acid content.
15
  Proteins are present in higher levels than amino 
acids with an average of 168.6 mg/100g in honey.  As with the amino acids, the 
protein content is highly variable and is reported to range from 57.7 to 567 
mg/100g.
15
  This protein is of bee and plant origin, with enzymes being the most 
significant form of protein present.  Invertase, amylase and glucose oxidase are 
the most common enzymes in honey but catalase and phosphatase have also been 
found at lower levels.
3, 12
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Figure 1.1: Chemical structures of some aromatic compounds found in manuka 
honey. 
 
A number of minerals are commonly found in honey.  These include potassium, 
sodium, calcium, magnesium, copper, iron, manganese, chloride, sulphur, 
phosphate and others.  The mineral content of honey is on average 169 mg/100g 
but this is highly variable, ranging from 20 to 1030 mg/100g of honey.
13
  The 
mineral content of honey has been found to be highly dependent on environmental 
pollution.  Levels of minerals and trace elements are generally higher in industrial 
areas due to pollution.
12
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Honey contains vitamins in low levels.  Ascorbic acid is present at the highest 
concentrations with an average of 200 mg/100g found in honey.  Other vitamins 
present include riboflavin, pantothenic acid, niacin, thiamine and pyridoxine at 
levels from 5.5-360 µg/100g.
3
 
 
When bees collect nectar to be used in honey production, they inevitably collect 
pollen at the same time.  This results in traces of pollen being present in honey.  
Melissopalnyology (pollen analysis) is the traditional method used to determine 
the floral origin of honeys.  This involves using a microscope to identify the types 
of pollen present in the honey.
12
 
 
1.2 Medicinal Properties of Honey 
The use of honey as a wound dressing and medicine dates back to ancient 
civilisations.  Like other traditional medicines it fell out of favour when 
antibiotics were discovered in the mid 20
th
 century.  However, the increasing 
problem of antibiotic resistance has resulted in a renewed interest in honey as a 
wound treatment.
26
  This renewed interest has been helped by accounts of honey 
effectively treating chronic wound infections which have resisted other forms of 
treatment.
27-31
  Honey has shown its effectiveness as a potent antibiotic agent for 
the treatment of infected wounds and is even being employed to prevent infection 
and improve healing in some wounds.
32, 33
 
 
The principal benefit of using honey as a dressing is its antibacterial activity 
against a large number of pathogenic bacteria and fungi.
34-36
  Methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci bacterial 
strains show resistance to a range of antibiotics which makes their treatment 
problematic when they infect wounds.  Clinical studies have found that honey is 
very effective as an antibiotic against these resistant strains.
30, 37, 38
  Pseudomonas 
aeruginosa is another resistant strain, isolated from burns, which has been treated 
with honey.
39
 
 
As well as being a potent antibacterial agent, honey also exhibits other properties 
which assist with wound healing.  In vitro studies have shown that honey activates 
B and T-lymphocytes and phagocytes, and stimulates the release of tumour 
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necrosis factor α, interleukin 1 and 6 cytokines.40  These cytokines convey signals 
in the immune system.
41
  This explains the observation that honey wound 
dressings increase immunity and stimulate the immune response.
40
 
 
The stimulation of the immune system, and the subsequent inflammation, by 
honey does not lead to long term chronic inflammation.  By reducing the 
infiltration of inflammatory cells and providing antioxidants to scavenge free 
radicals, honey is able to prevent prolonged inflammation.
42, 43
  This lack of 
prolonged inflammation helps to reduce necrosis, scarring, oedema, pain and post-
burn contracture.
39, 42, 44
 
 
One of the simplest ways in which honey can assist wound healing is simply by 
creating a physical barrier between the wound and outside sources of infection.
45
  
The debridement (removal of dead tissue) is also assisted by application of honey.  
This occurs through the activation of proteolytic enzymes which remove necrotic 
tissue without the need for chemical or surgical removal.
44-46
 
 
Honey contains the enzyme glucose oxidase which catalyses the transformation of 
glucose to gluconic acid releasing hydrogen peroxide in the process.
3
  These low 
levels of hydrogen peroxide help to stimulate the growth of blood vessels 
(angiogenesis), fibroblasts and epithelial cells, assisting with the repair of tissue 
damage.  The continuous supply of low level hydrogen peroxide to the wound 
also avoids excessive free radical generation and tissue damage caused by higher 
levels of hydrogen peroxide.
47
 
 
Dressing wounds with honey also helps to draw lymph through tissue with 
osmotic pressure.  This provides a moist healing environment with increased 
oxygenation and nutrient supply to promote healing.
48
  This moist environment 
enhances the rate of healing and prevents dressings from sticking to the wound, 
effectively allowing dressings to be changed painlessly and without damaging 
delicate regenerating tissue.
42, 46
 
 
Honey has also been observed to have a deodorising effect when used as a wound 
dressing.  The antibacterial activity of honey helps to prevent odour producing 
bacteria from inhabiting the healing environment.  Additionally, honey provides a 
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supply of glucose which can be metabolised by bacteria in place of amino acids.  
The lactic acid produced from the metabolism of glucose is preferable to the 
malodorous amines, ammonia and sulphur compounds produced by the 
metabolism of amino acids.
48
 
 
The principle medical application of honey is as an antibiotic wound dressing for 
chronically infected wounds.
27-31
  It has also been effectively applied as a wound 
dressing to patients with complicating factors like immunosuppression.
49
  Honey 
is now showing potential as a routine dressing for a range of uninfected wounds 
due to its ability to promote rapid healing and prevent infection.
50, 51
 
 
Aysan et al.
52
 conducted a study on rats which showed honey could be applied 
during abdominal surgery to prevent post-operative peritoneal adhesions.  
Peritoneal adhesions occur after 90% of all laparotomies and can cause intestinal 
obstruction, intra-abdominal abscess, ureteral obstruction and chronic abdominal 
pain.  The rapid healing promoted by honey and the physical barrier it forms both 
help to prevent post- operative peritoneal adhesions and its associated problems. 
 
Another medical application for honey which has been recently discovered is as 
an adhesive.  Clinical studies have found honey to be very effective as an 
adhesive for split thickness skin grafts, being capable of holding the graft in place 
without the need for sutures.  The antibacterial activity of honey provided an 
additional benefit by preventing infection.
53
 
 
Finally, confectionary made from UMF 15 manuka honey was found to reduce 
dental plaque and gingivitis when chewed after meals.
54
   
 
1.2.1 Antibacterial Activity of Manuka Honey 
Several different factors, namely osmotic pressure, acidity and hydrogen peroxide, 
contribute to the antibacterial activity of honey of all origins.  Manuka honey 
contains all these factors and an additional factor known as non-peroxide activity.   
 
 9 
1.2.1.1 Osmotic Pressure 
With the average composition of honey over 79% sugar and only 17.2% water, 
honey is super-saturated with sugars resulting in very strong interactions between 
sugar and water molecules.
3, 13
  This osmotic pressure limits the amount of water 
which is available to micro-organisms, thus inhibiting their growth.  The amount 
of water available to micro-organisms is measured by a quantity known as water 
activity (aw) with higher values reflecting higher availability of water.
55
  Most 
species of bacteria are inhibited by conditions where aw is below 0.94.  Honey 
typically has a water activity within 0.47 to 0.70 aw, well below the inhibition 
limit of most bacteria.
56
  It has been calculated that honey exerts enough osmotic 
pressure to inhibit bacterial growth when diluted to levels as low as 2-12% (v/v 
honey in water) depending on the species of bacteria.
34, 55
 
Artificial honey is a solution of sugars in the same proportions as honey and 
should possess the same water activity as honey.  The low water activity of 
undiluted artificial honey makes it effective against most species of bacteria.  
However, this antibacterial activity is lost when it is diluted while honey has been 
observed to retain its antibacterial activity when diluted.  A study of 18 species of 
bacteria found that honey completely inhibited bacterial growth when diluted to 
50% whilst artificial honey did not.
35
 
1.2.1.2  Acidity 
Osmotic pressure is not the only antibacterial factor present in honey.  Honey is 
typically acidic due to the presence of gluconic acid and gluconolactone.
55
  The 
enzyme glucose oxidase, present in bee secretions, acts to convert glucose to 
gluconic acid in honey.
3
  This gluconic acid then spontaneously undergoes an 
intramolecular esterification to form gluconolactone.  An equilibrium between the 
acid and the lactone exists which maintains a constant level of the free gluconic 
acid.
55
  As a result the average pH of honey is 3.91 
13
 but it does vary between 3.2 
and 4.5.
13, 55
  The optimum pH for the growth of many pathogenic bacteria is 
between 7.2 and 7.4 but the minimum pH which pathogenic bacteria can tolerate 
is typically between 4 and 4.5.  The acidity of honey is likely to be inhibiting to 
many bacterial species but it is unlikely to be effective in the wound environment 
due to the buffering capacity of body fluids neutralising the acidity of honey.
55
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1.2.1.3  Hydrogen Peroxide 
In most honeys it is hydrogen peroxide which accounts for all the observed 
antibacterial activity.
57
  Hydrogen peroxide was identified by White et al.
58
 as the 
major antibacterial agent in honey.  Hydrogen peroxide is formed in honey by the 
enzyme glucose oxidase from bee secretions.  This enzyme catalyses the oxidation 
of glucose to gluconic acid and hydrogen peroxide (Figure 1.2).  The presence of 
hydrogen peroxide and acidity due to gluconic acid help to prevent spoilage of the 
honey while it ripens.
3, 55
 
 
 
Figure 1.2: The enzymatic oxidation of glucose to gluconic acid and hydrogen 
peroxide. 
 
While glucose oxidase is active while the honey matures, it is practically inactive 
in full strength honey.
34
  The lack of activity in full strength honey is thought to 
be the result of gluconic acid, produced by the enzyme, lowering the pH to a point 
where the enzyme is no longer active.  However, when honey is diluted the 
enzyme activity increases by a factor of 2,500 to 50,000 and hydrogen peroxide is 
produced.
55, 59
 
 
Honey contains a number of components which destroy hydrogen peroxide.  The 
enzyme catalase, which catalyses the decomposition of hydrogen peroxide, occurs 
naturally in honey.
60, 61
  The decomposition of hydrogen peroxide to oxygen and 
water is also catalysed by transition metal ions and ascorbic acid present in honey.  
It is these components which destroy the hydrogen peroxide generated during the 
ripening of honey, leaving full strength honey with negligible levels of hydrogen 
peroxide.
55
 
 
High levels of hydrogen peroxide are known to cause DNA damage leading to 
cell injury and death.
62-64
  These problems of tissue damage associated with high 
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levels of hydrogen peroxide are not an issue when honey is used as an 
antibacterial agent.  The activation of the glucose oxidase enzyme when honey is 
diluted, combined with negligible residual levels of hydrogen peroxide before 
dilution, make honey an effective source of hydrogen peroxide.
55
  Honey can be 
used to supply controlled levels of hydrogen peroxide continuously over time to 
provide effective antibacterial activity without the tissue damage usually caused 
by applying hydrogen peroxide solution directly as an antibiotic.
47
 
 
The level of hydrogen peroxide antibacterial activity of honey varies 
considerably.
65, 66
  Variations in the levels of the hydrogen peroxide destroying 
components, particularly catalase, are responsible for the differences in hydrogen 
peroxide activity of honeys.
59
 
1.2.1.4 1.2.1.4 Non-Peroxide Activity and Methylglyoxal 
Some honeys have been found to contain an additional antibacterial activity which 
cannot be attributed to osmotic pressure, acidity or hydrogen peroxide.  Addition 
of catalase to honey results in the enzymatic decomposition of hydrogen peroxide 
and consequently a decrease in the peroxide antibacterial activity.  While the 
enzymatic removal of hydrogen peroxide completely removes the activity of most 
honeys, some have been observed to retain significant levels of antibacterial 
activity.  This activity has been defined as the non-peroxide activity.
67
 
 
A survey of 26 different types of monofloral New Zealand honeys found that non-
peroxide activity was only present in 38% of manuka and 25% of viper’s bugloss 
(Echium vulgare) honeys.  Some manuka honeys in particular were observed to 
retain the majority of their antibacterial activity after the removal of hydrogen 
peroxide, suggesting that their antibacterial activity is due largely to the non-
peroxide component.
57
 
 
Since the discovery of high non-peroxide activity in manuka honey in the late 
1980’s, there has been extensive and continuous research to try and identify the 
source of this activity.  Mavric et al.
68
 identified high levels of methylglyoxal 
(MGO) in manuka honey and showed it was responsible for the non-peroxide 
activity observed in manuka honeys.  Using high performance liquid 
chromatography, MGO was detected as its quinoxaline derivative at levels 
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ranging from 38 to 761 mg/kg in six manuka honeys.  These levels were 
significantly higher than those observed in 50 samples of other honey types which 
had an average of 3.1mg/kg and ranged between not detectable to 5.7 mg/kg.
68, 69
  
A similar study determined the MGO levels for 49 manuka and 34 non-manuka 
honey samples directly, and using the o-phenylenediamine derivatisation to form 
its quinoxaline derivative.  Both methods showed similar levels of MGO in 
manuka honey which varied from 38 to 828 mg/kg.  A positive relationship 
between the level of MGO and the antibacterial activities of the honeys was also 
observed.
70
 
 
Mavric et al.
68
 found that their six manuka honeys exhibited antibacterial activity 
against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) at 
minimum concentrations of 15-30% (v/v with water).  These levels correspond to 
MGO concentrations of 1.1 to 1.8 mM.  The minimum concentration of MGO 
needed to inhibit these bacteria is 1.1mM suggesting that the high levels of MGO 
found in manuka honey is responsible for its non-peroxide activity.  Further to 
this, addition of 1.9 mM MGO to an inactive forest honey gave it an antibacterial 
activity comparable to that of a 20% manuka honey containing a natural MGO 
level of 1.9 mM.
68
 
 
The identification of MGO as the component responsible for the non-peroxide 
activity has since been confirmed by isolation and identification of the active 
fraction of manuka honey.
70
  Early work by Snow
71
 and Farr
72
 identified fractions 
of the reversed phase and size exclusion chromatograms of manuka honey which 
contained its non-peroxide activity.  Using a combination of these techniques, 
Adams et al.
70
 isolated 13.2 mg of the active compound from 50g of manuka 
honey with a high non-peroxide activity.  Nuclear magnetic resonance 
spectroscopy and co-elution with an authentic sample of methylglyoxal were used 
to confirm that the active compound is MGO.   
 
The source of the high levels of MGO found in manuka honey is unclear and the 
subject of ongoing investigations. 
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While the non-peroxide antibacterial activity of manuka honey has now been 
attributed to its high MGO levels, it is not known what role MGO plays in the 
other medicinal effects of honey detailed in Section 1.2. 
 
Wound healing is often impaired in individuals suffering from diabetes.  While 
the exact mechanism of this healing impairment is not known, the accumulation 
of advanced glycation end products (AGEs) has been implicated.  MGO is a 
potent glycation agent and readily forms AGEs.  In addition to endogenous 
sources of AGEs, exogenous dietary intake of AGEs such as MGO has been 
shown to further impair wound healing.  An in vivo study of non-diabetic and 
diabetic mice on high and low AGE (N-carboxymethyl-lysine and MGO) diets 
showed that wound closure was slowest for diabetic mice on a high AGE diet.  
Wound closure in non diabetic mice was found to be independent of the dietary 
AGE intake while diabetic mice on a low AGE diet showed rates of wound 
closure intermediate between those of non diabetic and high dietary AGE diabetic 
mice.  The high AGE diet decreased epithelialization, vascularity, granulation 
tissue formation and collagen organisation in wounds on diabetic mice.  
Inflammatory cell infiltration was also prolonged for diabetic mice on high AGE 
diets and thicker scars were observed to form.  The dominant mode of wound 
closure was reepithelialization in mice on high AGE diets, and wound contraction 
for mice on low AGE diets.
73
 
 
AGEs have been shown to regulate a variety of inflammatory cell responses and 
growth-promoting events which normally occur during wound healing.  However, 
excessive AGEs could impair normal cellular functions and wound tissue 
remodelling through promotion of oxidative stress.
73
    
 
Prolonged exposure of rats to MGO impaired wound healing and induced 
diabetes-like vascular damage.  Impaired infiltration and reduced proliferative 
rates of regenerative cells was observed to cause immature granulation of wounds.  
A number of pro-inflammatory and profibrotic responses were also observed, 
including increased TNF-alpha (tumour necrosis factor-alpha) in regions of 
angiogenesis.
74
 
 
 14 
MGO can disrupt extra cellular matrix (ECM) interactions of endothelial cells 
leading to anoikis (where cell detaches from ECM and dies) of endothelial cells 
and decreased angiogenesis.  The mechanism which causes this is binding of 
MGO to arginine residues at RGD and GFOGER integrin-binding sites of 
collagen (type IV) which are responsible for cell-cell and cell-matrix interactions, 
thus impairing ECM attachment of cells.
75
 
 
The toxicity of methylglyoxal has been the subject of a large number of in vivo 
and in vitro studies.  Ghosh et al.
76
 found that acute doses of 2 grams 
methylglyoxal per kilogram of body weight had no adverse effects when applied 
orally, subcutaneously or intravenously to mice and rats.  Chronic doses of up to 1 
g/kg body weight per day were also given orally, subcutaneously or intravenously 
to mouse, rats and dogs with no adverse effects being observed for 90 days after 
the treatment.  However, other studies contradict these findings.  A review by 
Kalapos
77
 identified a number of studies reporting methylglyoxal to be toxic.  A 
single dose of 800 mg methylglyoxal per kilogram of body weight, given 
intraperitoneally, was lethal to mice within 4 hours.  The acute toxicity of 
methylglyoxal is not of high concern in the case of manuka honey since even 
manuka honeys with very high levels of MGO will not contain a lethal dose in a 
serving.  To achieve a dose of 800 mg per kilogram would require one to consume 
a kilogram of UMF 30 manuka honey (MGO 800 mg/kg) for every kilogram of 
body weight, in a single serving.   
 
Of much greater concern are the chronic effects of MGO.  MGO is known to have 
a role in the development of diabetes complications and is also thought to be 
responsible for encephalopathy in short-bowel syndrome.  The reaction of MGO 
with DNA can cause cancer but paradoxically it can also exert an anti-cancer 
effect through its cytotoxicity.
76, 77
  Clearly there is a need for further research on 
the toxicity of MGO and in particular the role it plays in the wound healing 
properties of honey.  
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1.3 Flavonoids 
The flavonoids are a large and diverse group of phenolics with a basic C6-C3-C6 
structure in common.  The two C6 aromatic rings are designated ring A and ring B 
with the C3 unit bridging them. 
78, 79
 
 
 
Figure 1.3: The structure of flavone.
78, 79
 
 
Flavonoids can be subdivided into a number of classes based on the oxidation 
state of the C3 bridging unit.
79
  The most significant of these classes are the 
flavones, their 3-hydroxy derivatives the flavonols and the anthocyanidins.  Some 
other classes of flavonoids are the flavanones, the flavan-3-ols or catechins, the 
flavanonols or dihydroflavonols, the isoflavones, chalkones and aurones.  The 
skeletal structures of these classes are shown in figure 1.4.
79, 80
  Individual 
compounds in these classes differ in the number and positions of substituents on 
the aromatic rings.  Typically these substituents are hydroxy-groups which are 
often methylated or glycosylated.
79, 81
 
 
It has been observed that the majority of flavonoids found in nature exist as 
glycosides, with glycosylation typically occurring at the hydroxyl-groups.
78, 79, 81
  
However, there is a class of flavonoids called the C-glycosylflavonoids which 
have sugars linked to the aromatic skeleton through carbon-carbon bonds.
81
  
Sugars can be present at more than one position on the flavonoid and it is not 
uncommon for the sugars to be di- or trisaccharides, though monosaccharides are 
certainly the most common.
79
  While it is not unusual for extracts to contain free 
flavonoids as their aglycones, their presence is usually attributed to glycosidase 
enzymes which rapidly form the aglycone from the glycoside during extraction.
79
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It is interesting to note that flavonoid glycosides have only recently been found in 
honey; the majority of studies finding only flavonoid aglycones in honey.
12
  This 
is probably due to the action of amylase enzymes in bee saliva which would 
rapidly cleave the glycosidic linkage to liberate the flavonoid aglycones.
82
 
 
 
Figure 1.4: The structural skeletons of some of the flavonoid classes. 
79, 80
 
 
1.3.1 Biochemistry of Flavonoids 
The natural occurrence and biosynthesis of flavonoids is almost exclusively 
limited to the higher plants.
79, 83
  While there are a few reports of flavonoids in 
animals such as butterflies, these are most certainly the result of sequestration 
from plants in the diet rather than biosynthesis.
79, 81
  It has been reported however, 
that the mould Aspergillus candidus is capable of biosynthesising the flavonoid 
flavonin by the same route as the higher plants.
79
 
 
The biosynthesis of flavonoids occurs on a large scale, with an estimated 2% of 
the total carbon fixed by photosynthesis in plants being used to make flavonoids.
79
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The biosynthetic origin of the C6-C3-C6 lies in both the polyketide and shikimate 
biosynthetic pathways.  Ring B and the linking C3 unit are formed via the 
shikimic acid pathway whilst ring A is the result of condensation of three acetate 
units in the polyketide pathway.
78, 79, 84
 
 
Flavonoids occur in all parts of plants including the roots, stems, leaves, flowers, 
pollen, fruit, seeds, wood and bark.
79, 83, 85
  While particular flavonoids can be 
characteristic of some plant tissues, they are generally not confined to that tissue 
and will be found in other areas of the plant at lower levels.
83
 
 
The main function of flavonoids in plants seems to be as a pigment, providing 
colour to the plant’s flowers to attract pollinators.78, 81, 86  The strong light 
absorbance of flavonoids in the ultra-violet region also allows them to act as a 
protective screen against harmful UV-B radiation.
79, 81, 86
   
 
Flavonoids can also act as protective agents against a number of attacking 
organisms including viruses, bacteria, fungi, herbivorous animals (both vertebrate 
and invertebrate) and even encroaching plants.
79, 81, 86
  This protection is afforded 
by both allelopathic and phytoalexin mechanisms.  Allelopathic flavonoids 
produced by certain species of plants, such as ferns, inhibit the germination and 
growth of encroaching plants.  Plants are also known to produce flavonoid 
phytoalexins in response to infection.  The flavonoid phytoalexins produced are 
antibiotic and help fight off the invading pathogen.
78, 81
  Flavonoids are also 
known to alter gene expression and inhibit energy transfer in plant cells.
82, 86
 
 
Another important function of the flavonoids in plants is as messengers.  Some 
plants, particularly the legumes, are able to release flavonoids from their roots into 
the surrounding soil.  These flavonoids are taken up by nitrogen fixing bacteria 
where they induce expression of nod genes.  Through this communication the 
bacteria is symbiotically incorporated into the root structure where the plant 
benefits from its nitrogen fixation.
81, 82
 
 
It is estimated that the average human ingests 0.5-2 g of flavonoids per day on a 
normal diet.
82, 86
  Such a large intake of relatively unknown flavonoids has led to 
much research into the effects of flavonoids on animal and human physiology.
82
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Flavonoids have been reported to possess anti-inflammatory activity, oestrogenic 
activity, enzyme inhibition activity, antimicrobial activity, antiallergic activity, 
antioxidant activity, vascular activity, antiviral, antithrombotic, anaesthetic 
activity and cytotoxic antitumour activity.
1, 82, 86
  These activities give flavonoids 
the potential to prevent or treat cancers, cardiovascular disease, hypertension, 
allergies, vascular fragility, duodenal ulcers, gastric ulcers, diabetes, and bacterial 
and viral infections.
1, 82
 
 
Propolis (bee glue) has been recognised for its healing properties in civilisations 
as early as Ancient Greece where it was prescribed by Hippocrates (460-377 BC) 
as a topical treatment for sores and ulcers.  The antimicrobial activity of propolis 
is attributed to its high flavonoid content, in particular the flavonoids galangin and 
pinocembrin.
82, 86
  Pure flavonoids and many plant extracts containing high levels 
of natural flavonoids have been found to possess antimicrobial activity against a 
variety of bacterial species including methicillin resistant Staphylococcus 
aureus.
82, 86
 
 
One of the most prominent and medically useful properties of the flavonoids is 
their ability to scavenge free radicals.  Free radicals are highly reactive oxidising 
species such as the hydrogen peroxide radical and the hydroxyl radical. While 
these free radicals are produced during important physiological processes such as 
respiration and the immune response, left unchecked they can cause extensive 
cellular damage.  Flavonoids can scavenge these free radicals, reducing them to 
non-reactive species and being oxidised themselves in the process.  The oxidation 
of a flavonol to a p-quinone via a p-hydroquinone is shown in figure 1.5.  The 
resulting p-quinone easily polymerises to an insoluble polymer which can be 
decomposed by the organism.
82
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Figure 1.5:  The oxidation of flavonols.
82
 
 
The LD50 for flavonoid aglycones injected into the blood of rats has been reported 
as ~2g/kg of body weight.
82
  Another study measured the oral toxicity to rats of a 
flavonoid extract from the bracken, Pteridium aquilinum.  It was shown that the 
LD50 was over 20.0g/kg of body weight and no mutagenic effect was observed in 
the sperm or the micronucleus test.
87
  Consumption of flavonoids is unlikely to 
have an acutely toxic effect in humans.  This is due to the low solubility of 
flavonoid aglycones in water, a short residence time in the intestine and a low 
coefficient of absorption (about 15%).  However, there are rare cases where 
flavonoids can induce allergic reactions in humans.
82
 
 
It is inevitable that the human diet will contain flavonoids since they are 
ubiquitous in plants.  This has certainly been the case throughout the history of the 
human race so it can be considered unlikely that chronic exposure to flavonoids 
would have serious negative health effects.
82
  However, in vitro studies have 
shown flavonoids to have a number of gene inducing, mutagenic, hormone 
influencing and other physiological effects which may be of some concern.
78, 82
  
In spite of this it is generally considered that regular consumption of flavonoids 
does not pose a health risk. The half life of a typical flavonoid in the human body 
is only one to two hours so daily exposure to flavonoids in the diet does not cause 
them to accumulate in the body.
82
 
 
The flavan-3-ols epicatechin, epicatechin gallate and epigallocatechin gallate have 
been found to form adducts with C2, C3, C4 and C6 sugar fragments, and 
significantly reduce the levels of these fragments in vitro.
88, 89
  These sugar 
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fragments include methylglyoxal which has recently been identified in manuka 
honey as the source of its non-peroxide antibacterial activity. 
70, 88, 89
  Section 
1.2.1.4 highlighted a number of the physiological effects of methylglyoxal in 
biological systems.  The observation that catechins can moderate the formation of 
methylglyoxal in aqueous sugar systems, and facilitate its removal as an adduct, 
suggests that catechins and potentially other flavonoids may play a significant role 
in the physiological effects of methylglyoxal in manuka honey.  The adduct 
formation, shown in figure 1.6, was found to occur at the C6 and C8 positions of 
the catechin A ring.  The A ring is structurally similar in all the flavonoid classes 
so it is feasible that this adduct formation is not restricted to the catechins.
89
  It 
must be noted however that methylglyoxal exists at significantly higher levels 
(38-828 mg/kg) in manuka honey than the total flavonoid content (0.306 mg/kg) 
of manuka honey.  It should be considered unlikely that flavonoids would be 
capable of eliminating the free methylglyoxal in manuka honey through adduct 
formation.
24, 70
 
 
 
Figure 1.6: The formation of adducts between epicatechin and methylglyoxal 
(MGO).
89
 
1.3.2 Identification of Flavonoids 
Traditional methods for the identification of flavonoids made use of colour 
reactions with reagents such as aqueous sodium hydroxide, concentrated sulphuric 
acid, magnesium-hydrochloric acid and sodium amalgam with acid.  Colour 
changes observed when the flavonoid undergoes reaction with these reagents 
gives information on the oxidation state of the C3 bridging unit and hence the 
class of the flavonoid.  Variations in the colour changes can also be used to 
identify substitution patterns of flavonoids to a limited extent.
90
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Degradative studies have also been of historical importance in the identification of 
flavonoids.  These studies normally utilise alkaline hydrolysis with subsequent 
identification of the benzene ring fragments.
79, 81, 90
 
 
While colour reactions and degradative studies were of great importance in the 
early days of flavonoid chemistry, they have been superseded by spectroscopic 
techniques which require much less material for characterisation and yield more 
structural information much more quickly.  The information which can be gained 
through ultraviolet and visible absorption (UV-Vis) and nuclear magnetic 
resonance (NMR) spectroscopy is enough to determine the structure of most 
flavonoids.
81, 91, 92
 
1.3.2.1 Ultraviolet-Visible Absorption Spectroscopy 
The large degree of conjugated unsaturation in the flavonoids causes them to 
absorb strongly in the ultraviolet and visible regions of the electromagnetic 
spectrum.
79
  They typically exhibit two major absorption peaks in the region of 
240 to 400 nanometres.  These peaks are commonly referred to as Band I (usually 
300-380 nm) and Band II (usually 240-285 nm).  Band I is associated with 
absorption due to the B-ring cinnamoyl system while Band II is the result of 
absorption involving the A-ring benzoyl system (see figure 1.7).
81, 91-93
 
 
The assignments of Band I and II is supported by the UV spectra of substituted 
flavonoids.  Flavones and flavonols which are oxygenated in the A-ring but not in 
the B-ring (e.g. chrysin and galangin) tend to exhibit a pronounced Band II with 
only a weak Band I in their UV spectra.  If the B-ring is also oxygenated (e.g. 
quercetin and kaempferol) then Band I is more pronounced and will appear at 
longer wavelengths.
92, 93
  Further evidence is found in the UV spectra of the 
flavanone and dihydroflavonol classes of flavonoids.  These classes lack the 
double bond between C2-C3 of the bridging unit (see figure 1.4).  As such there is 
no conjugation between the A- and B-ring systems.  The reduction in length of the 
B-ring conjugated system significantly reduces the intensity of the Band I 
absorption so that it appears as only a shoulder or low intensity peak next to the 
intense Band II absorption.
81, 93
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Figure 1.7:  The conjugated systems responsible for the major ultraviolet-visible 
absorption peaks of flavonoids.
91-93
 
 
Simple inspection of the UV spectra of a flavonoid in methanol can give 
information about the degree of oxygenation and the substitution pattern.  
Increasing oxygenation of the B-ring causes a bathochromic shift (i.e. to longer 
wavelengths) of Band I.  For example the flavonols galangin, kaempferol, 
quercetin and myricetin all have the same 3,5,7 oxidation pattern on their A- and 
C-rings but differ in the oxidation of their B-rings.  These differences are enough 
to shift the position of the Band I peak to the wavelengths shown in table 1.2. 
 
Table 1.2: The effect of oxygenation on the position of the Band I absorption peak 
of flavonols.
91, 93
 
Flavonol Hydroxyl Positions Band I Absorption 
Wavelength 
Galangin 3,5,7 359 nm 
Kaempferol 3,5,7,4 367 nm 
Quercetin 3,5,7,3,4 370 nm 
Myricetin 3,5,7,3,4,5 374 nm 
 
 
Changes in the B-ring oxidation pattern generally do not produce shifts in Band II 
but they can cause it to appear as either one or two peaks.  These are designated 
IIa and IIb with IIa being the peak at longer wavelength.  The 3,4 and to a lesser 
extent the 3,4,5 B-ring oxidation pattern causes flavones and flavonols to exhibit 
two Band II peaks (or one peak with a shoulder on the longer wavelength side).  
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In contrast, flavones and flavonols with the 4 B-ring oxidation pattern only show 
a single Band II peak.
91, 93
  In the flavanones and dihydroflavonols the oxidation 
pattern of the B-ring has no noticeable effect on the UV spectra.
93
 
 
The oxidation pattern of the A-ring has an effect on the wavelength of the Band II 
absorption and in the case of the flavones and flavonols, a smaller effect on the 
Band I absorption.  Flavanones and dihydroflavonols do not exhibit significant 
Band I absorption peaks.  The 5-hydroxyl group is particularly significant in this 
regard, its presence in a flavonoid increasing the wavelength of the Band II 
absorption by 6-17 nm and shifting Band I by 3-10 nm.
91, 93
 
 
Just as the oxidation pattern of the A- and B-ring of the flavonoids can have a 
significant effect on the UV spectra, so too the nature of the oxygen also has an 
effect on the spectra.  The shifts mentioned previously refer to free hydroxyl 
groups added to or removed from the flavonoid.  Methylation or glycosylation of 
the 3-, 5- or 4-hydroxyl groups will produce a hypsochromic shift (i.e. to shorter 
wavelengths), particularly in the Band I absorption peak.  Substitution of the 3-
hydroxyl group produces a hypsochromic shift of 12-17 nm in Band I but this can 
be as large as 22-25nm in flavonols which do not contain a free 5-hydroxyl 
group.
91, 93
  Band II is not affected by substitution at the 3-hydroxyl group.
92
  
Methylation or glycosylation of the 5-hydroxyl group produces a hypsochromic 
shift of 5-15 nm in both Bands I and II.  Substitution of the 4-hydroxyl group 
causes a hypsochromic shift of 2-10 nm in Band I while Band II may undergo 
smaller shifts of 2-6 nm (bathochromic) in flavones or 1-2 nm (hypsochromic) in 
flavonols.
91-93
  Similar substitutions at other positions have little or no effect on 
the UV spectrum.
91, 93
 
 
Acetylation of a flavonoid’s phenolic hydroxyl group nullifies the effect of that 
hydroxyl group on the UV spectrum.  This effect has been utilised to great effect 
in the location of methoxyl groups in polyhydroxyflavones.  Acetylation of the 
free hydroxyl groups in such a flavonoid causes its UV spectrum to approximate 
that of the parent methoxyflavone allowing the location of the methoxyl group to 
be determined.
91-93
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While there is much information to be obtained simply from examination of the 
UV spectrum of flavonoids in methanol, there exist specific reagents which 
further enhance this information.  These specific reagents react with one or more 
functional groups in the flavonoid to produce noticeable shifts in the UV 
spectrum.
91
  These reagents include sodium methoxide, sodium acetate, sodium 
acetate/boric acid, aluminium chloride and aluminium chloride/hydrochloric 
acid.
91-93
 
 
Bases such as sodium methoxide and sodium acetate are able to ionise the 
hydroxyl groups of flavonoids and thus change the UV spectrum.  Sodium 
methoxide is a strong base and ionises all the free hydroxyl groups to some extent.  
As a result, sodium methoxide causes bathochromic shifts to the spectra of 
flavonoids with free hydroxyl groups.  This reagent is particularly useful for 
detecting the presence of free 3- and 4-hydroxyl groups.  A large bathochromic 
shift of 40-65 nm in Band I, without a decrease in the peaks intensity, is indicative 
of a free 4-hydroxyl group.  Flavonols without a free 4-hydroxyl group also 
show a large bathochromic shift of 50-60 nm in Band I upon addition of sodium 
methoxide.  The shifted Band I peak is often decreased in intensity, indicating the 
presence of a free 3- hydroxyl group.
81, 91, 93
 
 
Flavonols containing free hydroxyl groups at both position 3 and 4 are unstable in 
alkali and their UV spectrum will consequently degenerate on addition of sodium 
methoxide.  This will usually occur over a few minutes so it is useful to measure 
the UV spectrum immediately after addition of the reagent and again five minutes 
later to allow time for decomposition to occur.  The presence of a 3,3,4-
trihydroxyl system makes the flavonol even more unstable and decomposition will 
be rapid.  While these oxidation patterns are most commonly associated with 
alkali instability, other patterns may also be sensitive to alkali.  The 5,6,7; 5,7,8 
and 3,4,5 oxygenation patterns are worth particular mention for their instability 
in alkali.
81, 91, 93
 
 
The lack of a significant Band I absorption in the flavanones and dihydroflavonols 
means that sodium methoxide cannot be used to detect free 4- hydroxyl groups in 
these compounds.  Sodium methoxide is still a useful reagent for these classes of 
flavonoids since the absence of a shift in the Band II absorption is a clear 
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indication that the A-ring is not hydroxylated.  In addition, this reagent can be 
used to determine the presence or absence of a free 5-hydroxyl group.  A 
bathochromic shift of 34-50 nm indicates a 5,7-dihydroxy system while similar 
flavanones and dihydroflavonols without the free 5-hydroxyl group will exhibit a 
larger shift of 55-60 nm.  In both these cases the shift is accompanied by an 
increase in intensity of the Band II absorption.
91, 93
   
 
In flavanones and dihydroflavonols the 5,6,7 and 5,7,8 oxygenation patterns are 
unstable in alkaline conditions and the UV spectra of such flavonoids show 
degeneration upon addition of sodium methoxide.  Some flavanones, particularly 
those without a free 5-hydroxyl group, will isomerise to chalcones under alkaline 
conditions, resulting in a completely different UV spectrum (with a Band I peak in 
the 400 nm region).
91, 93
 
 
Sodium acetate is a weaker base than sodium methoxide.  Consequently, only the 
more acidic of the phenolic hydroxyl groups are significantly ionised.  In the 
flavones and flavonols these are the 3,7- and 4-hydroxyl groups.  Ionisation of 
hydroxyl groups at the 3 and 4 positions mainly affects the Band I absorption 
while ionisation of a free 7-hydroxyl group causes a bathochromic shift of the 
Band II absorption peak by 5-20 nm.  In flavonoids without a 7-hydroxyl group, 
or where this group is protected by methylation or glucosylation, there is no 
significant change in Band II on addition of sodium acetate.  This makes sodium 
acetate particularly useful for the detection of free 7-hydroxyl groups.
81, 91-93
  The 
size of this shift is severely reduced in flavones (but not flavonols) possessing 
oxygen substituents at the 6 and 8 positions.  This is probably due to the 6- and 8- 
substituents reducing the acidity of the 7-hydroxyl group.
91-93
  Protected 7-
hydroxyl groups can be detected when the flavone or flavonol also has a 4-
hydroxyl group.  Addition of sodium acetate to such flavones and flavonols with 
substituted 7-hydroxyl groups will exhibit a Band I shift the same or larger than 
that observed by reaction with sodium methoxide.
91
 
 
Reaction with sodium acetate can also be used to detect free 7-hydroxyl groups in 
the flavanones and dihydroflavonols.  When both a 7- and 5-hydroxyl group are 
present in a flavanone or dihydroflavonol, a bathochromic shift of 34-37 nm is 
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observed.  This shift is increased to 51-58 nm when the 5 position is 
deoxygenated.
81, 91, 93
 
 
As is the case for sodium methoxide, addition of sodium acetate to flavonoids 
with alkali sensitive oxygenation patterns causes decomposition of the flavonoid 
and degeneration of the UV spectrum.  Those groupings which caused 
degeneration of the UV spectra when sodium methoxide is added have a similar 
effect when sodium acetate is added.
91, 93
 
 
 When flavonoids are reacted with boric acid in the presence of sodium acetate, 
the boric acid will chelate with orthodihydroxyl groups.  This occurs at all 
orthodihydroxyl groups on the flavonoid nucleus except for the C-5, 6 pairing.  
These complexes are thought to be of the type shown in figure 1.8.
81, 93
 
 
 
Figure 1.8: The proposed structure of the complex formed by reaction of 
orthodihydroxyl groups on the flavonoid nucleus, with boric acid in the presence 
of sodium acetate.
81, 93
 
 
The formation of these complexes can cause a noticeable bathochromic shift in 
the absorption bands of the UV spectrum.  For the typical ranges of shifts 
observed refer to table 1.3.  Orthodihydroxyl groups on the B ring of the 
flavanones and dihydroflavonols are not detectable by this technique due to the 
lack of conjugation between the two ring systems.
91, 93
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Aluminium chloride will also form complexes with certain functional groups in 
the flavonoid nucleus.  Those flavonoids which contain the ketone functionality at 
C-4 (this includes the flavones, flavonols, flavanones and dihydroflavonols) and 
hydroxyl groups at C-3 or C-5 will form acid-stable complexes with AlCl3.  
Orthodihydroxyl groups (other than the C-5,C-6 pair) will also complex with 
AlCl3.  These orthodihydroxyl complexes are not stable under acid conditions 
however and will decompose to the uncomplexed flavonoid in the presence of 
acid.  The structures and reactions of these complexes are shown in figure 1.9.
81, 
91, 93
 
 
Table 1.3: The bathochromic shifts observed in the UV spectrum of flavonoids 
reacted with boric acid and sodium acetate.
91, 93
 
Flavonoid Class Orthodihydroxyl 
Position 
Bathochromic Shift 
Observed 
Flavones and Flavonols A-ring (6,7 and/or 7,8) 5-10 nm (Band I) 
B-ring 12-30 nm (Band I) 
Flavanones and 
Dihydroflavonols 
A-ring (6,7 and/or 7,8) 10-15 nm (Band II) 
B-ring Not Detectable  
 
The formation of aluminium complexes with the orthodihydroxyl groups of 
flavonoids causes bathochromic shifts in both absorption bands.  Addition of acid 
causes these complexes to decompose and a hypsochromic shift is observed in the 
UV spectrum.  Table 1.4 shows the characteristic hypsochromic shifts observed 
when a solution of AlCl3 and a flavonoid is acidified.
81, 91, 93
  If a flavone or 
flavonol has orthodihydroxyl groups on both the A- and B-rings then the shifts are 
cumulative.
91
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Figure 1.9: The complexation of flavonoids with AlCl3 in the presence and absence of acid.
93
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Table 1.4: The shifts observed in the UV spectra of flavonoids in methanol and 
AlCl3 solution when acidified.
91, 93
 
Flavonoid Class Orthodihydroxyl 
Position 
Hypsochromic Shift of 
the AlCl3/HCl UV 
Spectra Relative to the 
AlCl3 Spectra. 
Flavones and Flavonols B-ring (2 adjacent OH) 30-40 nm (Band I) 
B-ring (3 adjacent OH) 20 nm (Band I) 
A-ring (C-6,7 and C-7,8) 20-25 (Band I) 
Flavanones and 
Dihydroflavonols 
B-ring Not Detectable in UV 
Spectrum 
A-ring (C-6,7 and C-7,8) 11-30 nm (Band II) 
 
The addition of acid to a methanolic AlCl3 solution of a flavonoid decomposes 
complexes between AlCl3 and orthodihydroxyl groups.  Any remaining shift in 
the UV spectrum, compared to the spectrum in methanol, is due to complexation 
between a free 3- or 5-hydroxyl group, the C-4 keto functionality and AlCl3.  The 
bathochromic shifts observed for these complexes are shown in table 1.5.
81, 91, 93
  
In flavones and flavonols, the complex formed with a free 3-hydroxyl is more 
stable than that formed with a free 5-hydroxyl group.  This makes the 3-hydroxy-
4-keto complex more favoured than the 5-hydroxy-4-keto complex in flavones 
and flavonols containing free hydroxyls at both C-3 and C-5.  In the 
dihydroflavonols and flavanones, the 3-hydroxy-4-keto complex is actually more 
unstable than that formed with orthodihydroxyl groups.  As a result, these 
complexes also decompose when acidified.  They can be distinguished from the 
orthodihydroxyl complexes by the disappearance of the shift on addition of 
sodium acetate (which has no effect on orthodihydroxyl complexes).
91
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Table 1.5: The bathochromic shifts in the UV spectrum due to complexation of 
AlCl3 with the 3- or 5-hydroxyl groups and the 4-keto group.
81, 91, 93
 
Class of Flavonoid AlCl3 Complex Bathochromic Shift of 
AlCl3 UV Spectra 
Relative to the MeOH 
Spectra. 
Flavones and Flavonols 5-hydroxy-4-keto 35-55 nm (Band I) 
5-hydroxy-4-keto (with 
oxygenation at C-6) 
17-20 nm (Band I) 
Flavonols 3-hydroxy-4-keto 50-60 nm (Band I) 
Flavanones and 
Dihydroflavonols 
5-hydroxy-4-keto 20-26 nm (Band II) 
Dihydroflavonols 3-hydroxy-4-keto 30-38 nm (Band II) 
 
1.3.2.2 Nuclear Magnetic Resonance (NMR) Spectroscopy 
Both proton (
1
H) and carbon (
13
C) NMR spectroscopy is a useful technique for the 
characterisation of all flavonoids.  Originally, the NMR study of flavonoids was 
limited to those which were soluble in deuteriochloroform (CDCl3) or carbon 
tetrachloride (CCl4).  This confined early work to relatively non-polar flavonoids, 
particularly highly methylated flavonoid aglycones.  The introduction of 
hexadeuteriodimethylsulfoxide (DMSO-d6) in 1964, and the development of CCl4 
soluble trimethylsilyl ether (TMS-ether) derivatives in 1965, has opened up NMR 
to most naturally occurring flavonoids.
81, 91, 93
 
 
Most flavonoid aglycones and glycosides are sufficiently soluble in DMSO-d6 to 
allow direct NMR analysis without the need to prepare derivatives.  There are a 
number of disadvantages associated with using DMSO-d6.  The high boiling point 
of DMSO-d6 makes the recovery of flavonoids from this solvent difficult.  Some 
flavonoids are also known to decompose in DMSO-d6 and its tendency to absorb 
moisture can also be problematic.
91, 93
 
 
 31 
The use of TMS-ether derivatisation of flavonoids to make them soluble in CCl4 
is the most widely used technique for NMR of flavonoids.  All hydroxyflavonoids 
and their glycosides may be converted into soluble TMS-ether derivatives and no 
interfering signals are observed.  The flavonoids can be recovered from their 
derivatives by treatment with aqueous methanol.  Partial trimethylsilylation can 
also be utilised to get information about the substitution at the C-3, 6 and 8 
positions, and the TMS-ethers can be easily converted into acetates or methyl 
ethers for more information to assist structural assignment.  A limitation of the 
TMS-ether derivatisation is that it converts the hydroxyl protons to ethers and 
consequently these signals are not observed.
91, 93
 
 
Table 1.6: Typical 
1
H chemical shifts and multiplicities for flavonoids.
81, 91, 93
 
Position Range of Chemical 
Shifts (ppm) 
Commonly Observed 
Signal Multiplicities 
H-5 7.7-8.2 doublet 
H-6 5.7-7.1 doublet or doublet of 
doublets 
H-8 5.9-7.0 doublet 
H-1,2,3,4,5 (B-ring) 6.7-7.9 doublets and/or doublet 
of doublets 
H-3 (flavone) ca. 6.3 singlet (sharp) 
H-2 (flavanone) 5.0-5.5 doublet of doublets 
H-3 (flavanone) ca. 2.8 doublets of doublets 
H-2 (dihydroflavonol) 4.8-5.0 doublet 
H-3 (dihydroflavonol) 4.1-4.3 doublet 
hydroxyl protons ca. 9.7-12.4 singlets (may be 
broadened) 
methoxyl protons 3.5-4.1 singlet 
glucosyl protons 3.3-4.2 (H-1 further 
downfield) 
complex 
 
Proton NMR of flavonoids can yield significant information about oxygenation 
and substitution patterns.  Table 1.6 shows the typical regions of the 
1
H NMR 
spectrum where flavonoid proton signals will appear.  The combination of 
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chemical shift and multiplicity of the standard flavonoid proton signals allows the 
oxygenation pattern to be determined.  The natures of substitutions present in the 
flavonoid are also apparent from the presence of other signals such as methoxyl or 
glucosyl protons.  Determination of where these substitutions are on the flavonoid 
nucleus is more complicated and requires advanced interpretation of partially 
trimethylsilylated derivatives or two dimensional NMR.
81, 91, 93
 
1.3.3 Analysis of Flavonoids in Honey 
Honey contains a range of flavonoids with the total level being about 0.005-
0.010%.  These flavonoids are thought to originate from nectar, pollen which has 
a flavonoid content of 0.5%, and propolis which has a flavonoid content of 10%.
12
 
 
Any analysis of the flavonoids in honey is affected by two major problems.  The 
first of these is the high sugar content of honey which interferes with the direct 
and complete extraction of flavonoids.
94, 95
  Liquid-liquid extractions are 
hampered by the formation of inconvenient interphases due to the high sugar 
content
95
  The use of the non-ionic polymeric resin Amberlite XAD-2 allows the 
sugars and polar compounds to be removed, leaving a fraction containing 
flavonoids and other phenolic compounds.
94, 95
   
 
Phenolic acid derivatives make up the larger part of the phenolic fraction obtained 
from XAD-2 extraction and are part of the second problem of honey flavonoid 
analysis.  The analysis of flavonoids is hampered by interference from other UV-
absorbing compounds, including the phenolic acid derivatives.
94
  Column 
chromatography through Sephadex LH-20 is an effective method for the 
separation of flavonoids from other phenolics.  Observing the elution of the 
phenolics fraction under 360nm UV light clearly shows the phenolic acid 
derivatives eluting first as a blue fraction.  The flavonoids elute later as a dark 
purple fraction.
94
   
 
There are some disadvantages associated with the use of Sephadex LH-20 to clean 
up phenolic fractions.  Firstly, the technique is time consuming and complex, 
requiring a dark room setup to follow the chromatography under UV light.  The 
separation of the flavonoids from the other phenolics is often not clear cut and a 
portion of the flavanones, which elute very closely to the phenolic acids, is 
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discarded.  This prevents an accurate quantification of the flavanones being 
made.
95
  An alternative to Sephadex LH-20 chromatography has been developed 
to separate the flavonoids from the other phenolics.  A simple liquid-liquid 
extraction with diethyl ether preferentially removes the flavonoids (recovery 
>95% after three extractions) from an aqueous solution of the phenolic fraction, 
leaving the majority of the phenolic acid derivatives and any remaining polar 
compounds in the aqueous layer.
95
  Further studies have raised concerns that this 
simplified procedure may only be effective when used to analyse light coloured 
honeys which are rich in flavonoids and contain few phenolic acid derivatives.  
Darker honeys tend to contain more phenolic acid derivatives and the simplified 
extractive technique may not be as effective as chromatography through Sephadex 
LH-20.
96
 
 
The principal method used to analyse flavonoid fractions is high performance 
liquid chromatography with detection by UV absorbance.
1, 12, 94
  Such HPLC 
systems are usually binary, starting with an acidified (e.g. formic acid) aqueous 
solvent and changing to an organic solvent such as methanol over the duration of 
the HPLC run.  An alternative to UV detection is liquid chromatography coupled 
to electrospray mass spectrometry (LC-MS).  This technique has the advantage of 
providing additional information about the structure of flavonoids from 
fractionation patterns, potentially allowing new flavonoids to be identified without 
the need for them to be isolated.
1
 
 
Capillary electrophoresis (CE) has also been used as an alternative method for the 
analysis of flavonoids.  Micellar electrokinetic chromatography (MEKC) or 
micellar electrokinetic capillary chromatography (MECC) is a variation of CE 
which has been successfully used to separate and identify flavonoids extracted 
from honey.
1, 97-99
  The main disadvantage of this technique is that different 
conditions are required depending on which flavonoids are being targeted.  An 
early study by Delgado et al. optimised three sets of chromatographic conditions 
for honey flavonoid analysis.
98
 
1.3.3.1 Flavonoids in Honey 
With the exception of two recent studies, the flavonoids found in honey exist as 
aglycones.
1, 12, 100, 101
  Flavonoid glycosides in floral nectar are generally converted 
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to their aglycones by hydrolytic enzymes in the bee saliva and/or honey.
12, 101, 102
  
Recently it has been reported that Acacia (Robinia pseudoacacia) honey contains 
eight rhamnose and hexose glycosides of kaempferol.  It has been suggested that 
flavonoid rhamnosides are not hydrolysed by bee secretions like other honey 
glycosides (e.g. kaempferol 3-diglucoside).  This is likely because rhamnosidase 
enzymes have not been reported in bee secretions.
101
  Another study of Lithuanian 
honey found the flavonoid glycoside hyperoside (quercetin-3-O-galactoside) in 
willow honey, and vitexin (apigenin-8-C-glucoside) in caraway and lime 
honey.
100
  The discovery of flavonoid glycosides in honey significantly increases 
the number of flavonoids which could be investigated as markers of honey floral 
origin.  However, it is not possible to study these glycosides using the established 
XAD-2 extraction method, the increased polarity of these glycosides requiring an 
alternative extraction techniques.
101
 
 
The flavonoids found in honey belong to the flavone, flavonol, flavanone and 
dihydroflavonol classes.
1, 12
  Parent structures of these flavonoid classes are 
shown in figure 1.4.  At least 26 flavonoids have been identified in honeys of 
various floral origins.  The structures of some of these flavonoids are shown in 
figure 1.10. 
 
Honey produced in the Northern Hemisphere is characterised by the presence of 
the propolis derived flavonoids.  The most significant of these are pinocembrin, 
pinobanksin and chrysin but pinobanksin-3-acetate, galangin, galangin-3-methyl 
ether, pinocembrin-7-methyl ether and tectochrysin have also been identified in 
honey and propolis from temperate areas of Europe, North America and Asia.
103, 
104
  In these areas the poplar tree is native and honey bees will preferentially 
harvest its bud exudates to create propolis.  In contrast, honeys from most 
equatorial regions and Australia contain minimal levels of these propolis 
flavonoids.  A lack of poplar trees in these areas means that bees have to find 
alternative sources of material for propolis, consequently incorporating different 
flavonoids into the honey.
1, 103-105
  Several honeys from Central and South 
America, and New Zealand have been found to contain flavonoids from poplar 
bud exudates based propolis.  This is due to imported bee colonies seeking out 
non-native poplars which have been planted in these areas.
1, 103, 105
  These findings 
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show that honey flavonoid profiling can be a useful tool for the determination of 
the geographical origin of honeys.
12, 103, 106, 107
 
 
  
 
Figure 1.10: The structures of some flavonoids found in honey.
1, 12, 94, 108
 
 
Flavonoids have also shown potential to be marker compounds for the floral 
origin of honeys.  The flavanone hesperetin has been identified exclusively in 
citrus honey and its source has been identified as hesperidin (hesperetin-7-
rutinoside) in orange nectar which is hydrolysed to the aglycone by bee 
enzymes.
99, 107, 109-112
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The flavonoid profile of heather honeys can be characterised by the presence of 
flavonoids with a trioxygenated B ring.  The most significant of these are 
myricetin, myricetin-3-methyl ether and myricetin-3-methyl ether.  Myricetin-3-
methyl ether, abscisic acid and ellagic acid together in honey has been suggested 
as a potential marker for heather honey since the only other monofloral honey 
they have all been found in is that of the botanically related calluna.
96, 110, 113
 
 
Studies have shown that French sunflower honey contains the propolis derived 
flavonoids pinocembrin, chrysin, pinobanksin and galangin, as well as quercetin 
from the sunflower nectar, as the most significant flavonoids.  Consequently, high 
levels of quercetin have been suggested as a marker for European sunflower 
honey.
104, 108, 110, 112
  Australian sunflower (Helianthus annus) honey also contains 
relatively high levels of quercetin but this flavonol is also found in other 
Australian honeys including tea tree (Melaleuca quinquenervia) honey, heath 
(Banksia ericifolia) honey, brush box (Lophostemon conferta) honey, crow ash 
(Guioa semiglauca) honey and several species of Eucalyptus honey..
114, 115
  
Australian sunflower honey can be distinguished from these other honeys by a 
profile containing quercetin, quercetin-3,3-dimethyl ether, myricetin and luteolin 
as the main flavonoids.
114
 
 
Kaempferol-3-sophoroside has been identified as the only significant flavonoid in 
rosemary nectar.  This glycoside is the proposed source of kaempferol in 
rosemary honey, which occurs at levels of 0.33-2.48 mg/kg with a coefficient of 
variation which is much lower than that of other flavonoids present.  As a result, 
kaempferol is a useful marker for the floral origin of rosemary honey.
112, 116, 117
  
Earlier studies had identified 8-methoxykaempferol and apigenin as potential 
marker flavonoids.
99, 111
 
 
Flavonoid profiles containing the flavonoids myricetin, tricetin, quercetin, luteolin 
and kaempferol are characteristic of Eucalyptus honeys of European and 
Australian origin.
1, 105, 115, 118
  In addition to these flavonoids being markers for 
Eucalyptus honeys in general, their individual levels show species-specific 
differences.  River red gum (Eucalyptus camaldulensis) honeys contain tricetin as 
the main flavonoid marker, whereas mallee box (Eucalyptus pilligaensis) honeys 
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have luteolin as the main flavonoid marker.
115
  Bloodwood (Eucalyptus 
intermedia) honeys have myricetin and tricetin as their main flavonoids.  
Yapunyah, (Eucalyptus ochrophloia), narrow-leaved ironbark (Eucalyptus crebra) 
and black box (Eucalyptus largiflorens) honeys contained no myricetin, their 
profiles having tricetin, quercetin and/or luteolin as their main flavonoids.
105
 
 
Other Australian honeys including tea tree (Melaleuca quinquenervia), heath 
(Banksia ericifolia), brush box (Lophostemon conferta), crow ash (Guioa 
semiglauca) and sunflower (Helianthus annus) honeys have been found to have 
flavonoid profiles of myricetin, tricetin, quercetin and luteolin like the previously 
studied Australian Eucalyptus honeys.  A possible reason for this similarity in 
profiles is that the honeys studied may be partially derived from the nectar of 
Eucalyptus trees which are abundant and provide nectar throughout the year.
114
 
 
In an interesting development, the kaempferol glycosides kaempferol-3-O-
(hexoxyl) robinoside-7-O-rhamnoside, kaempferol-3-O-(hexoxyl)robinoside, 
kaempferol-3-O-hexoside-7-O-rhamnoside, kaempferol-3-O-robinoside-7-O-
rhamnoside, kaempferol-3-O-robinoside and kaempferol-7-O-rhamnoside have 
been identified in acacia (Robinia pseudoacacia) honeys at levels of 100-800 
μg/100g.  These flavonoids have also been found in acacia nectar collected from 
the same region as the honeys.
101
  This is one of only two studies which have 
found flavonoid glycosides in honey.  The other study found hyperoside 
(quercetin-3-O-galactoside) in Lithuanian willow honeys and vitexin (apigenin-8-
C-glucoside) in Lithuanian caraway and lime honeys.
100
  An earlier study of 
Croatian acacia honeys did not look for flavonoid glycosides but was able to 
identify the aglycones, quercetin, luteolin, kaempferol, apigenin, chrysin and 
galangin.
119
 
 
In a study of French alder honey, 8-methoxykaempferol was the only flavonoid 
detected.  Consequently it has been suggested as a marker for alder honey.
110
  
Other honeys including lime-tree, chestnut and rapeseed honeys have been found 
to contain marker compounds with characteristic UV spectra.  The identities of 
these unknowns are yet to be determined.
112
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Not all monofloral honeys can be distinguished by the presence of a major 
flavonoid.  Croatian sage (Salvia officinalis) honey was found to contain 
quercetin, luteolin, kaempferol, apigenin, chrysin and galangin.  These flavonoids 
are all found in other European honeys but it may still be possible to identify sage 
honeys by the relative amounts of these flavonoids and the presence of abscisic 
acid as a dominating constituent in the phenolic fraction.
120
 
 
In 1999 and 2000 Weston et al. reported that the flavonoid profile of New 
Zealand manuka honey was similar to that of most European honeys, containing 
only the propolis derived flavonoids pinobanksin, pinocembrin, chrysin and 
galangin at a total average level of 14.9μg/100g of honey.  A total of 19 manuka 
honeys of varying UMF ratings from throughout the North Island of New Zealand 
were studied.  No differences were observed in the flavonoid profile of manuka 
honey from different geographical regions and there was no correlation of 
flavonoid content with UMF rating of the honeys.
23, 121
    Similar levels of the 
same propolis derived flavonoids were observed in New Zealand heather (Calluna 
vulgaris), clover (Trifolium repens), and beech (Nothofagus spp.) honeydew 
honeys.
121
 
 
A later study by Yao et al. has found significantly higher levels of flavonoids in 
Australasian Leptospermum honeys including New Zealand manuka honey.  New 
Zealand manuka (Leptospermum scoparium) honey was found to have an average 
flavonoid content of 3060μg/l00g of honey while Australian jelly bush 
(Leptospermum polygalifolium) honey had an average flavonoid content of 
2220μg/l00g of honey.24  These levels were significantly higher than the 
14.9μg/l00g reported by Weston et al.121  The difference in these results has been 
attributed to the extraction method used by Weston et al. which used insufficient 
XAD-2 resin for the mass of honey analysed.
24
   
 
As well as identifying higher levels of flavonoids in manuka honey the study by 
Yao et al.  also found a range of flavonoids which were not reported in the 
original study.  The flavonoids found in manuka honey include myricetin, tricetin, 
pinobanksin, quercetin, luteolin, quercetin 3-methyl ether, kaempferol, 8-
methoxykaempferol, pinocembrin, quercetin 3,3-dimethyl ether, isorhamnetin, 
chrysin and two unidentified flavonoids.  Of these flavonoids, quercetin (13.8%), 
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isorhamnetin (12.9%), chrysin (12.6%), luteolin (12.6%) and one of the unknown 
flavonoids (12.7%) were the main constituents, making up 64.6% of the total 
flavonoid content.  Leptospermum honeys can be characterised by a flavonoid 
profile mainly consisting of quercetin, luteolin, quercetin 3-methyl ether, luteolin 
and an unknown flavonoid.  Australian jelly bush honey can be distinguished 
from New Zealand manuka honey by its significant myricetin content.  New 
Zealand manuka can be distinguished from jelly bush honey by the presence of 
chrysin and the phenolic acids, gallic acid ( average of 7500μg/100g) and abscisic 
acid (32800μg/100g total trans,trans- and cis,trans-abscisic acids) which are 
present in high levels in manuka honeys.  However, this study was limited to only 
two manuka honey samples so further work is needed to confirm a flavonoid 
profile for manuka honey.
24
 
 
1.4 Aims of the Present Research 
The aim of the present research is to investigate the flavonoids in New Zealand 
manuka honey and how they are related to the floral origin and/or UMF level of 
the honey.  Primary objectives are: 
 
 Modify the established flavonoid extraction method to permit analysis of small 
honey samples. 
 Determine whether the non-peroxide antibacterial activity of manuka honey is 
contained in the sugar fraction or the phenolic fraction. 
 Extract and analyse the flavonoids from a range of manuka honey samples and 
determine if any flavonoids could be potential floral markers. 
 Investigate potential relationships between the flavonoid profile of manuka 
honey and its non-peroxide antibacterial activity. 
 Isolate and characterise any unknown flavonoids found in manuka honey. 
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 Chapter 2: Materials and Methods 
2.1 Materials 
Thirty two manuka honey samples with non-peroxide antibacterial activities ranging 
between very low to 27.3 UMF, were kindly supplied by Comvita New Zealand Ltd. 
(Te Puke, New Zealand).  UMF measurements of these manuka honeys were provided 
by Dr Christopher Adams from previous research carried out in this research group.
70
  
A bulk sample of active manuka honey (6kg, from Haddrell’s of Cambridge, New 
Zealand) was used for the optimisation and testing of the extraction method.  Fifteen 
kilograms of manuka honey was sourced from Natures Country Gold (Hamilton, New 
Zealand) for use in the isolation of flavonoids.  Eight non-manuka New Zealand 
honeys and accompanying data were kindly supplied by Airborne Honey Ltd. 
(Leeston, New Zealand).  These included one sample each of rata (Metrosideros spp.), 
rewarewa (Knightia excelsa), beech (Nothofagus spp.) honeydew, clover (Trifolium 
spp.), kamahi (Weinmannia racemosa), viper’s bugloss (Echium vulgare), thyme 
(Thymus vulgare) and nodding thistle (Carduus nutans) honeys.  All honeys were 
stored in a cold room (5-8ºC) when not being used. 
 
Solvents used in this study were methanol, acetonitrile, water, dimethyl sulfoxide and 
diethyl ether.  Methanol used in the extraction of flavonoids was redistilled from drum 
grade while the methanol used for HPLC was of HPLC grade and supplied by either 
Scharlau or Ajax Finechem (as was available).  For spectroscopy of flavonoids, HPLC 
grade Multisolvent methanol from Scharlau was used since the Ajax HPLC methanol 
absorbed more strongly in the region of 200-260 nm.  Acetonitrile used was of HPLC 
grade and obtained from Burdick & Jackson. 
 
Water used in the extraction of flavonoids was deionised and obtained from a Crystal 
Pure Ultra Pure Water System.  Higher grade Milli-Q water was used as a solvent in 
the HPLC system.  This was obtained from a Barnstead E-pure system (18.2 MΩcm).  
Dried and purified diethyl ether was obtained from a Pure Solv Solvent Purification 
System (Model: PS-SD-5) as needed and used promptly. 
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The dimethyl sulfoxide used for the cleaning of HPLC systems was of 
spectrophotometric grade and supplied by Aldrich Chemical Company.  Deuterated 
dimethyl sulfoxide-d6 (99.9 atom% D containing 0.03% v/v TMS), obtained from 
Sigma-Aldrich, was used as the solvent for NMR analysis of isolated flavonoids.   
 
The authentic chemical compounds used for identification and quantification in this 
study are shown in table 2.1 along with their source.  D(-)-fructose  (analytical grade), 
glacial acetic acid (analytical grade) and concentrated hydrochloric acid were 
obtained from Ajax Finechem.  Sucrose (analytical grade), D(+)-glucose (analytical 
grade) and sodium metal (sticks in paraffin) were obtained from BDH.  Boric acid 
(reagent grade) was obtained from May and Baker while aluminium chloride (reagent 
grade) was obtained from Merck.  Sodium hydroxide (flaked and purified for nitrogen 
determination) was obtained from J. T. Baker Chemical Co. 
 
XAD-2 Amberlite resin (pore size 9 nm, particle size 0.3-1.2 mm) used in the 
extraction of flavonoids from honey was obtained from Sigma-Aldrich.  Sephadex 
LH-20 resin was obtained from Amersham Pharmacia Biotech AB. 
 
Tryptic soy broth was obtained from Bacto™ and nutrient agar was sourced from 
Difco.  Catalase (from Bovine liver, 2950 units/mg) was purchased from Sigma-
Aldrich while AnalaR grade phenol was purchased from BDH.  Freeze dried cultures 
of Staphylococcus aureus (ATCC 9144) were obtained from Environmental Science 
and Research Ltd and used as a bead culture for producing cultures in liquid media. 
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Table 2.1: The authentic chemicals used for identification and quantification 
Common Name Chemical Name Source 
Caffeic acid 3(3,4-Dihydroxyphenyl)-prop-2-
enoic acid 
1 
(+)-Catechin hydrate (98%) 3,5,7,3,4-Pentahydroxyflavane  
(2R, 3S) 
2 
Chlorogenic acid 
(predominantly trans) 
3-Caffeoyl quinic acid 2 
Chrysin 5,7-Dihydroxyflavone 2 
trans-Cinnamic acid (99+%) trans-3-Phenylprop-2-enoic acid 2 
p-Coumaric acid 3(4-Hydroxyphenyl)-prop-2-enoic 
acid 
1 
(-)-Epicatechin (97%) 3,5,7,3,4-Pentahydroxyflavane 
(2R, 3R) 
2 
Galangin 3,5,7-Trihydroxyflavone 2 
Gallic acid (97%) 3,4,5-Trihydroxybenzoic acid 1 
Isorhamnetin (pure) 3,5,7,4-Tetrahydroxy-3-
methoxyflavone 
3 
Kaempferol (pure) 3,5,7,4-Tetrahydroxyflavone 3 
Luteolin 5,7,3,4-Tetrahydroxyflavone 1 
Myricetin (approx 85%) 3,5,7,3,4,5-Hexahydroxyflavone 1 
Naringin (pure) 5,4-Dihydroxyflavanone-7-O-
rhamnoglucoside 
3 
Pinocembrin 5,7-Dihydroxyflavanone 1 
Quercetin dihydrate (98%) 3,5,7,3,4-Pentahydroxyflavone 2 
(+)-Rutin hydrate (95%) 5,7,3,4-Tetrahydroxyflavone-3-O-
rutinoside 
2 
Syringic acid (98%) 3,5-Dimethyl-4-hydroxybenzoic 
acid 
2 
1 = Sigma-Aldrich Inc., 2 = Aldrich Chemical Company, Inc.,3 = Indofine Chemical 
Company Inc. 
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2.2 General Methods 
2.2.1 Freeze-Drying 
A Labconco Bulk Tray Drier was used to freeze-dry samples when required.  Liquid 
samples were frozen with liquid nitrogen prior to freeze-drying while solid samples 
were dried without freezing.  Samples were left on the freeze drier for 20-48 hours 
depending on the amount of drying required.   
2.2.2 Evaporation 
Large volumes of liquid were reduced using two rotary evaporators.  The first system 
comprised a Büchi Rotavapor R-200, Büchi Heating Bath B-490 and a Büchi Vac
®
 V-
500 vacuum pump.  The second system was an Eyela rotary evaporator equipped with 
an Eyela Water Bath SB-650 and a Büchi Vac
®
 V-500 vacuum pump.  Both systems 
were run with their water bath set to 40ºC. 
 
Once liquid volume had been reduced enough to fit in a sample vial, further 
evaporation was achieved using a blow down block.  This system consisted of a 
Pierce Reacti-Therm Heating Module set to heat samples to 40ºC, and a Pierce 
Reacti-Vap Evaporating Unit which blew nitrogen gas over the samples.  
 
2.2.3 Statistical Analysis 
Statistical analysis was performed by Dr Ray Littler (Department of Statistics, 
University of Waikato, Hamilton, New Zealand) using Minitab statistical software. 
 
2.3 High Performance Liquid Chromatography (HPLC) 
Three different HPLC systems were used in this study and were referred to as systems 
A, B and C. 
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2.3.1 HPLC System A 
This system was used as a coarse separation to filter honey phenolic extracts prior to 
analytical analysis by HPLC.  This coarse separation was necessary to protect HPLC 
system B which was used for the quantitative analysis of honey phenolics. 
 
HPLC system A consisted of a Waters 515 pump and 996 PDA detector (240-400nm), 
Alltech Elite Degassing System and a Rheodyne 7725i injector fitted with a 5mL 
loop.  A Waters reversed phase C18 column (Nova-Pak® C18 4μm 8x100mm Radial-
Pak™) was fitted inside a Waters radial compression module (RCM 8x10) and 
protected by a guard cartridge (Waters Resolve™ C18 Guard-Pak HPLC Precolumn 
Insert) which was replaced as required.   
 
The system was operated isocratically with 2mL/min of methanol.  Extracts were 
injected into this system and the elution of phenolics was followed by their UV 
absorbance (240-400nm maximum absorbance plot).  A fraction was collected as 
appropriate to the extract type being filtered.  Small extracts, such as those in the 
analysis of honey phenolic profiles, were collected as a fraction between 1.0min and 
7.0min.  Higher loading rates, such as those used to filter bulk phenolic extracts, 
required a larger fraction to be collected to recover the phenolics. 
 
2.3.2 HPLC System B 
Flavonoid extracts were analysed using HPLC system B.  System B was a binary 
HPLC system operated using Waters Empower Pro software (Waters Empower 2, 
build number 2154).  Two Waters 515 HPLC pumps were operated remotely with 
their flows being combined through a mixer (Grace Binary Large Volume Mixer SS 
Housing with 350μL Mixer Cartridge).  This mixer setup was required to suppress 
noise generated by the mixing of eluents at high pressure. 
 
Samples and standards were warmed (40ºC) and injected manually using a Rheodyne 
7725i injector system fitted with a Rheodyne loop (5μL).  Separation of extracts was 
achieved using a Waters Symmetry Shield™ octadecylsilane HPLC column (RP18, 
5μm, 3.0x250mm).  A matching guard column (Waters Universal Sentry™ Guard 
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SymmetryShield™ Column in a Waters Universal Sentry™ Guard Column Holder) 
was fitted to protect the analytical column.  This guard column did not need to be 
replaced during the course of the analysis of samples. 
 
A binary gradient was operated on this system.  Solvent A was Milli-Q water and 
methanol (5% v/v) to prevent microbial growth, acidified with acetic acid (0.075% 
v/v).  Solvent A was prepared in batches (1L) which were sonicated (20min) to assist 
removal of dissolved gasses prior to using in the HPLC.  Solvent B was methanol.  A 
degasser (Waters In-Line Degasser AF) was also utilised in the HPLC system to 
further remove dissolved gasses.  The gradient shown in table 2.2 was run at a 
constant combined flow rate (0.3mL/min).  Detection was achieved using a Waters 
996 Photodiode Array Detector (240.0-400.0nm). 
 
Table 2.2: The gradient system used for the analytical HPLC analysis of flavonoid 
extracts. 
Time (min) Solvent A %
1
 Solvent B %
2
 
0 70 30 
15 70 30 
20 40 60 
60 0 100 
70 0 100 
73 70 30 
78 70 30 
1
 Acetic acid (0.075% v/v) and methanol (5% v/v) in Milli-Q water 
2
 Methanol 
 
2.3.2.1 Alternative HPLC Conditions Used During Early Method 
Development 
Early extraction method development was analysed using an alternative set of HPLC 
conditions.  The same HPLC instrument was utilised but several changes were made 
to the operating conditions.  Firstly, acetonitrile was used instead of methanol as 
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solvent B.  The total flow rate (0.4mL/min) was also different and the gradient 
program was that described in table 2.3.   
 
The HPLC conditions were later changed after the column became contaminated and 
had to be cleaned.  After cleaning it was found that the strong solvent had to be 
changed to methanol to achieve an acceptable peak shape.  This change of solvent 
necessitated the change of flow rate and gradient program. 
 
Table 2.3: The gradient system used for the analytical HPLC analysis of early 
flavonoid extracts. 
Time (min) Solvent A %
1
 Solvent B %
2
 
0 77 23 
3 77 23 
4 67 33 
30 30 70 
30.1 0 100 
33 0 100 
36 77 23 
44 77 23 
1
 Acetic acid (0.075% v/v) and methanol (5% v/v) in Milli-Q water 
2
 Acetonitrile 
 
2.3.2.2 Identification and Quantification 
Peaks in the HPLC chromatograms were identified by comparison of the retention 
time and UV spectra with those of authentic standards.  Where authentic standards 
were not available the peak had to be isolated and characterised according to the 
methods described in Sections 2.6 and 2.7. 
 
Quantification of the flavonoids was achieved by comparing their absorbance in the 
HPLC chromatograms to four external standards.  Pinocembrin at 290nm was used to 
quantify all flavanones and dihydroflavonols.  Chrysin at 340nm was used to quantify 
flavones and flavonols with unsubstituted B rings.  Similarly, kaempferol at 340nm 
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was used for those flavones and flavonols with a singly oxygenated B ring, while 
quercetin at 340nm was used for all other flavones and flavonols. 
 
Pinocembrin (3.25±0.02mg), chrysin (2.91±0.02mg), kaempferol (2.47±0.02mg) and 
quercetin dihydrate (2.99±0.02mg) were weighed out and dissolved in HPLC grade 
methanol (5.00±0.05mL).  This 0.5mg/mL stock solution was sonicated (15min) to 
ensure complete dissolution and then diluted to create six standards using the scheme 
shown in table 2.4.  These standards were analysed on HPLC system B using the 
method described in Section 2.3.2.1.  A calibration curve of peak area versus 
concentration was created and subsequently used to quantify the flavonoids in 
samples analysed by HPLC. 
 
Table 2.4: Preparation of quantitative flavonoid standards. 
Volume of 0.5mg/mL 
Stock Solution (mL) 
Volume Solution Made 
Up To (mL) 
Approximate 
Concentration of the 
Standard (mg/mL) 
0.0200±0.0002mL 2.000±0.004mL 0.005 
0.04±0.0002mL 2.000±0.004mL 0.01 
0.1000±0.0002mL 2.000±0.004mL 0.025 
0.2000±0.0002mL 2.000±0.004mL 0.05 
0.400±0.002mL 2.000±0.004mL 0.1 
1.000±0.002mL 2.000±0.002mL 0.25 
 
2.3.2.3 Cleaning the HPLC Column 
During the course of this research it was found that certain components of honey 
persisted in the HPLC column, causing the quality of the chromatography to be 
severely reduced.  When the column became contaminated in this way the peaks of 
flavonoids became broadened and resolution was reduced. 
 
The most effective method for cleaning the HPLC column once it was contaminated 
was found to be multiple injections of dimethyl sulfoxide (200μL).  These could be 
run using the gradient system being used for the experiment or alternatively they 
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could be injected into a constant flow of methanol.  The injections were repeated until 
the chromatography was restored to optimal condition (observed using a standard 
mixture of flavonoids). 
 
2.3.3 HPLC System C 
HPLC system C was a semi-preparative system used to isolate flavonoids from bulk 
extracts of honey phenolics.  The system consisted of two Waters 515 pumps, an 
Alltech Elite Degassing System,  Rheodyne 7725i injector fitted with sample loop 
(500μL), and a Waters 996 photodiode array detector.  A reversed phase 
octadecylsilane Waters Xterra Prep column (PR18, 10μm, 7.8mmx300mm) was used 
in this system without a guard column. 
 
A binary mobile phase system the same as that used for the analytical HPLC (Section 
2.3.2) was used for the semi-prep HPLC.  This consisted of solvent A which was 
Milli-Q water acidified with acetic acid (0.075% v/v) and contained methanol (5% 
v/v) to prevent microbial growth; and solvent B which was straight HPLC methanol.  
An overall flow rate (4mL/min) was maintained throughout the gradient program 
shown in table 2.5. 
 
Table 2.5:  The gradient program used in the semi-prep HPLC separation of 
flavonoids. 
Time (min) Solvent A %
1
 Solvent B %
2
 
0.0 60 40 
5.0 60 40 
10.0 50 50 
60.0 20 80 
60.2 0 100 
65.0 0 100 
67.0 60 40 
70.0 60 40 
1
 Acetic acid (0.075% v/v) and methanol (5% v/v) in Milli-Q water 
2
 Methanol 
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Bulk phenolic extracts were centrifuged (5000rmp, Heraeus Sepatech Medifuge) prior 
to injection onto the semi-prep HPLC system at high loading rates (up to 150μL).  
Fractions were collected from the photodiode array outlet as appropriate. 
 
2.4 Well Diffusion Assay for Non-Peroxide Antibacterial Activity 
2.4.1 Preparation of Assay Plates 
Nutrient agar (23.0g) was dissolved in distilled water (1.0L) and then divided into 
150mL amounts which were sterilised in an autoclave.  The prepared flasks of  
nutrient agar were stored at room temperature until required, at which point the flasks 
were steamed in a water bath (30min, 100ºC) to sterilise and liquefy the agar.  The 
agar was then transferred to another water bath (30min, 50ºC) to cool to a temperature 
which was tolerable to the bacterial culture. 
 
Cultures of Staphylococcus aureus were prepared by inoculating tryptic soy broth 
(30g/L) with S. aureus bead culture and incubating (18h, 37ºC).  The S. aureus culture 
was diluted with tryptic soy broth until it had an optical density of 0.5AU.  The 
optical density was measured using a Thermo Spectronic Helios γ spectrophotometer 
(540nm) with tryptic soy broth used as a blank. 
 
Square assay plates (Corning® 431111 sterile bioassay dish, 245mmx245mmx18mm) 
were prepared on a level surface.  Nutrient agar (150mL, 50ºC) was inoculated with S. 
aureus culture (100μL, 0.5AU optical density as prepared above) and carefully poured 
into the assay plate.  Once the plates had solidified they were stored upside-down 
overnight at 4ºC. 
 
2.4.2 Preparation of Samples and Standards 
A 10% stock solution of phenol (10g phenol/100mL distilled water) was diluted to 
give phenol standards at 2, 3, 4, 5, 6 and 7% (w/v).  These standards were stored at 
4ºC in the dark for up to one month before being replaced. 
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Whole honey samples, fractions added to clover honey and syrupy fractions were 
prepared by weighing the sample (ca. 2.10g) and dissolving in distilled water 
(2.1mL).  The resulting 50% (w/v) solutions were incubated (37ºC, 30min) to soften 
the honey and then stirred until homogenous.   
 
50% (w/v) solutions of honey/syrup samples were further diluted by combining equal 
volumes (1:1) of sample with catalase solution (41mg/20mL distilled water).   
2.4.3 Antibacterial Assay 
Wells (8mm Ø) were punched into the agar plate in a regular 8x8 grid using a flamed, 
cooled cork borer and a sterilised inoculating needle was used to remove the agar 
wells.  The 8x8 grid of wells were filled with samples and standards according to a 
Quasi-Latin square of 16 numbered wells repeated 4 times over the plate (once in 
each pair of rows and columns) as shown in figure 2.1.  The arrangement of samples 
in this template distributes the samples over the plate to remove bias due to edge 
effects. 
 
Samples (prepared as above) and standards were placed in each well (100μL) at their 
allocated positions.  The plates were then incubated (18h, 37ºC) before measuring the 
clearance zones around wells using a digital calliper (Mitutoyo 500.321).   
 
The clearing zones for each sample were squared and compared with a standard curve 
of squared clearing zone versus % (w/v) phenol standard concentration. This allowed 
the equivalent phenol concentration of the 25% (w/v) honey solution to be 
determined.  The phenol equivalent antibacterial activity of undiluted honey was 
calculated by multiplying by a conversion factor of 4.65 to account for the dilution 
(4x) and the density of honey (~1.4g/mL). 
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Figure 2.1: The Quasi-Latin square arrangement of sample and standard wells 
used in the well diffusion assay of antibacterial activity. 
 
2.5 Extraction of Flavonoids from Honey for Analysis 
The method used to extract flavonoids from honey is a variation of that developed by 
Ferreres et al.
94
  This method has been modified over the course of this study to allow 
antibacterial testing of fractions and a reduction of the sample mass required from 
fifty grams to five grams. 
2.5.1 Cleaning and Swelling of the Amberlite XAD-2 Resin 
Amberlite XAD-2 resin was cleaned by soaking in methanol overnight.  This was 
considered enough to desorb any contaminants which could later elute into the 
flavonoid fraction.  When the resin became contaminated with large particulates or 
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microbial growth it was cleaned up by swirling the resin in methanol and decanting 
off the contaminants with methanol.  This procedure allowed the resin to be cleaned 
up with minimal losses of the resin.  Smaller particulates were separated from the 
resin by filtering the resin on cotton cloth over a sieve which allowed the fine 
particulates to be washed out of the resin. 
 
Removal of the resin from solvents was achieved by filtering it on a Büchner funnel.  
While this would not completely dry the resin, it was considered enough to remove 
excess solvent. 
 
Before using the resin for extractions it was left to soak overnight in a 50% solution of 
methanol and water.  This allowed the resin to swell to its working volume.  This step 
was only necessary when the resin was dry.  Provided it was kept covered in solvent 
at all times (except when filtering on the Büchner funnel to remove excess solvent) it 
could be reused without having to swell the resin overnight. 
 
2.5.2 Testing the Flavonoid Extract of Manuka Honey for 
Antibacterial Activity 
Active manuka honey (Comvita UMF30+, ca. 50g) was mixed with acid water 
(250mL, adjusted to pH 2 with HCl) and stirred (20min) until homogenous.  The 
solution was filtered through cotton wool to remove particulates.  A glass column 
(Ø2cmx70cm) of swelled XAD-2 resin (187g dry weight) was prepared by flushing 
with Milli-Q water (400mL) to remove methanol residues.  The filtered solution was 
then poured into the glass column of XAD-2 resin and held (30min) before being 
dripped through and the eluent collected (the aqueous fraction).  The column was 
washed with acid water (250mL) and then Milli-Q water (300mL) to elute the sugars 
and other polar constituents.  The aqueous column washings were collected and 
combined with the previously collected aqueous fraction. 
 
Sodium hydroxide solution (1.0000 ±0.0002 mol/L) was added to the aqueous 
fraction to neutralise the acid water used in the extraction.  Sufficient sodium 
hydroxide solution was added to increase the pH of the aqueous fraction to that of 
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honey diluted to the same degree with water (pH 3.5 ±0.1).  This fraction was then 
concentrated to a syrupy consistency under vacuum at 35ºC. 
 
Phenolics were eluted from the resin by washing with methanol (400mL).  The eluent 
was collected and concentrated under vacuum at 35ºC before being made up to 2mL 
with Milli-Q water.  Half of this phenolic fraction (1mL) was added to clover honey 
(ca. 25g) which had been previously shown to have no detectable non-peroxide 
antibacterial activity.  This permitted the contribution that the phenolic made to the 
non-peroxide antibacterial activity of honey to be measured.   The remaining half of 
the phenolic fraction was added to clover honey (1g) to provide a test of the non-
peroxide antibacterial activity of the phenolic fraction at a concentration twenty five 
times that in the original honey.  The extraction of honey fractions for activity testing 
was done in duplicate. 
 
The manuka honey fractions, active manuka honey (Comvita UMF30+) and inactive 
clover honey were assayed for non-peroxide antibacterial activity according to the 
methods describe in Section 2.4. 
 
2.5.3 Modification of the Extraction Method to Use Smaller Honey 
Samples 
The original method
94
 called for fifty grams of honey to be extracted.  This was not 
feasible in a study of manuka honey, due to limitations on the amount of samples 
available, so the method has been modified to allow the extraction of flavonoids from 
five grams of honey. 
 
Active manuka honey (ca. 50g, 20g and 5g) was weighed out and dissolved in five 
parts acid water (pH 2 with HCl).  The solution was stirred until homogenous then 
filtered through cotton wool to remove particulates.  A glass column (Ø2cmx70cm) of 
swelled XAD-2 resin (187g dry weight) was washed with acid water (150mL) to 
remove methanol.  The honey solutions were then loaded onto the column and held 
there (1h) before being eluted. 
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The resin was washed with acid water (250mL) and then Milli-Q water (300mL) to 
elute the polar compounds.  The phenolics were eluted with methanol (650mL) until 
the eluent was no longer coloured yellow.  The eluent was collected and concentrated 
to dryness under vacuum at 40ºC before resuspending in Milli-Q water (5mL) and 
extracting with diethyl ether (5mLx3).  The resulting ether extract was concentrated to 
dryness under N2 gas at 40ºC and redissolved in methanol (2mL) before filtering 
(0.25μm syringe filter).  The filtered extract was then concentrated to dryness under 
N2 gas at 40ºC and made up to its volume with methanol (500μL for 50g extracts, 
200μL for 20g extracts and 50μL for 5g extracts).  The extracts were then analysed on 
HPLC system B using the alternative conditions described in Section 2.3.2.1.   
 
2.5.4 Final Extraction Method Applied to Analysis of Honey 
Flavonoids 
To extract flavonoids the honey sample (ca. 5g) was mixed with acid water (50mL, 
adjusted to pH 2 with HCl) and stirred until homogenous.  The resulting honey 
solution was filtered through cotton wool to remove solid particles. 
 
 Clean swelled XAD-2 resin (30g) was removed from the methanol, in which it was 
stored, on a Büchner funnel, and transferred to the filtered honey solution using acid 
water (50mL) to rinse the resin out of the funnel.  The filtered honey solution and 
resin was stirred (1h) by a magnetic stirrer, before being poured into a glass column 
(Ø2.5cmx40cm).  
 
The excess honey solution was run out of the column until the resin was just covered 
with solvent.  The resin was then washed with acid water (250mL) followed by 
deionised water (300mL) to remove sugars and polar constituents.  The phenolics 
were eluted with distilled methanol (400mL) and collected. 
 
The XAD-2 resin was left in the column, soaking in methanol, when not in use.  
When it was time to do another extraction the resin was removed by inverting the 
column and washing the resin out with methanol (methanol was found to be much 
more effective than water which caused the resin to stick to glass).  The resin was 
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then washed with acid water and partially dried under vacuum on a Büchner funnel to 
make it ready for the next extraction. 
 
The phenolic fraction was concentrated to dryness under vacuum at 40ºC, 
resuspended in deionised water (5mL) and extracted with diethyl ether (5mLx3).  The 
resulting ether extract was concentrated to dryness under N2 gas at 40º and 
redissolved in HPLC grade methanol (200μL). 
  
The extract was then submitted to a coarse separation on HPLC system A (described 
in Section 2.3.1) to filter out contaminants which were harmful to the analytical 
HPLC (system B).  The 200μL phenolic extract was injected onto the reversed phase 
HPLC system A and the fraction eluting between 1.0min and 7.0min was collected.  
The fraction recovered from the HPLC was concentrated under vacuum at 40ºC and 
redissolved in HPLC grade methanol (50μL) for analytical HPLC analysis on system 
B, as described in Section 2.3.2. 
 
2.5.5 Evaluation of Extraction Method 
2.5.5.1 Recovery Rate of Flavonoids Extracted from Solution 
To determine the extraction efficiency of the flavonoid extraction method a standard 
mixture containing quercetin dihydrate, kaempferol, pinocembrin and chrysin 
(0.5mg/5mL for each compound) was dissolved in methanol (0.5mL) and extracted 
using the method described in Section 2.5.4 as though it was a 5g sample of honey.  
This test was carried out in duplicate. 
 
The recovery rate of the reversed phase HPLC cleanup step (HPLC system A) 
developed in this study was assessed using a standard mixture of quercetin dihydrate 
(0.91mg), kaempferol (0.60mg), pinocembrin (0.88mg) and chrysin (0.56mg) 
dissolved in HPLC grade methanol (200μL).  The resulting standard solution was 
injected into the reversed phase HPLC system A as described in Section 2.3.1 and the 
recovered fraction (eluting 1.0-7.0min) was concentrated to dryness under vacuum at 
40ºC.  The dried extract was redissolved in methanol (5mL) and the recovery rate 
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determined by quantitative HPLC analysis on system B, using the method described 
in Section 2.3.2. 
 
2.5.5.2 Recovery Rate of Flavonoids Extracted from Artificial Honey 
An artificial honey was prepared in order to assess the impact of matrix effects on the 
recovery rate of the extraction method.  Chrysin (1.7mg), kaempferol (2.04mg), 
quercetin dihydrate (4.25mg), p-coumaric acid (12.54mg), gallic acid (2.77mg), 
caffeic acid (1.49mg) and chlorogenic acid (1.73mg) were weighed out and 
thoroughly mixed together.  Sucrose (5.7820g), D(+)-glucose (72.2727g) and D(-)-
fructose (80.2469g) were added to the phenolic mixture and shaken to mix 
thoroughly.  Deionised water (35mL) was added and the resulting syrup was warmed 
to 44ºC with warm tap water, and shaken until the artificial honey had a homogenous 
consistency.  This artificial honey was then extracted according to the method 
described in Section 2.5.4. 
 
2.5.5.3 Assessing the Reproducibility of the Extraction Method 
Eleven extractions of the same active manuka honey (supplied by Haddrell’s of 
Cambridge, New Zealand) were carried out over several weeks.  The quantitative 
results of these extractions were compared to assess the precision and reproducibility 
of the extraction method. 
 
2.6 Isolation of Honey Flavonoids 
2.6.1 Extraction of Phenolics Using Amberlite XAD-2 Resin 
Unknown compounds were isolated from 15kg of manuka honey.  Batches of honey 
(ca. 1kg) were dissolved in acid water (pH 2 with HCl, ca. 3L) and stirred until 
homogenous.  Clean and swelled Amberlite XAD-2 resin (500g) was added to the 
honey solution and stirred (1 hour) by a magnetic stirrer.  The resin and honey 
solution slurry was then poured into a glass column (Ø4cmx120cm) and the honey 
solution drained out.  The resin was washed with acid water (2L) and deionised water 
(1L) to remove the sugars and other polar compounds.  All the aqueous washings and 
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the honey solution were collected and later subjected to a second extraction on XAD-
2 resin. 
 
The phenolics were eluted from the resin by washing with distilled methanol (600mL) 
and then deionised water (1L).  It was observed during this study that the previously 
reported washing method which used 750mL of methanol was insufficient to recover 
all phenolics.  Increasing the volume of the methanol wash was not effective so an 
additional washing with deionised water was implemented.  This water washing was 
intended to make any remaining phenolics adsorb back onto the resin so that they 
could be eluted with the next batch of extracted phenolics 
 
The column was inverted and deionised water flushed through to wash the resin out of 
the column.  The resin was then partially dried on a Büchner funnel and added back to 
the aqueous washings to increase the recovery of flavonoids by extracting those 
compounds not recovered during the first treatment.  In this extraction process the 
honey was not filtered prior to extraction because it was found that 1kg batches of 
honey quickly overloaded the cotton wool filters used for the analytical extraction of 
honey samples.  This resulted in fine particulates building up in the resin over time 
which reduced the flow rate of the XAD-2 column.  This problem was resolved by 
washing the resin with deionised water over a cotton cloth filter which permitted the 
contaminating particulates to pass through.  The clean resin could then be scraped off 
the cloth and partially dried on a Büchner funnel to make it ready for the next 
extraction. 
 
The phenolic extracts were combined and concentrated under vacuum at 40ºC until 
the extract reached a syrupy consistency. 
2.6.2 Liquid-Liquid Extraction and Cleanup of the Extract 
The combined phenolic extract obtained from the XAD-2 resin extraction was 
resuspended in Milli-Q water (150mL).  The extract was then filtered through cotton 
wool to remove solids which had not dissolved.  The filtrate was then subjected to 
eight extractions with diethyl ether (150mL).  The ether extracts were combined and 
concentrated to dryness under vacuum at 40ºC. 
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The extract was redissolved in distilled methanol (40mL) and centrifuged (5000rpm, 
Heraeus Sepatech Medifuge) to separate out a white waxy solid.  The supernatant was 
then run through HPLC system A (described in Section 2.3.1) to filter out 
contaminants.  The extract was injected in batches (1mL) with the eluent being 
continuously collected and combined.  The combined eluent from the HPLC 
injections was concentrated to dryness under vacuum at 40ºC. 
 
2.6.3 Sephadex LH-20 Separation of the Phenolic Extract 
The flavonoids were separated from the phenolic acids by chromatography on a 
Sephadex LH-20 column according to the method described by Bohm.
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The extract was dissolved in distilled methanol (40mL) and poured into a column of 
Sephadex LH-20 (Ø4cmx30cm) which had been pre-soaked in 30% (v/v) distilled 
methanol in water.  The phenolics were then eluted and collected using increasing 
stronger methanol solutions as shown in table 2.6.  The flow rate was increased by 
applying a light head pressure with N2 gas. 
 
Table 2.6: The solvents used in Sephadex LH-20 chromatography of phenolic extract 
and the fractions collected. 
Fraction 
Number 
Solvent Strength 
(% methanol v/v in water) 
Volume of Solvent Used 
(mL) 
1 30 250 
2 30 250 
3 60 250 
4 60 250 
5 80 250 
6 80 250 
7 100 250 
8 100 250 
9 100 250 
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2.6.4 HPLC Separation of Individual Flavonoids 
Individual flavonoids were isolated from the extract using the semi-preparative HPLC 
system C, as describe in Section 2.3.3.  The extract was centrifuged (5000rmp, 
Heraeus Sepatech Medifuge) prior to injection onto the semi-prep HPLC system at 
high loading rates (up to 150μL).  Fractions were collected from the photodiode array 
outlet to isolate targeted flavonoids 
 
The flavonoids isolated from the semi-prep HPLC system were subjected to a further 
fraction collecting step on the analytical HPLC described in Section 2.3.2.  For this 
work the sample loop size was increased from 5μL to 200μL to prevent sample losses. 
 
2.7 Characterisation of Isolated Flavonoids 
2.7.1 UV-Visible Spectroscopy 
2.7.1.1  Preparation of Spectroscopic Reagents for UV-Visible Spectroscopy 
Spectroscopic reagents were prepared according to the methods published by Mabry 
et al.
93
  Anhydrous sodium acetate (Panreac, analytical grade) was ground to a 
powder and stored in a labelled vial.  Boric acid (May and Baker, reagent grade) was 
ground to a powder and stored in a labelled vial.  Powdered boric acid was added to 
methanol (20mL, Scharlau HPLC grade) until the solution was saturated.  Sodium 
metal (1.8825g, BDH, sodium sticks in paraffin) was cut into small pieces and washed 
with petroleum spirits (X4, drum grade).  The sodium metal pieces were added 
cautiously to methanol (75mL, Scharlau HPLC grade) to create a sodium methoxide 
solution.  Aluminium chloride (2.5800g, Merck, reagent grade) was added to 
methanol (52mL, Scharlau HPLC).  Concentrated hydrochloric acid (21mL, Ajax, 
36%) was diluted with distilled water (42mL).  All reagent solutions were stored in 
Schott bottles at room temperature in the dark when not being used. 
 
2.7.1.2 UV-Visible Spectroscopy of Isolated Flavonoids 
UV-Visible spectra of isolated flavonoids were recorded on a Varian Cary 100 Scan 
UV-Visible Spectrophotometer.  The spectrophotometer was operated and results 
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processed using Cary WinUV Scan Application software (version 3.00(182)).  Spectra 
were recorded in a quartz cuvette (1cmx1cmx4.5cm) which did not absorb over the 
spectral region of interest. 
 
A small amount of the isolated flavonoid (ca. 1mg) was dissolved in HPLC grade 
methanol (10mL) to create a stock solution.  The UV-visible spectrum was taken of 
this solution at a rapid scan rate (600nm/min) to check the optical density.  The 
concentration of the flavonoid solution was then adjusted so that the optical density of 
the major absorption peak (between 250-400nm) was within 0.6 to 0.8AU. 
 
The spectrum of the flavonoid stock solution (2-3mL) was measured at a normal scan 
speed (50nm/min) over the 200-500nm region.  Additional spectra were measured 
over the regions of peak maxima at a reduced scan rate (10nm/min) to determine the 
wavelength of maxima accurately. 
 
Sodium methoxide solution (3 drops) was added to the cuvette of flavonoid in 
methanol.  The spectrum was then recorded immediately at a normal scan rate.  After 
five minutes the spectrum was re-recorded to check for decomposition of the 
flavonoid.  The solution in the cuvette was then discarded. 
 
Aluminium chloride solution (6 drops) was then added to fresh flavonoid stock 
solution (2-3mL) in the cuvette.  The spectrum was then recorded at a normal scan 
rate.  Hydrochloric acid (3 drops) was then added to the cuvette containing aluminium 
chloride and flavonoid in methanol.  The spectrum was recorded again and the 
solution discarded. 
 
An excess of powdered anhydrous sodium acetate was added to fresh flavonoid stock 
solution (2-3mL) in the cuvette and shaken.  The powdered sodium acetate formed a 
layer (1-2mm) at the bottom of the cuvette.  The spectrum was recorded immediately 
and again after ten minutes to check for decomposition.   
 
Finally, an excess of powdered anhydrous boric acid was added with shaking to 
saturate the sodium acetate and flavonoid solution.  The spectrum was then recorded 
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and the solution discarded.  In cases where the flavonoid decomposed in the presence 
of sodium methoxide, a different method was used to obtain a boric acid/sodium 
acetate spectrum.  Boric acid solution (5 drops) was added to fresh flavonoid stock 
solution (2-3mL) which was quickly saturated with powdered sodium acetate and the 
spectrum recorded immediately. 
 
2.7.2 Nuclear Magnetic Resonance Spectroscopy of Isolated 
Flavonoids 
NMR spectra of isolated flavonoid samples were obtained using a Bruker Avance 
DRX fitted with a 400MHz Bruker Spectrospin superconducting magnet (52mm).  
Proton and carbon 1D experiments were carried out using a 5mm dual 
13
C/
1
H probe 
head.  Samples were thoroughly dried by freeze drying over several days and 
dissolved in dimethylsulfoxide-d6 for NMR analysis.  Operation of the NMR and 
processing of spectra were performed using Topspin software (Bruker).  
1
H, 
13
C and 
HMBC experiments were carried out. 
 
2.7.3 Mass Spectrometry of Isolated Flavonoids 
Mass spectrometry was performed by Jonathon Puddick using a Bruker Daltronics 
autoflex II MALDI-TOF mass spectrometer.  The spectrometer was operated in 
reflector mode (acceleration voltage 19kV, reflector voltage 20kV). 
 
Isolated flavonoid samples were dissolved in methanol and spotted onto an 
anchorchip (600μm, Bruker) and the methanol evaporated to leave a neat sample.  
Calibration of the spectrometer was against 2,5-dihydroxybenzoic acid ions 
(153.02Da and 307.05Da) laid on a neighbouring sample spot.  A pulsed ion 
extraction (60ns) and suppression (to 100Da) were used to obtain mass spectra of the 
samples in negative ion mode.
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 Chapter 3: Results and Discussion 
3.1 The Antibacterial Activity of Fractions from the XAD-2 
Extraction of Manuka Honey 
Activity testing of fractions obtained from the XAD-2 extraction of manuka 
honey was carried out to determine whether the non-peroxide antibacterial activity 
was eluted with the phenolics or the sugars.  Antibacterial activity was measured 
for the aqueous fraction of the extraction which contained the sugars and other 
polar compounds, and the methanol fraction which contained the phenolics 
including the flavonoids and phenolic acids.  As a comparison, the activity of the 
original manuka honey and a sample of inactive clover honey, which was used as 
an artificial matrix for the methanol fractions, were tested.  The results of the 
activity testing are shown in table 3.1 and illustrated in the graph (figure 3.1). 
 
Table 3.1: The non-peroxide antibacterial activities of fractions from the XAD-2 
extraction of manuka honey compared to the activity of the original honey. 
 Non-Peroxide Antibacterial Activity 
(% Phenol Equivalents) 
Aqueous Sugar Fraction 30.5 ± 0.7
a
 
MeOH Phenolic Fraction 1:1 No Detectable Activity
 a
 
MeOH Phenolic Fraction 25:1 37 ± 1
 b
 
Manuka Honey 30.6 ± 0.8
 a
 
Clover Honey No Detectable Activity
 b
 
 
a
Mean and 95% confidence interval from 48 determinations. 
b
Mean and 95% confidence interval from 32 determinations. 
 
It is clear that the aqueous fraction of the extraction, with an activity of 30.5 ± 0.7 
% phenol equivalents, accounts for the majority of the antibacterial activity of 
manuka honey (activity of 30.6 ± 0.8 % phenol equivalents).  The methanol 
fraction, which contained the flavonoids, did not exhibit any detectable 
antibacterial activity at the concentration it occurs in whole manuka honey.  The 
methanol fraction did exhibit an activity of 37 ± 1 % phenol equivalents when 
concentrated to levels twenty five times that which it naturally occurs in honey. 
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Figure 3.1: Graph showing the non-peroxide antibacterial activity of the XAD-2 
extraction sugar fraction, the methanol fraction at its natural concentration and 
concentrated 25 times, the original manuka honey and the inactive clover honey 
used as an artificial matrix. 
 
Weston et al.
23
 reported a similar result in 1999.  Using the XAD-2 extraction 
method developed by Ferreres et al.
94
, carried out under neutral conditions, the 
activity of antibacterial activity of carbohydrate and phenolic fractions were 
determined.  It was found that all the antibacterial activity of manuka honey eluted 
with the carbohydrate fraction while the phenolics showed no significant activity.   
 
The results of the present study and the early work by Weston et al.
23
 have shown 
that the antibacterial activity of manuka honey elutes with the carbohydrates in the 
XAD-2 extraction technique.  This is not surprising since methylglyoxal, a sugar 
decomposition product, has been identified as responsible for the non-peroxide 
antibacterial activity of manuka honey.
68, 70
  Sharing common structural features 
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with carbohydrates, methylglyoxal would be expected to elute with them and the 
other polar constituents of honey. 
 
While it is apparent that the phenolics do not make a significant contribution to 
the antibacterial activity of manuka honey, the present study has also shown that 
the phenolic fraction of manuka honey is antibacterial, if only when concentrated.  
Antibacterial activity is not the only biological activity which has been attributed 
to the flavonoids.  These natural products have been shown to have a range of 
activities including anti-inflammatory activity, oestrogenic activity, enzyme 
inhibition activity, antiallergic activity, antioxidant activity, vascular activity, 
antiviral, antithrombotic, anaesthetic activity and cytotoxic antitumour activity.
1, 
82, 86
  The flavonoids may not make a significant contribution to the antibacterial 
activity of manuka honey but they may still contribute to other therapeutic 
properties of honey. 
 
The biggest problem usually associated with the bioassay for non-peroxide 
antibacterial activity has always been the reproducibility of the antibacterial assay.  
Variation is seen between the results measured by different analysts, on different 
days, on different agar plates and even within the same plate.  A range of factors 
such as temperature, agar thickness, materials used and well positions cause an 
uncertainty level of the order of 1 % phenol equivalents in all activity 
measurements.  In the present study an effort has been made to account for these 
variations.  Two extractions on XAD-2 resin were carried out to provide two sets 
of fractions for activity testing.  These fractions were then tested on two separate 
occasions over four agar plates.  The use of the Quasi-Latin square distribution of 
wells is also standard practice in the antibacterial assay of honey and serves to 
average out effects associated with the position of individual wells on the agar 
plate (e.g. wells at the edge show less activity).  The large number of wells used 
for each sample in this study (48 for the carbohydrate and 1:1 phenolic fractions, 
and manuka honey; 32 for the 25:1 phenolic fraction and clover honey) has 
allowed the variations to be averaged out giving the 95% confidence intervals 
shown in table 3.1 (calculated using a t distribution). 
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3.2 Identification and Quantification of Flavonoids by HPLC 
Flavonoids in HPLC chromatograms were identified by their co-elution with 
authentic standards whenever possible.  The collection of standards available for 
comparison with HPLC peaks was limited and in many cases the peaks could not 
be identified beyond classifying them as flavonoids based on their UV spectra.  
Identification of these unknown flavonoids required them to be isolated, 
characterised and then used as a standard for identification of HPLC flavonoid 
peaks.  This has restricted the progress of the present study.  Other research 
groups have built up extensive collections of isolated flavonoids over time, with 
which they can compare their HPLC chromatograms of honey phenolics.  Such 
research groups have a distinct advantage in this area of research since some of 
the flavonoids, such as pinobanksin a common flavonoid in honey, are not easy to 
source commercially.  Table 3.2 shows the flavonoid peaks, their retention time 
and their UV absorption spectra maxima along with the means by which they 
were identified (by comparison with standard or isolation and characterisation). 
 
Four standards were used for the quantitative analysis of flavonoids by HPLC.  
Chrysin (at 340nm) was used as a standard for the flavones and flavonols with an 
unsubstituted B-ring.  This included the flavonol galangin, the flavone chrysin and 
their derivatives.  Similarly, kaempferol (at 340nm) was used as the standard for 
quantifying those flavones and flavonols with a single oxygen substituent on the 
B-ring.  Pinocembrin (at 290nm) was used to quantify the flavanones and 
dihydroflavonols while quercetin (at 340nm) was used as a standard for all other 
flavones and flavonols.  The standards used to quantify each flavonoid peak are 
shown in table 3.2.  Calibration curves showing the HPLC peak area versus the 
concentration of these compounds are shown in figures 3.2, 3.3, 3.4 and 3.5. 
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Table 3.2: The phenolic compounds identified and quantified by HPLC. 
Name Identification
 a
 Quantification
 b
 Rt (min)
 c
 λmax (nm)
 d
 
Flavonoids found in manuka honey samples. 
Pinobanksin I P 33.9 292 
Unknown Compound 01 NA Q 34.4 342 
Unknown Flavonoid 01 NA P 38.3 286 
Quercetin S Q 38.7 367, 256 
Luteolin S Q 39.3 350, 255 
Unknown Flavonoid 02 NA P 40.4 292 
8-Methoxykaempferol I K 41.2 375, 272 
Pinocembrin S P 41.5 290 
Unknown Flavonoid 03 NA Q 42.4 360, 258 
Unknown Flavonoid 04 NA K 43.7 361, 253 
Isorhamnetin S K 44.3 373, 255 
Kaempferol S K 45.5 364, 255 
Unknown Flavonoid 05 NA P 46.4 291 
Chrysin S C 46.7 314, 269 
Galangin S C 50.0 360, 266 
Unknown Flavonoid 06 NA C 50.6 311, 269 
Flavonoids found in non-manuka honey samples. 
Unknown Flavonoid 07 NA P 31.1 289 
Unknown Flavonoid 08 NA P 32.0 294 
Unknown Flavonoid 09 NA P 33.2 288 
Unknown Flavonoid 10 NA C 47.9 351,268 
Unknown Flavonoid 11 NA C 48.3 322, 260 
Unknown Flavonoid 12 NA C 48.6 349, 268 
Unknown Flavonoid 13 NA C 52.1 349, 268 
a
 The method used to identify the compound: S – authentic standard, I – isolation and 
characterisation and NA- not identified. 
b
 The quantification standard used for the compound: Q – quercetin, K – kaempferol, P – 
pinocembrin and C – chrysin. 
c
 The retention time of the compound on HPLC System B 
d
 The peak maxima in the UV absorbance spectrum (240-400nm) of the compound under HPLC 
System B conditions. 
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HPLC detection of flavonoids was carried out at two different wavelengths due to 
the differences in the UV-Visible absorption spectra of the flavanones and 
dihydroflavonols compared with the flavones and flavonols.  The flavone and 
flavonol class of flavonoids exhibit two major absorption bands with Band I 
usually occurring between 300 to 380nm, and Band II usually occurring between 
240 to 285nm.  The flavanones and dihydroflavonols do not exhibit a Band I 
absorption, having only the Band II absorption.  Thus it is necessary to detect the 
flavanones and dihydroflavonols at a wavelength within their Band II absorption 
for the best sensitivity.  For this experiment the wavelength of 290nm was chosen 
to be consistent with the previous work on honey flavonoids by Ferreres et al.
95
   
 
While it would also be possible to detect the flavones and flavonols at this 
wavelength, an alternative wavelength of 340nm was chosen.  The particular 
choice of 340nm is also consistent with the work of Ferreres et al.
95
 , allowing the 
results of this study to be compared to with published work.
24
  The choice of a 
detection wavelength within the Band I absorption region has the added benefit of 
improving the sensitivity of the analysis.  The Band I absorption of flavones and 
flavonols typically occurs at lower wavelengths than 290nm and they only absorb 
weakly at this wavelength.  Analysis at 340nm also reduces interference from 
phenolic acid derivatives which absorb strongly at 290nm. 
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Figure 3.2: The HPLC calibration curve of quercetin, measured at 340nm. 
 
 
Figure 3.3: The HPLC calibration curve of kaempferol, measured at 340nm. 
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Figure 3.4: The HPLC calibration curve of pinocembrin, measured at 290nm. 
 
 
Figure 3.5: The HPLC calibration curve of chrysin, measured at 340nm. 
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A problem which was frequently observed during this study was precipitation of 
standards.  Left overnight in a methanol solution, the flavonoids would often 
precipitate out.  This made quantitative analysis difficult since the concentration 
of flavonoid standards was uncertain and it could not be guaranteed that the 
sample extracts were homogenous.  To minimise this problem all standards and 
samples were warmed to 40ºC prior to analysis by HPLC.  This was enough to 
redissolve any precipitates and ensure the solution was homogenous.  
Precipitation of polyphenolic compounds appears to be a common problem.  In 
the brewing industry chill haze is a precipitate that forms when beer is chilled.  
Polyphenolics are a major contributor to this haze and much effort is made to 
remove them during the brewing process.
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3.3 Evaluation of the Extraction Method 
3.3.1 The Effect of Sample Size on Phenolic Recovery 
The Chemistry Department of the University of Waikato has a large collection of 
manuka honey samples which were made available for this study.  Unfortunately, 
the majority of these samples had only about 10 grams of honey remaining.  This 
was not enough for extraction by the XAD-2 method established by Ferreres et al. 
which uses at least 50 grams of honey.
94
  This study has attempted to scale down 
the XAD-2 extraction method to permit extraction of honey phenolics from 
samples as small as 5 grams. 
 
In order to determine the effect of sample size on phenolic recovery, multiple 
extractions of 50, 20 and 5 gram samples of the same manuka honey were carried 
out under the same conditions and the extracts were analysed by HPLC.  Table 3.3 
shows the peak areas at 340nm for the peaks eluting at 15.9 and 20.5 minutes, as 
well as the total area of the chromatogram at 340nm.  The peak areas have been 
adjusted to account for small weight differences between samples of the same 
nominal weight.  At these early stages of the research project it was not deemed 
necessary to identify and quantify the individual flavonoids in the honey extracts.  
Comparison of the total area of the chromatogram and the areas of two significant 
flavonoid peaks was used to assess the effect of sample size on honey phenolic 
recover. 
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Table 3.3: Adjusted peak areas measured at 340nm, of two significant peaks and 
the total chromatogram, for different sized sample extractions. 
Sample Size (g) Peak Area (at 340nm) 
15.9min Peak 20.5min Peak Total 
Chromatogram 
50 (3.4 ± 1.3) x 10
6
 (1.4 ± 0.8) x 10
6
 (1.7 ± 0.8) x 10
8
 
20 (3.3 ± 0.8) x 10
6
 (1.6 ± 0.3) x 10
6
 (1.9 ± 1.0) x 10
8
 
5 (3.4 ± 1.6) x 10
6
 (1.4 ± 0.7) x 10
6
 (2.1 ± 1.0) x 10
8
 
 
All the results showed a high level of variability but it is apparent that the sample 
size does not have a significant effect on the recovery of honey phenolics by the 
XAD-2 extraction method.  Calculated 95% confidence intervals for the average 
total chromatogram area at 340nm were (1.7 ± 0.8) x 10
8
 for the 50g extractions, 
(1.9 ± 1.0) x 10
8
 for the 20g extractions and (2.1 ± 1.0) x 10
8
 for the 5g sample 
extractions.  These results all agree within the limits of uncertainty, showing that 
the recovery of honey phenolics from a 5g sample is no better or worse than from 
a 50g or 20g sample.  It is also clear from the large uncertainty in these 
confidence intervals that the variation in honey phenolic recovery between 
samples of the same nominal mass is much more significant than that between 
samples of different nominal mass.  The results for the two peaks studied show 
similar large variations which are independent of the nominal sample mass.   
 
The peak areas of individual extractions are shown in figures 3.6, 3.7 and 3.8.  
These graphs illustrate that the peak area and its variation are not significantly 
affected by the size of the honey sample extracted.  This result is not surprising 
since the XAD-2 extraction is a form of solid phase extraction.  In solid phase 
extraction it would normally be expected that the recovery of target analytes 
would be greater when smaller samples are extracted.  This is because matrix 
effects are a common problem with interfering compounds (for example the 
phenolic acids in the present study) occupying the surface of the solid phase.
122
  
Thus, when large samples are analysed there is a risk that the solid phase will be 
saturated with interfering compounds, which will prevent the complete recovery 
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of the target analyte.  Smaller samples are less likely to saturate the solid phase 
with interfering compounds and should allow more complete recovery of the 
honey phenolics.  The fact that the recovery did not increase as the sample size 
decreased shows that saturation of the solid phase is not a problem for 50g 
extractions. 
 
While the high level of uncertainty in these results is a concern, it is not sufficient 
reason to restrict the XAD-2 extraction method to honey samples of 50g or larger 
since the variability in the recovery of phenolics is independent of the sample size.  
Extracting phenolics from the smaller sample size of 5g meant that a much larger 
stock of samples could be analysed.  Many of these samples could not have been 
extracted if 50g of honey was required. 
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Figure 3.6: Total chromatogram area at 340nm, of the phenolics extracted from 
differently sized samples. 
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Figure 3.7: Area of the 15.9min phenolic peak extracted from differently sized 
samples, measured at 340nm. 
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Figure 3.8: Area of the 20.5min phenolic peak extracted from differently sized 
samples, measured at 340nm. 
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3.3.2 The Recovery Rate of Flavonoids 
It had been previously reported, by those who developed the XAD-2 extraction 
method for honey phenolics, that the technique recovered honey phenolics at more 
than 80%.
1, 24, 104, 107
  An experiment was carried out in order to assess the 
recovery rate of flavonoids for the modified extraction method developed in this 
study.  To test the recovery rate of flavonoids an artificial honey, a mixture of 
glucose, fructose, sucrose and water, was prepared with known levels of 
quercetin, kaempferol and chrysin added.  The phenolic acids p-coumaric acid, 
chlorogenic acid, gallic acid and caffeic acid were also added.  This artificial 
honey was considered a good model for the complex matrix that is real honey.  
Extraction of the phenolics from this artificial honey allowed the recovery rates 
shown in table 3.4 to be determine. 
 
The results show that the extraction method employed in this study is very 
inefficient at recovering the flavonoids from an artificial honey matrix.  Quercetin 
was only recovered at an average rate of 10 ± 6% while kaempferol and chrysin 
were recovered at the slightly higher rates of 16 ± 7% and 19 ± 9% respectively.  
These results are significantly lower than the >80% recovery rate reported by 
other groups.
1, 24, 104, 107
  This could possibly be due to the more sophisticated 
method used to test the recovery rate in this study.  The previously reported work 
does not specify how the recovery rate was determined.  Work by D’Arcy 
reported recovery rates of 38% for quercetin, 88% for chrysin and 92% for 
hesperetin.  These were measured by simply mixing a methanol solution of 
flavonoid standards with XAD-2 resin.
1
  Honey is a complex matrix and no matrix 
effects were accounted for in the earlier work.  The present study has attempted to 
account for the effects of the honey matrix by measuring the recovery of 
flavonoids from an artificial honey matrix.  It is possible that other components of 
the honey including the carbohydrates and phenolic acids could interfere with the 
extraction of flavonoids and reduce their recovery rate. 
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Table 3.4: The recovery rate of flavonoids from an artificial honey matrix. 
Sample Name Quercetin Kaempferol Chrysin
AA Ext Eff 16.38% 16.91% 15.33%
AB Ext Eff 3.38% 6.68% 10.63%
AC Ext Eff 17.69% 21.82% 24.87%
AD Ext Eff 9.13% 7.80% 10.86%
AF Ext Eff 15.40% 27.92% 36.85%
AG Ext Eff 4.07% 14.58% 14.34%
AH Ext Eff 4.87% 14.36% 21.25%
Mean 10% 16% 19%
S.D. 6% 7% 9%
95% C.I. 6% 7% 9%
% Recovery Rate
 
 
The large amount of carbohydrates could potentially carry some of the flavonoids 
through the XAD-2 extraction, preventing them from binding to the resin and 
causing them to elute with the aqueous fraction.  Honey also contains a lot of 
phenolic acids which also adsorb onto the resin.  If there are sufficient phenolic 
acids in the honey then they can overload the resin, preventing flavonoids from 
being adsorbed and thus reducing their recovery. 
 
A large degree of variance was observed in these results.  The standard deviation 
was greater than 40% of the mean for all three of the flavonoid recovery rates 
determined.   A possible reason for this variance was thought to be inconsistencies 
in the artificial honey.  It is very difficult to prepare a homogenous artificial honey 
due to its syrupy nature.  Despite the great care taken in this study to mix the dry 
ingredients together thoroughly before adding water, it is possible that the 
flavonoids are not evenly spread throughout the artificial honey.  This would 
explain why the recovery rate appeared to be so highly variable since higher 
recovery rate results would come from artificial honey with higher levels of 
flavonoids (compared to the average level for the whole honey). 
 
To further investigate the possibility that matrix effects may be limiting the 
recovery rate of flavonoids, the recovery rate was measured using the method 
described by D’Arcy.1  Flavonoid standards were dissolved in methanol and 
mixed with XAD-2 resin to extract the phenolics.  Two such standard solutions 
were put through the whole extraction process, including filtration on HPLC 
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system A.  The recovery rates of the quercetin, pinocembrin, kaempferol and 
chrysin from these standard solutions are shown in table 3.5.  The table shows an 
additional result which was measured for a standard solution which was put 
through the cleanup step on HPLC system A. 
Table 3.5: The recovery rate of flavonoids from a simple solution.  Two standard 
solutions were put through the whole extraction process and one was put only 
through the final HPLC cleanup step. 
Extraction Type Quercetin Pinocembrin Kaempferol Chrysin
Whole Extraction 1 38 60 39 45
Whole Extraction 2 28 48 34 35
HPLC Cleanup Step 60 88 66 75
% Recovery Rate
 
The recovery rate for quercetin was measured at 38 and 28% in two tests of the 
entire extraction process.  These values were well short of the >80% recoveries 
reported by the Tomas-Barberan et al.
24, 104, 107
  They do however compare well 
with the average quercetin recovery rate of 38% reported by D’Arcy.1  Both 
results are within the range of 16-65% measured by D’Arcy. 
 
Kaempferol was recovered at a rate of 39 and 35% in this experiment.  These 
recovery rates are similar to quercetin which is not unsurprising given their 
structural similarities (kaempferol has one less hydroxyl group).  These values are 
below the >80% recovery rate reported by in the literature. 
24, 104, 107
 
 
The other flavone studied, chrysin, was recovered at rates of 45 and 35%.  Both 
measurements were again well below the >80% reported in the literature.  D’Arcy 
reported recovery rates in the range of 85-99%, much higher than those measured 
in the present study. 
1, 24, 104, 107
 
 
The other flavonoid recovery rate measured in this study was that of pinocembrin.  
Pinocembrin is a flavanone while the others were flavones and flavonols.  The 
difference in flavonoid class had a noticeable effect on the recovery rate.  The 
flavanone pinocembrin was recovered at rates of 60 and 48% which were 
significantly higher than those found for the flavones and flavonols studied.  The 
recovery rate of the flavanone was still outside the > 80% rate reported in the 
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literature.  While D’Arcy1 did not measure the recovery rate of pinocembrin, 
recovery rates of 84-95% were reported for the flavanone hesperetin.  These rates 
are significantly higher than those found in the present study. 
1, 24, 104, 107
 
 
These recovery rates were much higher than those measured for the flavonoids in 
an artificial honey matrix.  This suggests that matrix effects may have an 
influence on the recovery of flavonoids.  More research is needed to confirm this 
however, since the low recovery of flavonoids from the artificial honey could still 
be due to an inhomogeneous distribution of flavonoids in the artificial honey.  
 
With the exception of quercetin, the extraction method used in this study was not 
achieving the same recovery rates reported by other groups.  The HPLC cleanup 
step that was introduced in this study was identified as an area where loss of 
phenolics could occur.  This cleanup step was implemented after it was found that 
running phenolic extracts through the analytical HPLC caused the 
chromatography conditions to deteriorate as an unidentified contaminant built up 
on the column and interfered with analysis.  This contaminant was removed by 
injecting dimethyl sulfoxide into the system and the cleanup step was 
implemented to filter out the contaminant before extracts were analysed.  The 
recovery of flavonoids from this step was measured by running a methanol 
solution, containing measured levels of flavonoids, through the cleanup step and 
measuring the levels remaining post cleanup. 
 
The results of the cleanup recovery test are shown in table 3.5.  The recovery rates 
were found to be 60, 88, 66 and 75% for quercetin, pinocembrin, kaempferol and 
chrysin respectively.  These results show that significant amounts (up to 40%) of 
the flavones and flavonols are lost in the cleanup step.  The flavanone 
pinocembrin appeared to be less affected by the cleanup step, only losing 12%.  
Clearly the HPLC cleanup step is making a significant contribution to the loss of 
flavonoids in the extraction method.  The cleanup step was kept in the extraction 
method despite this loss because it was very effective at protecting the analytical 
HPLC column.  Contamination problems which were a constant recurring 
problem before the implementation of the cleanup step did not occur once the 
samples were cleaned up on the sacrificial reversed phase HPLC column. 
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The low recovery rates found in this experiment are a concern.  If only 28% of 
some flavonoids are being recovered then there is significant uncertainty in the 
quantitative levels of flavonoids reported for honeys analysed in this study.  It is 
highly likely that the actual levels of flavonoids will be higher than those 
measured in this study. 
 
3.3.3 The Reproducibility of the Extraction Method 
The experiments evaluating the modified XAD-2 extraction method discussed in 
Sections 3.3.1 and 3.3.2 showed that the extraction method gave results with 
relatively high levels of variability.  To investigate this variability and assess the 
reproducibility of the method, a bulk manuka honey sample was extracted eleven 
times over several weeks.  The results of these analyses are shown in table 3.6. 
 
The total flavonoid content was observed to vary within the range of 0.64 to 
1.20mg/100g with a standard deviation of 0.18mg/100g.  This standard deviation 
equates to a coefficient of variation of 19% showing that the results are subject to 
a high level of variability.  The standard deviations for most of the individual 
flavonoid contents showed a similar level of variability with the coefficients of 
variation being between 10 and 37% for pinobanksin, luteolin, pinocembrin, 
isorhamnetin, chrysin and the unknown flavonoids 01-06. 
 
The kaempferol, galangin and unknown compound 01 contents showed higher 
levels of variation with coefficients of variation as large as 87, 73 and 115%.  The 
higher level of variation in the kaempferol and galangin levels, compared to the 
other flavonoids, is probably due to a combination of small peak areas and overlap 
with other closely eluting peaks.  This made integration of these peaks difficult 
and could have contributed to the high level of variation observed.  The 
kaempferol peak was particularly difficult to integrate and could not be identified 
in 7 of the 11 extractions studied due to its small peak area and overlap with the 
isorhamnetin and unknown flavonoid 05 peaks.  The unknown compound 01 
content variability cannot be explained by small peak areas and overlapping 
peaks.  This compound produced large, resolved peaks in most of the manuka 
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Table 3.6: The results of multiple analyses of the flavonoid content of a manuka honey sample. 
PB UN01 F01 Q L F02 8MK PC F03 F04 IRM K F05 C G F06 Total
A 0.223 0.020 0.061 0.090 0.017 0.102 0.009 0.013 0.023 0.013 0.082 0.025 0.016 0.695
B 0.317 0.049 0.091 0.099 0.025 0.208 0.011 0.022 0.035 0.039 0.140 0.037 0.051 1.123
C 0.207 0.023 0.039 0.020 0.164 0.007 0.015 0.025 0.021 0.095 0.003 0.017 0.635
D 0.250 0.098 0.077 0.082 0.021 0.180 0.008 0.021 0.027 0.029 0.123 0.052 0.039 1.008
E 0.270 0.048 0.053 0.083 0.025 0.171 0.015 0.018 0.030 0.003 0.017 0.097 0.042 0.022 0.895
F 0.328 0.070 0.086 0.099 0.023 0.204 0.012 0.025 0.038 0.010 0.021 0.130 0.054 0.030 1.130
G 0.328 0.191 0.082 0.090 0.028 0.192 0.009 0.021 0.037 0.007 0.022 0.121 0.037 0.030 1.195
A1 0.305 0.007 0.051 0.075 0.017 0.182 0.012 0.012 0.028 0.022 0.102 0.008 0.018 0.838
B1 0.332 0.010 0.041 0.105 0.020 0.185 0.018 0.016 0.031 0.039 0.119 0.010 0.038 0.963
A2 0.359 0.013 0.062 0.097 0.030 0.231 0.015 0.017 0.035 0.027 0.149 0.012 0.026 1.072
B2 0.290 0.007 0.058 0.086 0.019 0.176 0.015 0.013 0.035 0.026 0.031 0.128 0.007 0.028 0.919
Mean 0.292 0.049 0.064 0.091 0.022 0.181 0.012 0.017 0.031 0.011 0.026 0.117 0.026 0.029 0.952
S.D.b 0.049 0.056 0.018 0.009 0.004 0.032 0.003 0.004 0.005 0.010 0.008 0.021 0.019 0.011 0.179
95% C.I.c 0.033 0.037 0.012 0.006 0.003 0.022 0.002 0.003 0.003 0.007 0.006 0.014 0.013 0.007 0.120
C.V.(%)d 16.7 114.6 28.2 10.3 19.0 17.9 29.2 23.4 16.2 87.2 32.6 17.6 73.0 36.7 18.8
%e 30.6 5.1 6.7 9.5 2.3 19.1 1.2 1.8 3.3 1.2 2.7 12.3 2.7 3.0
Concentration of flavonoids (mg/100g of honey)aExtraction 
Number
 
a
  PB – pinobanksin (3,5,7-trihydroxyflavanone), UN01 – unknown compound 01, F01 – unknown flavonoid 01, Q – quercetin (3,5,7,3,4-pentahydroxyflavone), L – luteolin 
(5,7,3,4-tetrahydroxyflavone), F02 – unknown flavonoid 02, 8MK – 8-methoxykaempferol (3,5,7,4-tetrahydroxy-8-methoxyflavone), PC – pinocembrin (5,7-dihydroxyflavone), 
F03 – unknown flavonoid 03, IRM – isorhamnetin (3,5,7,4-tetrahydroxy-3-methoxyflavone), F04 – unknown flavonoid 04, K – kaempferol (3,5,7,4-tetrahydroxyflavone), F05 – 
unknown flavonoid 05, C – chrysin (5,7-dihydroxyflavone), G – galangin (3,5,7-trihydroxyflavone), F06 – unknown flavonoid 06. 
b
  Standard deviation. 
c
  95% confidence interval for 11 determinations  
d
  Coefficient of variation (standard deviation/mean x 100%).  
e
  Individual flavonoid level as a percentage of total flavonoid content. 
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samples studied (see Section 3.4.4).  While it did occur in lower levels (compared 
to other manuka honeys) in the particular sample used for this experiment, it still 
gave a large peak which equated to 5.1% of the total flavonoid content.  An 
alternative reason for the large variation in results for this compound could be that 
it is not a flavonoid.  The UV spectrum of unknown compound 01 shows a single 
absorbance with a maximum absorption occurring at 342nm.  This spectrum does 
not show the expected Band I and II absorptions of the flavones and flavonols; or 
the single Band II absorption of the flavanones and dihydroflavonols.  Thus it is 
probably not a flavonoid and should not be expected to have the same extraction 
properties as the flavonoids. 
 
While the majority of the flavonoids showed less variation than kaempferol, 
galangin and unknown compound 01, they still showed a significant level of 
variation which will have an impact on the results of this study.  Possible reasons 
for this variation are: 
 
 The recovery rates measured in Section 3.3.2 show that, at best, the extraction 
method only recovers 60% of the flavonoids and recovery rates were a lot less in 
most cases.  A consequence of low recovery rates is lower concentrations of 
flavonoids in the phenolic extract.  If the flavonoids were recovered at higher 
rates then flavonoid content would be higher and the variation should be less 
significant. 
 The quality and history of the XAD-2 resin used in this study was not known.  It 
is feasible that the resin was not extracting at its peak performance.  This would 
explain the low recovery rates and contribute to variation in extraction results. 
 An important source of variation in this experiment is the human operator.  The 
extraction of phenolics from honey is a complicated procedure involving many 
steps, some of which are quite difficult.  Transferring the XAD-2 resin from 
beaker to column, and vice versa, should be a simple procedure but it is 
hampered by the tendency of the resin to stick to glass when in aqueous 
conditions.  While every effort was made to standardise the extraction method it 
is inevitable that minor differences would occur between extractions, ultimately 
contributing to the large variation seen in results. 
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This experiment has shown that a single extraction of a honey sample is unlikely 
to provide a reliable estimate of the flavonoid profile.  The standard deviations 
were on average, 20% of the mean values (ignoring kaempferol, galangin and 
unknown compound 01).  For the purposes of this study, an uncertainty estimate 
of 20% will be applied to all flavonoid contents from analysis of a single sample. 
 
3.4 The Flavonoid Profile of New Zealand Honeys 
The flavonoid profile was determined for New Zealand manuka (Leptospermum 
scoparium) honey and a range of other New Zealand honeys. 
3.4.4 Manuka Honey 
A total of 31 different manuka honey samples were analysed to determine a 
flavonoid profile for manuka honey.  The results of this study are shown in table 
3.7.  The total flavonoid content of manuka honey was found to be, on average, 
1.16 ± 0.16mg/100g of honey.  The total flavonoid content varied between 0.59 
and 2.24mg/100g with a standard deviation of 0.46mg/100g.  This is several 
orders of magnitude higher than the 0.0147mg/100g total flavonoid content 
reported by Weston et al.
121
  The result found in this study is much closer to that 
reported by Yao et al.
24
 (3.06mg/100g of honey).  Yao et al. have previously 
explained that the differences in these results are probably due to incomplete 
extraction of honey flavonoids by Weston et al.
23, 121
  Martos et al.
104
 has reported 
that at least 100g of Amberlite XAD-2 should be used for extraction of phenolics 
from 100g of honey.
104
  In the study by Weston et al.
121
, only 54-60g of resin was 
used to extract phenolics from 150-236g of honey.
23, 121
  In the present study, 30g 
of XAD-2 was used to extract phenolics from 5g samples of honey.  This was a 
considerably higher ratio of resin to honey than used by Yao et al. (150g XAD-2 
for 100g of honey).
24
  Despite the large excess of resin used in this study, the 
recovery rates of flavonoids were found to be 60% at most, and a lot less for most 
of the flavonoids studied (see Section 3.3.2).  The low recovery rate of flavonoids 
experienced in this study is considered to be the reason for the differences in 
flavonoid content measured between this study and that by Yao et al.
24
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Table 3.7: The flavonoid content of New Zealand manuka (Leptospermum scoparium) honey.   
PB UN01 F01 Q L F02 8MK PC F03 F04 IRM K F05 C G F06 Total
ACT5+ 7.7 0.343 0.109 0.058 0.000 0.114 0.037 0.013 0.200 0.013 0.016 0.020 0.017 0.006 0.102 0.027 0.009 1.083
UMF10 11.1 0.313 0.152 0.065 0.020 0.130 0.036 0.017 0.213 0.013 0.029 0.026 0.019 0.009 0.118 0.052 0.016 1.229
UMF15 15.8 0.365 0.126 0.071 0.031 0.163 0.040 0.025 0.206 0.023 0.046 0.030 0.038 0.014 0.207 0.083 0.014 1.482
UMF20 17.1 0.392 0.240 0.062 0.115 0.138 0.042 0.004 0.231 0.018 0.092 0.034 0.146 0.012 0.442 0.051 0.016 2.036
UMF25 22.9 0.224 0.205 0.043 0.040 0.169 0.028 0.008 0.128 0.023 0.036 0.030 0.072 0.005 0.246 0.020 0.007 1.285
UMF30 27 0.200 0.279 0.039 0.016 0.147 0.015 0.010 0.112 0.013 0.016 0.016 0.012 0.006 0.081 0.021 0.008 0.990
BD12.5 13.8 0.585 0.420 0.094 0.037 0.268 0.040 0.036 0.337 0.030 0.044 0.042 0.027 0.016 0.168 0.072 0.020 2.235
BD15.2 17.7 0.297 0.188 0.039 0.049 0.121 0.023 0.020 0.157 0.018 0.024 0.024 0.072 0.004 0.151 0.033 0.011 1.231
BD21.1 20 0.166 0.229 0.047 0.006 0.202 0.027 0.010 0.129 0.015 0.020 0.017 0.013 0.008 0.081 0.038 0.013 1.021
BD28.8 27.3 0.144 0.254 0.058 0.002 0.111 0.022 0.014 0.137 0.010 0.016 0.016 0.006 0.012 0.086 0.023 0.011 0.923
M01 25.3 0.062 0.130 0.027 0.013 0.110 0.015 0.005 0.070 0.007 0.018 0.009 0.007 0.004 0.075 0.034 0.008 0.594
M03 23.6 0.262 0.232 0.075 0.014 0.334 0.062 0.019 0.227 0.020 0.040 0.025 0.022 0.020 0.168 0.078 0.024 1.622
M05 17.5 0.279 0.183 0.068 0.020 0.160 0.033 0.009 0.146 0.023 0.032 0.028 0.021 0.006 0.103 0.043 0.008 1.162
M09 17.7 0.240 0.138 0.082 0.043 0.170 0.043 0.016 0.127 0.020 0.042 0.017 0.016 0.003 0.070 0.030 0.005 1.062
M10 13.9 0.310 0.274 0.066 0.051 0.172 0.045 0.016 0.197 0.018 0.037 0.031 0.019 0.010 0.104 0.053 0.013 1.417
M11 14.8 0.254 0.291 0.064 0.000 0.133 0.047 0.011 0.191 0.015 0.029 0.023 0.016 0.009 0.090 0.042 0.010 1.225
M12 14.9 0.197 0.123 0.048 0.010 0.174 0.058 0.000 0.142 0.007 0.025 0.015 0.012 0.009 0.082 0.047 0.011 0.960
M14 10.9 0.141 0.088 0.060 0.012 0.051 0.026 0.005 0.110 0.006 0.017 0.009 0.006 0.003 0.043 0.016 0.006 0.599
M15 15.3 0.125 0.158 0.067 0.035 0.211 0.035 0.015 0.102 0.012 0.022 0.013 0.016 0.003 0.052 0.021 0.005 0.894
M17 14.2 0.273 0.105 0.112 0.000 0.082 0.063 0.000 0.176 0.000 0.012 0.013 0.000 0.003 0.038 0.017 0.005 0.899
M18 14.2 0.336 0.092 0.129 0.000 0.092 0.098 0.009 0.312 0.017 0.017 0.025 0.000 0.010 0.099 0.054 0.011 1.302
M20 1 0.340 0.039 0.034 0.017 0.029 0.018 0.083 0.239 0.010 0.017 0.017 0.011 0.003 0.051 0.016 0.004 0.927
M21 9.2 0.291 0.073 0.081 0.000 0.047 0.029 0.004 0.186 0.000 0.010 0.014 0.000 0.006 0.047 0.017 0.008 0.813
Concentration of flavonoids (mg/100g of honey)a
Sample UMF
 
Continued on page 78. 
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Table 3.7 (Continued from page 77): The flavonoid content of New Zealand manuka (Leptospermum scoparium) honey.   
PB UN01 F01 Q L F02 8MK PC F03 F04 IRM K F05 C G F06 Total
M22 8.3 0.235 0.075 0.075 0.000 0.051 0.017 0.000 0.164 0.000 0.008 0.014 0.000 0.007 0.046 0.015 0.005 0.711
M23 9.3 0.211 0.087 0.052 0.000 0.064 0.010 0.002 0.129 0.006 0.008 0.011 0.002 0.003 0.032 0.011 0.004 0.631
M26 7.3 0.325 0.004 0.056 0.017 0.128 0.023 0.007 0.185 0.014 0.018 0.017 0.016 0.004 0.064 0.022 0.004 0.904
M27 7.3 0.276 0.063 0.054 0.000 0.171 0.050 0.011 0.248 0.011 0.026 0.024 0.021 0.016 0.133 0.054 0.018 1.178
M29 8 0.284 0.081 0.059 0.000 0.048 0.026 0.007 0.177 0.005 0.012 0.015 0.031 0.005 0.060 0.022 0.005 0.837
M32 5.9 0.269 0.059 0.057 0.000 0.098 0.057 0.008 0.181 0.007 0.009 0.015 0.004 0.007 0.048 0.018 0.003 0.841
M34 4.5 0.309 0.051 0.044 0.000 0.131 0.061 0.003 0.018 0.004 0.012 0.021 0.008 0.005 0.063 0.020 0.004 0.754
NCG 0.264 0.064 0.049 0.000 0.144 0.045 0.005 0.198 0.007 0.016 0.019 0.021 0.004 0.061 0.024 0.005 0.926
Mean 0.267 0.157 0.061 0.024 0.136 0.038 0.012 0.174 0.013 0.029 0.022 0.032 0.008 0.131 0.035 0.010 1.155
S.D.b 0.098 0.096 0.021 0.043 0.062 0.018 0.014 0.064 0.008 0.029 0.009 0.051 0.005 0.132 0.020 0.005 0.461
95% C.I.c 0.036 0.034 0.008 0.015 0.022 0.006 0.005 0.023 0.003 0.010 0.003 0.018 0.002 0.047 0.007 0.002 0.164
C.V. (%)d 36.9 61.3 34.7 175.8 45.7 47.4 120.7 36.6 60.8 99.5 43.3 161.5 60.3 100.4 56.4 56.8 39.9
%e 23.1 13.6 5.3 2.1 11.8 3.3 1.0 15.1 1.2 2.5 1.9 2.7 0.7 11.4 3.0 0.8
Concentration of flavonoids (mg/100g of honey)a
Sample UMF
 
a
  PB – pinobanksin (3,5,7-trihydroxyflavanone), UN01 – unknown compound 01, F01 – unknown flavonoid 01, Q – quercetin (3,5,7,3,4-pentahydroxyflavone), L – luteolin 
(5,7,3,4-tetrahydroxyflavone), F02 – unknown flavonoid 02, 8MK – 8-methoxykaempferol (3,5,7,4-tetrahydroxy-8-methoxyflavone), PC – pinocembrin (5,7-dihydroxyflavone), 
F03 – unknown flavonoid 03, IRM – isorhamnetin (3,5,7,4-tetrahydroxy-3-methoxyflavone), F04 – unknown flavonoid 04, K – kaempferol (3,5,7,4-tetrahydroxyflavone), F05 – 
unknown flavonoid 05, C – chrysin (5,7-dihydroxyflavone), G – galangin (3,5,7-trihydroxyflavone), F06 – unknown flavonoid 06. 
b
  Standard deviation. 
c
  95% confidence interval from 31 determinations.  
d
  Coefficient of variation (standard deviation/mean x 100%).  
e
  Individual flavonoid level as a percentage of total flavonoid content. 
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The flavonoid profile of the manuka honeys studied mainly consisted of 
pinobanksin (0.27 ± 0.04mg/100g honey), pinocembrin (0.17 ± 0.02mg/100g 
honey), luteolin (0.14 ± 0.02mg/100g honey) and chrysin (0.13 ± 0.02mg/100g 
honey).  Together these main flavonoids represent 61% of the total flavonoid 
content (1.16 ± 0.16mg/100g honey).  Unknown compound 01, while not a 
flavonoid, was also found at relatively high levels, representing an average of 
14% of the total flavonoid content.  Eleven other flavonoids including quercetin, 
8-methoxykaempferol, isorhamnetin, kaempferol, galangin and the unknown 
flavonoids 01-06, occurred at lower levels in the manuka honeys studied.  
Chromatograms of a manuka honey sample (at 340nm and 290nm) are shown in 
figures 3.9 and 3.10.  Expanded views of the regions where flavonoids eluted are 
shown in figure 3.11.  The large unresolved peaks seen in the 290nm 
chromatogram at 22 and 26 minutes are phenolic acid derivatives.  These were too 
concentrated in the extracts studied so no attempt was made to quantify them. 
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Figure 3.9:  The full chromatogram of the M01 manuka honey sample, measured 
at 340nm. 
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Figure 3.10:  The full chromatogram of the M01 manuka honey sample, measured 
at 290nm. 
 
 
Flavonoids are: (1) pinobanksin, (2) unknown compound 01, (3) unknown flavonoid 01, (4) 
luteolin, (5) unknown flavonoid 02, (6) pinocembrin, (7) unknown flavonoid 03, (8) unknown 
flavonoid 04, (9) unknown flavonoid 05, (10) chrysin and (11) galangin. 
Figure 3.11: Expanded views of regions of the manuka honey extract 
chromatogram with flavonoids labelled. 
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The flavonoid results show similarities and differences when compared to 
previous studies of the flavonoid profile of manuka honey.  Weston et al.
23, 121
 
found only the propolis derived flavonoids pinocembrin, pinobanksin, chrysin and 
galangin in a study of 19 manuka honeys.  All these flavonoids were identified in 
the 31 manuka honeys analysed in the present study.  The present study has found 
eleven flavonoids in manuka honey which were not observed by Weston et al.
23, 
121
 
 
As explained earlier, the study by Weston et al.
23, 121
 under-reported the levels of 
flavonoids in manuka honey due to problems with the extraction method used.  
The results of the present study show a stronger resemblance to those of Yao et 
al.
24
 which identified quercetin (13.8%), isorhamnetin (12.9%), an unknown 
flavanone (12.7%), chrysin (12.6%) and luteolin (12.6%) as the main components 
of two manuka honey samples.
24
  The present study has also identified chrysin 
and luteolin as two of the main components (after pinocembrin and pinobanksin).  
In contrast however, isorhamnetin and quercetin were only found at low levels in 
the present study.  Pinobanksin, which was the main component of the manuka 
honey flavonoids in the present study, was not observed in the two manuka honey 
samples analysed by Yao et al.
24
 
 
A possible reason for the low levels of isorhamnetin and quercetin found in the 
present study is a low recovery rate of these flavonoids by the extraction method.  
It is interesting to note that, in this study, the flavones luteolin, and chrysin were 
found at levels over three times that of their flavonol counterparts, quercetin and 
galangin.  It is possible that the presence or absence of a 3-hydroxyl group on the 
flavonoid has a significant effect on its recovery rate, with higher rates being 
achieved for those flavonoids without 3-hydroxyls.  The results of the recovery 
rate tests described in Section 3.3.2 show a similar result with the flavone chrysin 
having slightly higher recovery rates (35-45%) than the flavonols quercetin (28-
38%) and kaempferol (34-39%).  When the experiment was designed it was 
thought that the oxygenation of the flavonoid B-ring would have a greater effect 
on the recovery rate since it is the oxidation pattern of the B-ring which has the 
greatest effect on HPLC retention times.  This lead to a selection of standards with 
different levels of B-ring oxygenation for the recovery rate testing.  In hindsight, 
it would have been useful to include luteolin and galangin in the recovery rate 
87 
 
tests.  This would have allowed the effect of hydroxylation at C-3, on the recovery 
rate, to be measured by comparison with quercetin and chrysin respectively.   
 
The high recovery rate observed for the flavanone pinocembrin (48-60%) also 
suggests that the oxidation level of the C-3 link of flavonoids may have an effect 
upon recovery rate. In the present study of 31 manuka honeys, a total of six 
unidentified flavonoids were found at mostly low levels.  From UV-spectra 
recorded on the photodiode array HPLC detector, it was found that three of the 
unidentified flavonoids were either flavanones or dihydroflavonols.  Of these two 
classes of flavonoids, only pinocembrin, pinobanksin and hesperetin have been 
previously identified in honeys.  Pinocembrin and pinobanksin were identified as 
other peaks in the manuka honey chromatogram, and it is unlikely that hesperetin 
will be in manuka honey since it has been exclusively found in citrus honey, for 
which it is an established floral marker.  The three unidentified flavanone and 
dihydroflavonols in the present study are therefore not likely to have been 
observed in honey before.  It is possible that the modified extraction method used 
in this study preferentially extracted the flavanones and dihydroflavonols over the 
flavones and flavonols, the difference between these classes being the oxidation 
level of the C-3 link 
 
In their study of two manuka honeys, Yao et al.
24
 observed two unknown 
flavonoids which they could not identify.  These two flavonoids had not been 
previously observed in any of the honeys they had profiled, except for Australian 
jelly bush (Leptospermum polygalifolium).  The Australian jelly bush is closely 
related to the New Zealand manuka tree, with both species belonging to the 
Leptospermum genus.  The research group of Tomas-Barberan are arguably the 
world leaders in honey phenolic profiling and have an extensive catalogue of 
honey flavonoids with which to compare their unknowns.  The unknown 
flavonoids that they found in Leptospermum honeys therefore have great potential 
to be floral markers for these honeys.  The UV absorption spectra presented for 
these unknowns
24
 show the single Band I absorptions characteristic of the 
flavanone and dihydroflavonol classes of flavonoids.
24
  Three of the unidentified 
flavonoids found in the present study show UV absorption spectra characteristic 
of these flavonoid classes.  Flavanones and dihydroflavonols do not show the 
same variation in their UV absorption spectra as do the flavones and flavonols.  
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This, and the different HPLC conditions used in the two studies, makes it difficult 
to correlate the unknown flavonoids of the present study with those reported by 
Yao et al.
24
 
3.4.5 Comparison with Other New Zealand Honeys 
For a comparison with manuka honey, a selection of eight other New Zealand 
honeys were analysed to determine flavonoid profiles.  This selection included 
rata (Metrosideros spp.), rewarewa (Knightia excelsa), beech (Nothofagus spp.) 
honeydew, clover (Trifolium spp.), kamahi (Weinmannia racemosa), viper’s 
bugloss (Echium vulgare), thyme (Thymus vulgare) and nodding thistle (Carduus 
nutans) honeys.  The flavonoid profiles of these honey samples are shown in table 
3.8. 
 
Only one sample of each type was analysed so the results cannot be considered 
proof of unique markers for the non-manuka honey types.  They do however serve 
as a useful comparison with manuka honey.  With the exception of the viper’s 
bugloss sample, all the honeys show a common flavonoid profile with manuka  
honey.  The main components of this profile are pinobanksin and pinocembrin 
with a number of other flavonoids also being common to all the New Zealand 
honey types.  Pinocembrin and pinobanksin were also found in viper’s bugloss 
honey at significant levels but isorhamnetin and unknown flavonoid 04 were the 
main constituents. 
 
Pollen analysis data was supplied with the non-manuka samples and is shown in 
table 3.9.  The pollen analysis shows that, with the exception of the thyme honey, 
the non-manuka honeys studied were highly monofloral.  This suggests that the 
common flavonoid profile observed in these honeys cannot be due to common 
nectar sources.  It is more likely that the common flavonoid profile is derived 
from propolis.  This is not surprising since pinocembrin and pinobanksin, along 
with chrysin, galangin and tectochrysin, have been reported as the main 
constituents of honeys produced in temperate areas of the Northern Hemisphere.  
These flavonoids accumulate in the bud exudates of poplars and are incorporated 
into honeys through propolis.
104
  While Populus species are not native in New 
Zealand they have been imported and it appears that imported bee colonies seek  
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Table 3.8: The flavonoid content of some non-manuka New Zealand honeys.   
PB UN01 F01 Q L F02 8MK PC F03 F04 IRM K F05 C G F06 Total
Rata 0.027 0.009 0.006 0.017 0.006 0.042 0.002 0.004 0.005 0.025 0.005 0.005 0.156
Rew arew a 0.239 0.008 0.012 0.007 0.004 0.017 0.013 0.189 0.009 0.013 0.018 0.009 0.004 0.061 0.024 0.008 0.656
Honeydew 0.065 0.036 0.012 0.023 0.002 0.020 0.066 0.009 0.013 0.004 0.002 0.016 0.016 0.291
Clover 0.214 0.039 0.059 0.016 0.246 0.017 0.019 0.010 0.004 0.047 0.013 0.006 0.705
Kamahi 0.029 0.001 0.006 0.016 0.011 0.045 0.004 0.009 0.002 0.027 0.004 0.002 0.155
Vipers Bugloss 0.028 0.005 0.006 0.002 0.010 0.012 0.009 0.030 0.008 0.044 0.094 0.010 0.006 0.016 0.010 0.004 0.298
Thyme 0.127 0.004 0.019 0.015 0.007 0.023 0.070 0.031 0.086 0.021 0.004 0.031 0.011 0.005 0.488
Nodding Thistle 0.297 0.035 0.059 0.068 0.020 0.262 0.013 0.148 0.000 0.019 0.005 0.068 0.022 0.006 1.044
Manuka Honey 
Meanb 0.267 0.157 0.061 0.024 0.136 0.038 0.012 0.174 0.013 0.029 0.022 0.032 0.008 0.131 0.035 0.010 1.155
95% C.I.c 0.036 0.034 0.008 0.015 0.022 0.006 0.005 0.023 0.003 0.010 0.003 0.018 0.002 0.047 0.007 0.002 0.164
Honey Type
Concentration of flavonoids (mg/100g of honey)a
 
a
  PB – pinobanksin (3,5,7-trihydroxyflavanone), UN01 – unknown compound 01, F01 – unknown flavonoid 01, Q – quercetin (3,5,7,3,4-pentahydroxyflavone), L – luteolin 
(5,7,3,4-tetrahydroxyflavone), F02 – unknown flavonoid 02, 8MK – 8-methoxykaempferol (3,5,7,4-tetrahydroxy-8-methoxyflavone), PC – pinocembrin (5,7-dihydroxyflavone), 
F03 – unknown flavonoid 03, IRM – isorhamnetin (3,5,7,4-tetrahydroxy-3-methoxyflavone), F04 – unknown flavonoid 04, K – kaempferol (3,5,7,4-tetrahydroxyflavone), F05 – 
unknown flavonoid 05, C – chrysin (5,7-dihydroxyflavone), G – galangin (3,5,7-trihydroxyflavone), F06 – unknown flavonoid 06. 
b
  Mean individual flavonoid level in manuka honey. 
c
  95% confidence interval, from 31 determinations, of the individual flavonoid level in manuka honey. 
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out these exotic trees as a source of resinous material for producing propolis.
103
  A 
study by Markham et al. identified pinobanksin, pinocembrin, chrysin, galangin, 
pinobanksin-3-acetate, pinocembrin-7-methyl ether, chrysin -7-methyl ether and 
galangin-7-methyl ether as the flavonoids in New Zealand propolis collected from 
beehives.
123
  The results of the present study indicate that propolis derived flavonoids 
are a common feature of all the New Zealand honeys studied. 
 
Table 3.9: Pollen analysis data for the non-manuka samples profiled.  The honeydew 
honey did not contain pollen and no data was available for the nodding thistle honey. 
Honey Type % of Total Pollen 
Count From 
Nominal Floral 
Source 
Rata 79.1 
Rewarewa 38.3 
Clover 87.5 
Kamahi 85.1 
Viper’s Bugloss 87 
Thyme 18 
 
 
Despite the common propolis-derived flavonoids of all the honey types studied, it 
may still be possible to distinguish manuka honey from other New Zealand honeys.  
The total flavonoid content of manuka honey was relatively high at 1.16 ± 
0.16mg/100g of honey.  Of the other honey types studied only the nodding thistle 
honey sample had a similar total flavonoid content of 1.04 mg/100g of honey.  The 
other honey samples contained total flavonoid contents between 0.71 and 
0.16mg/100g of honey.  These apparent differences in total flavonoid content could be 
used, in conjunction with other results, to distinguish manuka honey from other types 
of honey. 
 
While luteolin was present in seven of the eight non-manuka honey types studied, the 
levels were lower than half the average luteolin content found in manuka honey 
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(0.136 ± 0.022mg/100g honey).  The unknown compound 01 is also a potential 
marker for manuka honey.  It was found in five of the other honey types studied but at 
levels less than 0.04mg/100g of honey.  In contrast, manuka honey had an average 
unknown compound 01 content of 0.16 ± 0.03mg/100g honey. 
 
Luteolin (in conjunction with other flavonoids) has been previously identified as part 
of unique flavonoid profiles for Australian Eucalyptus honeys and several other 
Australian honey types.
24, 105, 114, 115
  Yao et al.
24
 have suggested that Australasian 
Leptospermum honeys may be distinguished from these other honeys by the lack of 
tricetin in their flavonoid profile and the presence of an unknown flavanone instead.
24
   
 
The presence of high levels of luteolin and unknown compound 01, along with a high 
total flavonoid content are potential marker compounds for manuka honey.  Further 
investigation is needed to identify unknown compound 01 before it can be confirmed 
as a marker for manuka honey. 
 
In addition to the six unknown flavonoids found in manuka honey, a further seven 
were found in the non-manuka honey samples which did not coincide with any of the 
standards available.  Table 3.10 shows the levels of these six unknown flavonoids in 
non-manuka honeys.  These flavonoids were not observed in the manuka honeys 
studied but may still have been present at low levels.  The chromatogram of the 
phenolic extract of manuka honey was complex and had large levels of phenolic acids 
which hindered the analysis of flavonoids eluting early in the flavonoid profile.  
Unknown flavonoids 07-09 in particular would have eluted in this region so it is 
possible that they were in manuka honey but were not detected under the noise of this 
region.  The flavonoid profile of these other New Zealand honey types should be 
investigated using a larger number of samples to determine if they are potential floral 
markers. 
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Table 3.10: The levels of some unknown flavonoids found in non-manuka New 
Zealand honeys. 
F08 F08 F09 F10 F11 F12 F13
Rata 0.002
Rew arew a 0.022
Honeydew 0.007
Clover 0.006 0.008
Kamahi 0.002
Vipers Bugloss 0.004 0.005 0.004
Thyme 0.024 0.008 0.002
Nodding Thistle 0.003 0.011 0.008
Honey Type
Concentration of flavonoids (mg/100g of 
honey)a
 
 
3.4.6 The Relationship of Flavonoid Profile with the UMF 
Antibacterial Activity of Manuka Honey 
As well as investigating the flavonoid profile of manuka honey for potential floral 
markers, there was also an interest in determining if there was any relationship 
between flavonoid profile and non-peroxide antibacterial activity.  This source of this 
activity has previously been identified as high levels of methylglyoxal.
68, 70
  It has 
recently been reported that the methylglyoxal in manuka honey is formed from 
dihydroxyacetone which has been traced to the nectar of manuka flowers.
124
  It has 
been known for some time that the dilution of manuka honey with nectar from other 
sources proportionally decreases the antibacterial activity.  A large range of L. 
scoparium varieties exist and it has been postulated that the nectar of these varieties 
produce different levels of antibacterial activity in honeys derived from them.
125
  It is 
feasible that any manuka nectar derived flavonoids in manuka honey will show a 
positive correlation with antibacterial activity.  Statistical analysis was used to 
compare the flavonoid profiles of the manuka honeys to their UMF non-peroxide 
antibacterial activity.  Scatter plots of UMF versus the concentration of individual 
manuka honey flavonoids are shown in figure 3.12
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Top row (left to right): pinobanksin, unknown compound 01, unknown flavonoid 01, quercetin. 
Second row (left to right): luteolin, unknown flavonoid 02, 8-methoxykaempferol, pinocembrin. 
Third row (left to right): unknown flavonoid 03, unknown flavonoid 04, isorhamnetin, kaempferol. 
Bottom row (left to right): unknown flavonoid 05, chrysin, galangin. 
Figure 3.12: Scatter plots of UMF non-peroxide antibacterial activity versus concentrations of individual manuka honey flavonoids. 
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The best relationship was observed between UMF and the levels of unknown 
compound 01.  Figure 3.13 shows an enlarged scatter plot of UMF versus unknown 
compound 01 concentration.  A straight line of best fit applied to the data appeared to 
go through the 20% uncertainty limits of most of the data points.  This result suggests 
that there may be a relationship between UMF and unknown compound 01.  Future 
work should focus on identifying unknown compound 01. 
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Figure 3.13: Scatter plot of unknown compound 01 concentration versus UMF non-
peroxide antibacterial activity. 
 
Luteolin also showed a potential linear relationship with UMF.  This is illustrated in 
figure 3.14 which shows luteolin concentration versus UMF non-peroxide activity.  
The linear relationship between these variables is not as strong as that for unknown 
compound 01 (R
2
 of 0.2268 compared with an R
2
 of 0.3645 for unknown compound 
01) but the line of best fit still passes within the uncertainty limits of most results. 
 
These linear relationships support the identification of luteolin and unknown 
compound 01 as marker compounds for manuka honey.  UMF non-peroxide 
antibacterial activity is largely restricted to manuka honey (some viper’s bugloss 
honeys also possess this activity however).  The recent discovery that this activity 
originates from dihydroxyacetone in the nectar of manuka flowers
124
 suggests that 
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higher incorporation of manuka nectar into manuka honey may cause higher levels of 
antibacterial activity.  As a consequence of this, it can be expected that flavonoids 
derived from manuka nectar will also be concentrated in highly active honeys. 
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Figure 3.14: Scatter plot of luteolin concentration versus UMF non-peroxide 
antibacterial activity. 
 
3.5 Isolation of Unknown Flavonoids 
One of the problems which had to be overcome in this study was a limited range of 
authentic flavonoid standards.  These standards were needed to identify the flavonoids 
in manuka honey by their co-elution and matching UV absorbance spectra in 
chromatograms of the honey phenolic extracts.  A number of flavonoid peaks were 
identified in the HPLC chromatograms which did not coincide with the available 
authentic standards.  To identify these unknown flavonoids it was necessary to isolate 
them as individual compounds and characterise them using the methods described in 
Sections 2.6 and 2.7. 
 
Isolation of flavonoids proceeded with the extraction of phenolics from 15kg of 
manuka honey on Amberlite XAD-2 resin.  The phenolic extract obtained from this 
procedure contained a large amount of insoluble material which was removed by 
extracting the phenolics from an aqueous solution with diethyl ether.  This afforded an 
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extract containing flavonoids and phenolic acid derivatives, the phenolic acid 
derivatives being present in much greater quantities.  Separation of the flavonoids 
from the phenolic acids was achieved by chromatography on Sephadex-LH20 resin.  
The phenolic acids eluted early, in a weak solvent while the flavonoids were 
concentrated in fractions 6 to 9.  Figure 3.15 shows the chromatogram of fraction 8, 
recorded at 340nm on HPLC system B.  It is clear that the fraction is largely free from 
the phenolics which elute in the first 30 minutes of the chromatography. 
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Figure 3.15: A HPLC chromatogram (340nm) of fraction 8. 
 
While there are a large number of flavonoids in fractions 6 to 9, many more than were 
detected in the analytical study of manuka honey flavonoids, time limitations meant 
that only two peaks were isolated in sufficient quantity for characterisation.  
Flavonoid A was obtained from fraction 7 by collecting the major peak eluting 
between 23.0-25.9min on the semi-prep HPLC system C (as shown in figure 3.16).  
This peak was further purified on HPLC system B where it eluted at 42.0 minutes.  A 
chromatogram of the final purified flavonoid A is shown in figure 3.17. 
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Figure 3.16: HPLC system C chromatogram of fraction 7 showing the collected 
fraction. 
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Figure 3.17: HPLC system B chromatogram of flavonoid A. 
 
Flavonoid B was obtained from the 15.5-17.0min peak (on HPLC system C) of 
fraction 6.  The collected fraction is shown in figure 3.18.  As with flavonoid A, this 
flavonoid was also purified on HPLC system B.  A chromatogram of the final purified 
flavonoid B, eluting at 34.8min is shown in figure 3.19. 
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Figure 3.18: HPLC system C chromatogram of fraction 6 showing the collected 
fraction. 
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Figure 3.19: HPLC system B chromatogram of flavonoid B. 
 
3.6 Characterisation of Unknown Flavonoids 
The two flavonoids isolated in this study were characterised using a combination of 
UV-Visible absorption spectroscopy, NMR spectroscopy and LDI-TOF mass 
spectrometry. 
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3.6.7 Flavonoid A 
3.6.7.1 UV-Visible Spectroscopy 
The UV spectra of flavonoid A in methanol and after the addition of sodium 
methoxide are shown in figure 3.20.  The methanol spectrum showed a Band II 
absorption at 271.1nm, a Band I absorption at 373.4nm and an additional minor 
absorption peak at 322.5nm.  The presence of both Band I and Band II absorptions 
showed that flavonoid A belongs to the flavone or flavonol classes (rather than the 
flavanone or dihydroflavonol classes which have only Band II absorptions).  The 
location of Band I in the region of 352-385nm is consistent with a flavonol rather than 
a flavone (Band I: 304-350nm). 
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Figure 3.20: The UV-Visible spectra of flavonoid A in methanol, before and after the 
addition of sodium methoxide. 
 
Further information about flavonoid A can also be gathered from its UV absorption 
spectrum in methanol.  A summary of this information is as follows: 
 Band II was a single peak without high wavelength shoulders.  This suggested that 
the B-ring did not have a 3,4- or 3,4,5- oxygenation pattern. 
 The long wavelength of the absorption bands suggests that flavonoid A is highly 
oxygenated and probably has a 5-hydroxyl. 
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Addition of sodium methoxide caused bathochromic shifts of Band I (32nm) and 
Band II (9nm) with an increase in intensity being observed for both peaks.  The 
increased intensity of Band I was suggestive of a free 4-hydroxyl, though the shift 
was smaller than expected (40-65nm).  No decomposition was observed when the 
sodium methoxide spectrum was re-recorded after five minutes, showing that 
flavonoid A did not possess an oxygenation pattern unstable in alkali.  Thus the 
presence of 3 and 4-hydroxyls were ruled out. 
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Figure 3.21: The UV-Visible spectra of flavonoid A in methanol, reacted with AlCl3 
and AlCl3/HCl reagents. 
 
The UV spectra of flavonoid A reacted with AlCl3 is shown in figure 3.21.  Addition 
of this reagent caused a bathochromic shift (60nm) of Band I to 434nm.  This shift is 
due to the formation of aluminium complexes with o-dihdroxyl, 3-hydroxyl-4-keto 
and/or 5-hydroxyl-4-keto functionalities.  Acidification with HCl did not change the 
spectra (also shown in figure 3.21) so it can be concluded that flavonoid A does not 
contain any o-dihdroxyl groups since the acid conditions disrupt only this type of 
complex.  The large bathochromic shift remaining (60nm) was consistent with 
complexation of a 3-hydroxyl-4-keto group (50-60nm).  This complex is formed 
preferentially to the 5-hydroxyl-4-keto complex so a 5-hydroxyl-4-keto group is still 
possible in flavonoid A. 
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Figure 3.22: The UV-Visible spectra of flavonoid A in methanol, reacted with NaOAc 
and NaOAc/H3BO3 reagents. 
 
The spectrum of flavonoid A reacted with sodium acetate is shown in figure 3.22.  
The bathochromic shift (6nm) of Band I to 277nm is consistent with a free 7-hydroxyl 
group (5-20nm shift).  Addition of H3BO3 caused the spectrum to return to that of 
flavonoid A in methanol.  This indicated that flavonoid A did not have any o-
dihdroxyl groups, except possibly at the C-5,6 position which does not form 
complexes with H3BO3. 
 
In summary, the UV spectral analysis yielded the following information about 
flavonoid A: 
 Highly oxygenated, probably with hydroxyls at the 3, 5, 7 and 4 positions. 
 No o-dihdroxyl groups, except possibly at the 5, 6 position. 
3.6.7.2 1H NMR Spectroscopy 
An assigned 
1
H NMR spectrum of flavonoid A, in DMSO-d6, is presented in figure 
3.23.  The spectrum is remarkably simple due to the small number of protons present 
in flavonoid A and the limited short range coupling between them.  Table 3.11 shows 
the chemical shift, multiplicity, integral and relative integral of the signals belonging 
to flavonoid A. 
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Firstly, the doublet of doublets centred at 6.99 and 8.09ppm occur in the region of the 
spectrum usually associated with B-ring protons (6.7-7.9ppm).  The doublet of 
doublet multiplicity pattern of these signals is consistent with a B-ring which is only 
substituted at the 4-position.  The 3J coupling constant (9.2Hz) for the 6.99 and 
8.09ppm doublets was the same for both signals confirming that they are coupling to 
each other.  The constant compares well with the 8.5Hz coupling constant reported for 
flavonoids with a 4-oxygenated B-ring.93 
 
Table 3.11: 
1
H NMR signals of flavonoid A. 
Label Chemical 
Shift (ppm) 
Multiplicity Relative 
Integral 
a 3.85 s 3 
b 6.30 s 1 
c 6.99 d 2 
d 8.09 d 2 
e-h 9.46 s 1 
e-h 10.15 s 1 
e-h 10.66 s 1 
e-h 12.18 s 1 
 
 
The large singlet at 3.85ppm is characteristic of a methoxyl group (3.5-4.1ppm) and 
the integral confirms that the proton environment producing this signal is a methyl 
group.  The other important signal in this spectrum is the singlet at 6.30ppm which 
belongs to a proton on the A-ring of flavonoid A.   
The lack of any long range W coupling in this signal is further proof that all but one 
of the A-ring positions are substituted.  These results suggest a flavonoid with a 
highly substituted A-ring. The remaining flavonoid A signals belong to the hydroxyl 
protons.  There are four such signals in the spectrum providing further confirmation 
(along with the methoxyl signal) that the flavonoid is highly substituted. 
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Figure 3.23: The 
1
H NMR spectrum of flavonoid A in DMSO-d6
104 
 
3.6.7.3 LDI-TOF Mass Spectrometry 
The highly conjugated nature of the flavonoids makes them ideal for mass spectral 
analysis by LDI-TOF.  Their strong absorbance of UV light meant that a matrix was 
not required to acquire a mass spectrum of flavonoid A.  The mass spectrum of 
flavonoid A produced a major ion with m/z of 315.079.  This is consistent with a 
tetrahydroxy-monomethoxyflavone (C16H12O7) which has a molecular mass of 316.06 
and would produce an [M-H]
-
 ion at m/z 315.06. 
 
3.6.7.4 Final Structural Assignment of Flavonoid A 
From the UV spectra, NMR spectrum and MS data it was deduced that flavonoid was 
a flavonol with a B-ring monosubstituted at the 4-position; and a trisubstituted A-
ring.  Three of these substitutions were simple hydroxyl groups while the fourth was a 
methoxyl group.  Since it was identified as a flavonol by UV analysis there was also a 
free 3-hydroxyl group. 
 
UV analysis showed that flavonoid A did not contain any o-dihydroxyl groups, except 
possibly at the 5,6-position.  It also showed that the flavonoid hydroxyls at the 5,7 and 
4-positions.  The doublet of doublets in the NMR spectrum showed that the methoxyl 
was not on the B-ring and must therefore have been on the A-ring at either the 6 or 8-
position.  These results leave two possible structures for flavonoid A: 8-
methoxykaempferol or 6-methoxykaempferol.  Table 3.12 shows UV absorbance 
spectral maximums for these compounds which have reported previously. 
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Figure 3.24: The 
13
C and 
1
H NMR assignment with HMBC correlations, of 8-methoxykaempferol, the proposed identity of flavonoid A
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Table 3.12: The UV absorption spectra of 6-methoxykaempferol, 8-
methoxykaempferol and flavonoid A in methanol. 
Absorption Maxima (nm) 
6-
methoxykaempferol
126
 
8-
methoxykaempferol
94
 
Flavonoid A 
256sh 257sh  
269 274 271.0 
 325 322.5 
366 375 373.4 
 
The UV spectrum of flavonoid A most closely resembles that of 8-
methoxykaempferol but the three spectra are very similar and flavonoid A cannot be 
conclusively characterised. 8-methoxykaempferol has been previously identified in 
honeys, while 6-methoxykaempferol has not been reported in honey.  Thus it would 
seem that identifying flavonoid A as 8-methoxykaempferol is a sensible conclusion.  
Further proof, in the form of a 
13
C NMR spectrum and HMBC correlation experiment, 
were obtained and confirmed that flavonoid B is 8-methoxykaempferol.  The structure 
of 8-methoxykaempferol, along with the 
13
C and 
1
H NMR shifts and HMBC 
correlations, is shown in figure 3.24. 
3.6.8 Flavonoid B 
3.6.8.1 UV Visible Spectroscopy 
The UV spectra of flavonoid B in methanol and after the addition of sodium 
methoxide are shown in figure 3.25.  The methanol spectrum showed a Band II 
absorption at 291.6nm, and no Band I absorption.  The absence of a Band I absorption 
showed that flavonoid B belongs to the flavanone or dihydroflavonol classes (rather 
than the flavone or flavonol classes which have both Band I and Band II absorptions).   
 
Addition of sodium methoxide caused a bathochromic shift (25nm) to 326nm with an 
increase in intensity being observed.  The bathochromic shift on addition of sodium 
methoxide showed that the A-ring was hydroxylated.  The small size of this shift 
(25nm) suggested that free hydroxyls were present at both the 5 and 7-positions 
(expect a 55-60nm shift if there is no free 5-hydroxyl).  No decomposition was 
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observed so flavonoid B probably does not have an unstable 5,6,7 or 5,7,8-
oxygenation pattern. 
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Figure 3.25: The UV-Visible spectra of flavonoid B in methanol, before and after the 
addition of sodium methoxide. 
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Figure 3.26: The UV-Visible spectra of flavonoid B in methanol, reacted with AlCl3 
and AlCl3/HCl reagents. 
 
The UV spectra of flavonoid B reacted with AlCl3 are shown in figure 3.26.  Addition 
of this reagent caused a bathochromic shift (24nm) of Band II to 316nm.  This shift is 
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due to the formation of aluminium complexes with o-dihdroxyl, 3-hydroxyl-4-keto 
and/or 5-hydroxyl-4-keto functionalities in the A-ring.  Acidification with HCl did not 
change the spectra (also shown in figure 3.26) so it can be concluded that flavonoid B 
does not contain any o-dihdroxyl groups in the A-ring since the acid conditions 
disrupt only this type of complex.  The presence of B-ring o-dihdroxyl groups could 
not be determined since there is no Band-I absorption.  The bathochromic shift 
remaining (25nm) was consistent with complexation of a 5-hydroxyl-4-keto group 
(20-26nm).  The 3-hydroxyl-4-keto group complex is less stable than the 5-hydroxyl-
4-keto group complex which is formed preferentially.  A consequence of this is that 
the presence or absence of a 3-hydroxyl could not be determined by UV analysis. 
 
The spectrum of flavonoid B reacted with sodium acetate is shown in figure 3.27.  
The bathochromic shift (34nm) of Band II to 326nm is consistent with free hydroxyls 
at both the 5 and 7-positions (34-37nm shift).  Addition of H3BO3 caused the 
spectrum to return to that of flavonoid B in methanol.  This indicated that flavonoid B 
did not have any o-dihdroxyl groups on the A-ring (except possibly at the 5,6-
postion).  It is not possible to identify B-ring o-dihdroxyl groups in flavanones and 
dihydroflavonols by UV analysis. 
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Figure 3.27: The UV-Visible spectra of flavonoid B in methanol, reacted with NaOAc 
and NaOAc/H3BO3 reagents. 
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In summary, the UV spectral analysis yielded the following information about 
flavonoid B: 
 Free hydroxyls at the 5 and 7-position. 
 No o-dihdroxyl group at the 7,8-position and therefore no free 8-hydroxyl. 
 
3.6.8.2  1H NMR Spectroscopy 
An assigned 
1
H NMR spectrum of flavonoid B, in DMSO-d6, is presented in figure 
3.28.  Table 3.13 shows the chemical shift and multiplicity of the signals belonging to 
flavonoid B. 
 
The two doublets centred at 4.58ppm and 5.14ppm was characteristic of the 
dihydroflavonol 3-H and 2-H protons.  A flavanone in contrast would be expected to 
have a H-3 signal further upfield at about 2.8ppm.  These doublets had matching 
3
J 
coupling constants (11.2Hz) confirming that these doublets arise from vicinal proton  
environments.  The large coupling constant is characteristic of a 1,2-diaxial proton 
arrangement.  This shows that the dihydroflavonol is in the R, 
R-absolute configuration at C-2 and C-3.
93
 
 
Table 3.13: 
1
H NMR signals of flavonoid B. 
Label Chemical 
Shift (ppm) 
Multiplicity 
a-c 7.36-7.44 2
nd
 order 
d 5.14 d 
e 4.58 d 
f 5.85 d of d 
g 7.51 d of d 
h 5.80 Under f signal 
i or j 10.15 s 
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Figure 3.28: The 1H NMR spectrum of flavonoid B in DMSO-d6.
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Two doublets of doublets were also observed in the spectrum.  These were centred at 
5.85ppm and 7.51ppm, within the region associated with A-ring protons.  The 
appearance of these signals as doublets of doublets was unexpected since the UV 
results had suggested that the A-ring was hydroxylated at the 5 and 7-positions.  This 
would leave the H-6 and H-8 protons which were expected to show long range W 
coupling with each other by appearing as doublet signals.  The observation of the 
doublet of doublet signal multiplicity can be explained by coupling of H-6 and H-8 
with the hydroxyl protons at the 5 and 7-positions.  Normally coupling with hydroxyls 
is not observed due to rapid exchange of the hydroxyl proton with water.  The 
DMSO-d6 used in this study was of a high grade which contained very little water.  
The small water peak observed in the spectrum is due to traces of water in the dried 
flavonoid B.  Under such conditions it is possible to observe coupling between the 
hydroxyl and aromatic protons.
127
 
 
The spectrum showed one well separated hydroxyl signal at 10.15ppm and what 
appeared to be a second under the 5.85ppm doublet of doublet signal.  For a 
dihydroflavonol with hydroxyls at the 5 and 7-position the NMR spectrum would be 
expected to show three hydroxyl signals.  It is possible that the third signal has been 
shifted downfield, out of the analysed range, by hydrogen bonding with the DMSO-d6 
solvent.
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A complex second order pattern is observed between 7.36-7.44ppm which was 
attributed to the B-ring protons.  The complexity of this signal suggested that the B-
ring of flavonoid B was unsubstituted. 
 
3.6.8.3 LDI-TOF Mass Spectrometry 
The LDI-TOF mass spectrum of flavonoid B showed two principal ions (m/z 271.371 
and m/z 272.366).  The more intense m/z 271.371 ion has been attributed to the [M-
H]
-
 ion while the other m/z 272.366 ion is thought to be a radical [M]
•-
 ion.  These 
results were consistent with a trihydroxyflavanone (C15H12O5) which has a molecular 
weight of 272.07. 
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3.6.8.4 Final Structural Assignment of Flavonoid B 
 
From the UV and 
1
H NMR spectroscopy, and mass spectrometry carried out on 
flavonoid B the following structural features have been identified: 
 Flavonoid B is a dihydroxyflavonol. 
 The A-ring has free hydroxyls at the 5 and 7-poistions. 
 The B-ring is probably not substituted. 
 There is no hydroxyl group at the 8-position. 
 Flavonoid B has three hydroxyl groups. 
 Flavonoid B has the R,R-absolute configuration at C-2 and C-3. 
 
From this information it was deduced that flavonoid B was 3,5,6-trihydroxyflavanone, 
more commonly known as pinobanksin.  The structure of this dihydroflavonol is 
shown in figure 3.29.  It is a common flavonoid in honey which originates from 
poplar bud exudates derived propolis.
12, 103
 
 
 
Figure 3.29: The structure of pinobanksin, the proposed identity of flavonoid B. 
 
There was sufficient flavonoid B isolated to achieve a good 
13
C NMR analysis.  The 
chemical shifts recorded in this analysis are shown in table 3.14 along with reported 
chemical shift values for pinobanksin from the literature.
128
  The chemical shift values 
show a good correlation confirming that flavonoid B is pinobanksin.  
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Table 3.14: A comparison of the 
13
C NMR spectra of flavonoid B and pinobanksin. 
Carbon  
Number 
Pinobanksin 
(in CDCl3)
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Flavonoid B 
(in DMSO-d6) 
2 83.5 83.7 
3 72.5 72.3 
4 196.0 197.5 
5 163.6 164.2 
6 96.9 97.4 
7 167.5 169.5 
8 96.0 96.4 
9 163.0 163.2 
10 100.5 100.7 
1 130.5 129.4 
2 127.6 128.1 
3 128.6 128.8 
4 129.2 129.0 
5 128.6 128.8 
6 127.6 128.1 
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Chapter 4: Conclusions 
 
All the non-peroxide antibacterial activity of manuka honey was found to elute with 
the carbohydrate fraction when phenolics were extracted from honey using Amberlite 
XAD-2 resin.  The phenolic fraction did not exhibit any measurable activity at its 
natural concentration but did show significant antibacterial activity when concentrated 
(see Section 3.1).  This showed that the phenolics in honey do possess some 
biological activity but are not a major contributor to the non-peroxide antibacterial 
activity. 
 
Modifications were made to the established XAD-2 method
104
 for extraction of 
phenolics from honeys.  Measurements of the phenolic content recovered by 
extraction of 50, 20 and 5g samples showed that recovery of phenolics was unaffected 
by the sample size extracted.  The changes made to the method reduced the sample 
size required from 50g to only 5g (Section 3.3.1).  This opened up a larger range of 
manuka honey samples, which would otherwise have been considered too small, to be 
extracted and analysed for flavonoid profiling. 
 
Measurement of the recovery rates of flavonoids raised some concerns about the 
reliability of the XAD-2 phenolic extraction method.  Extraction of flavonoid 
standards from an artificial matrix resulted in recovery rates of 10 ± 6% for quercetin, 
16 ± 7% for kaempferol and 19 ± 9% for chrysin (see Section 3.3.2).  Higher recovery 
rates of 28-60% were obtained for flavonoids extracted from simple methanol 
solutions using the methods established in the literature.
1
  This result has raised the 
possibility that matrix effects have been reducing the recovery of flavonoids by the 
extraction method, with the recovery rates reported in the literature not reflecting the 
true rates.   
 
The extraction rates measured in this study (28-60%) were lower than the >80% 
previously reported in the literature
104
, suggesting that the extraction method 
employed in this study needs further optimization to maximize the recovery of 
phenolics.  One aspect of the extraction method which is known to have reduced the 
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recovery rates of flavonoids was a coarse separation on a sacrificial HPLC column, 
used instead of filtering to remove contaminants from the phenolic extracts.  
Recovery rates of flavonoids from this step were found to be 60% for quercetin, 88% 
for pinocembrin, 66% for kaempferol and 75% for chrysin (see Section 3.3.2). 
 
The results of the recovery rate assessment and general observations in the later 
analysis of manuka honey flavonoids have suggested that the recovery rate of 
flavonoids may be more affected by the class of the flavonoid (i.e. the oxidation state 
of the C3 linkage) than its overall polarity.  The flavanones were observed to be 
recovered at the highest rates while the flavonols were recovered at the lowest rates 
and consequently only occurred at trace levels when honey extracts were analysed.  
The flavones appeared to be recovered at higher rates than the flavonols, but not the 
flavanones. 
 
Repeated extractions were carried out on a single honey sample to assess the 
reproducibility of the extraction method (see Section 3.3.3).  Extractions were found 
to be highly variable and several reasons, including low recovery rates and 
complicated extraction procedures, were suggested to explain the variability.  
Estimates of mean flavonoid content, for a particular sample, could be made by 
applying an uncertainty of 20% to the measurement from a single extraction of that 
sample. 
 
Analysis of the phenolic extracts from 31 samples of New Zealand manuka 
(Leptospermum scoparium) honey allowed a common flavonoid profile to be 
established for this honey type (see Section 3.4).  The total flavonoid content of 
manuka honey was found to range between 0.59-2.24mg/100g of honey, with an 
average of 1.16 ± 0.16mg per 100g of honey.  The flavonoid profile of manuka honey 
was found to mainly consist of pinobanksin (0.27 ± 0.04mg/100g honey), 
pinocembrin (0.17 ± 0.02mg/100g honey), luteolin (0.14 ± 0.02mg/100g honey) and 
chrysin (0.13 ± 0.02mg/100g honey), which together represented 61% of the total 
flavonoid content.  With the exception of luteolin, these flavonoids are known to 
originate in propolis derived from poplar bud exudates and are a common feature of 
honeys from temperate areas of the Northern Hemisphere.
103
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Eleven other flavonoids were found in the manuka honeys studied, including eight 
which did not coincide with the available authentic standards.  Two of these unknown 
flavonoids were subsequently isolated using a combination of XAD-2 extraction, 
liquid-liquid extraction, Sephadex-LH20 chromatography and HPLC (see Section 
3.5).  Characterisation of these flavonoids was achieved by UV absorption 
spectroscopy, 
1
H and 
13
C NMR spectroscopy, and LDI-TOF mass spectrometry (see 
Section 3.6).  These results lead to the identification of the unknown flavonoids as 8-
methoxykaempferol and pinobanksin, two flavonoids which have been previously 
reported in other many other honeys.
1, 12, 103, 111, 118
 
 
Phenolic extracts from eight samples of non-manuka, New Zealand honeys were 
analysed and their flavonoid profiles compared with that of manuka honey (see 
Section 3.4.5).  All the honeys studied showed similarities in their flavonoid profile, 
with pinocembrin and pinobanksin being the major constituents.  This shows that 
propolis is the main source of flavonoids in these New Zealand honeys.  Since 
propolis is the same in all types of floral honey, these propolis derived flavonoids are 
of no use in determining floral origin of honeys. 
 
 
A further seven flavonoids were found in the non-manuka honeys which did not 
coincide with the standards available and consequently could not be identified.  While 
they only occurred at low levels they also showed some variations with floral origin.  
It is possible that some of these flavonoids could be useful floral markers. 
 
Manuka honey can be distinguished from the other New Zealand honeys studied (see 
Section 3.4.5) by a combination of its high total flavonoid content, high luteolin 
content (higher than 0.05mg/100g of honey) and high levels of an unknown 
compound 01 which did not coincide with the standards available .  This compound 
was found to elute with the flavonoids at high levels (0.16 ± 0.03mg/100g of honey) 
in manuka honey.  It was clear from the UV absorption spectrum that this compound 
was not a flavonoid but further characterisation could not be achieved. 
 
Statistical analysis showed that a positive correlation existed between the 
concentration of unknown compound 01 and the non-peroxide antibacterial activity in 
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manuka honeys.  A similar relationship was observed for the luteolin levels in the 
manuka honeys studied (Section 3.4.6).  These correlations confirm the usefulness of 
unknown compound 01 and luteolin as marker compounds for manuka honey.  The 
correlation between these flavonoids the non-peroxide antibacterial activity of 
manuka honey could prove useful in future investigations into the source of this 
activity.  
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Chapter 5: Recommendations 
 
The results of this study have raised a number of concerns about the reliability and 
reproducibility of the XAD-2 phenolic extraction method.  The low recovery rates 
experienced in this study did not compare well to some of those reported in the 
literature.
24, 104
  To investigate the cause of these low recovery rates the extraction 
method needs to first be carried out exactly as described by these other researchers, 
and the flavonoid recovery rate measured.  If the recovery rate is not >80% then the 
following steps should be taken to attempt to improve the recovery rate: 
 The XAD-2 resin should be thoroughly cleaned by soxhlet extraction with methanol 
and acetone.  D’Arcy1 has previously described a method for this purification of the 
resin. 
 If cleaning the resin fails to improve the recovery rate then new resin should be 
used. 
 The volume of solvents required to optimise the recovery of flavonoids should be 
determined. 
 
 
Once the above recommendations have been carried out the recovery rate of 
flavonoids from a simple methanol solution should be comparable to those values 
reported by other groups.
1, 104
  If the recovery rates are still low in comparison then it 
should be considered that the recovery rates have been over estimated in the literature. 
 
This will provide a solid foundation from which to investigate the effects of matrix 
and flavonoid type on recovery rate.  Measurement of the recovery rate of flavonoids 
from an artificial honey should be repeated on an optimised XAD-2 extraction system 
and compared with rates for flavonoids from simple methanol solutions.  This should 
allow the effect of the honey matrix on flavonoid recovery to be determined. 
 
The recovery rates of the flavones and their corresponding flavonols should be 
compared to assess the effect of the 3-hydroxyl on the extraction efficiency.  This 
was not tested in the present study but the observation that flavones were more 
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abundant than their corresponding flavonols in the extracts analysed suggests that the 
flavones may be preferentially extracted.  This preferential extraction is a problem 
when the concentrations of individual flavonoids in honey are being compared since 
the flavonols will be under-represented. 
 
 
With the XAD-2 extraction method optimised for extraction from 50g samples it 
would be useful to re-investigate the effect of sample size on the extraction process.  
The benefit of being able to analyse small honey samples make this modification of 
the extraction method worthwhile, provided it does not adversely affect the 
reproducibility of the extraction.  The results of the present study showed that the 
variation in extraction results was large for all the sample weights extracted.  If this 
variability could be reduced then there may be a significant difference between the 
results of 5g and 50g honey extractions. 
 
The collection of flavonoid standards should be increased to allow identification of 
more flavonoids by comparison of retention time and UV absorbance spectra.  Some 
of the flavonoids found in honey are difficult to source commercially (e.g. 
pinobanksin) and will have to be isolated, purified and characterised so that they may 
be used as qualitative standards for future research. 
 
Six flavonoids were found in most of the manuka honeys, and a further seven in the 
non-manuka honeys which did not coincide with the known flavonoids for which we 
had authentic standards.  It is possible that these flavonoids could be unique floral 
markers for New Zealand monofloral honeys if future research is able to isolate and 
identify them to confirm their uniqueness.   
 
While only two flavonoids were isolated in the present study, the process of extracting 
and isolating these flavonoids from a bulk sample of manuka honey has yielded 
several fractions which are rich in flavonoids.  These fractions should contain the six 
unknown flavonoids found in the manuka honeys studied.  They may potentially 
contain many more interesting flavonoids which were not sufficiently concentrated to 
observe in the analytical study of manuka honey flavonoids.  Future research should 
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isolate and characterise the unknown flavonoids from these fractions so that they may 
be added to the collection of flavonoid standards and utilised in future work. 
 
The unknown compound 01 in particular needs to be isolated and characterised.  This 
compound showed a positive correlation with UMF antibacterial activity so its 
identity is of interest to the manuka honey industry.  It is possible that this unknown 
compound 01 may be a precursor of the dihydroxyacetone form which methylglyoxal 
derives.  Once it has been identified it is recommended that a future study search for 
the source of the compound in the nectar of manuka flowers.  It would also be 
worthwhile searching for luteolin and its glycosides in manuka nectar since it 
appeared to be a marker for manuka honey.  If the luteolin in manuka honey was 
derived from the nectar then the nectar should contain glycosides of luteolin which 
are hydrolysed by bee enzymes to form the aglycone in honey. 
 
Future analyses of the phenolic profiles of honey should be carried out on an LC-MS 
system rather than HPLC with photodiode array detection.  A combined UV 
absorption spectrum, molecular mass and fragmentation pattern recorded on such as 
system has the potential to allow many more unknown flavonoids to be identified 
rapidly without the need for isolation and characterisation. 
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Plate Number
Aqueous MeOH 1:1 MeOH 25:1 Manuka Honey Clover Honey
30.8 ND 42.8 32.3 ND
35.9 ND 39.7 34.8 ND
30.7 ND 33.6 33.0 ND
31.2 ND 33.8 33.3 ND
31.5 ND 43.1 35.4 ND
28.0 ND 33.4 34.8 ND
31.2 ND 44.1 35.7 ND
30.0 ND 35.8 31.4 ND
33.8 ND 31.8
32.5 ND 35.8
30.1 ND 33.0
30.3 ND 27.9
31.2 ND 30.8 28.6 ND
28.6 ND 36.4 27.9 ND
29.0 ND 35.4 28.5 ND
27.6 ND 34.2 27.8 ND
29.1 ND 35.3 30.5 ND
33.0 ND 36.8 31.0 ND
29.1 ND 35.8 29.1 ND
27.7 ND 34.7 28.6 ND
30.8 ND 31.0
27.1 ND 33.9
30.5 ND 27.9
28.4 ND 28.2
39.6 ND 35.2 35.7 ND
28.5 ND 39.5 29.4 ND
30.0 ND 35.5 25.8 ND
32.5 ND 42.0 31.3 ND
28.8 ND 39.7 33.3 ND
32.3 ND 31.5 28.1 ND
28.5 ND 43.1 34.5 ND
35.5 ND 38.8 28.6 ND
36.9 ND 33.3
31.1 ND 30.1
26.8 ND 35.2
31.7 ND 29.4
30.8 ND 31.6 28.6 ND
29.5 ND 38.4 28.0 ND
29.6 ND 36.7 28.3 ND
29.7 ND 40.4 26.7 ND
28.7 ND 30.8 30.5 ND
28.3 ND 37.9 28.5 ND
30.3 ND 34.5 29.2 ND
29.9 ND 37.3 25.9 ND
29.5 ND 29.1
30.3 ND 29.6
28.5 ND 28.7
31.1 ND 28.4
Mean 30.5 #DIV/0! 36.8 30.6 #DIV/0!
St Dev. 2.5 #DIV/0! 3.7 2.8 #DIV/0!
95% Conf. Limit 0.7 #DIV/0! 1.3 0.8 #DIV/0!
ND= no detectable activity
Equivalent % Phenol
1
2
3
4
Antibacterial Activity Testing of Extraction Fractions
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Acq. Method Set: Symmetry MeOH 3 aVial: 1
Date Processed: ****Injection #: 1
Processing Method: ****Injection Volume: 5.00 ul
Channel Name: ****Run Time: 78.0 Minutes
Proc. Chnl. Descr.: ****Sample Set Name:
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S A M P L E      I N F O R M A T I O N
Acquired By: SystemSample Name: Kaempferol
Date Acquired: 12/9/2008 4:18:23 PM NZDTSample Type: Standard
Acq. Method Set: Symmetry MeOH 3 aVial: 1
Date Processed: ****Injection #: 3
Processing Method: ****Injection Volume: 5.00 ul
Channel Name: ****Run Time: 78.0 Minutes
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S A M P L E      I N F O R M A T I O N
Acquired By: SystemSample Name: Chrysin
Date Acquired: 1/12/2009 3:21:48 PM NZDTSample Type: Unknown
Acq. Method Set: Symmetry MeOH 3 aVial: 1
Date Processed: ****Injection #: 4
Processing Method: ****Injection Volume: 5.00 ul
Channel Name: ****Run Time: 78.0 Minutes
Proc. Chnl. Descr.: ****Sample Set Name:
340nm Chromatogram
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S A M P L E      I N F O R M A T I O N
Acquired By: SystemSample Name: Galangin
Date Acquired: 12/10/2008 11:08:16 AM NZDTSample Type: Standard
Acq. Method Set: Symmetry MeOH 3 aVial: 1
Date Processed: ****Injection #: 1
Processing Method: ****Injection Volume: 5.00 ul
Channel Name: ****Run Time: 78.0 Minutes
Proc. Chnl. Descr.: ****Sample Set Name:
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Extraction of Flavonoids from Artificial Honey
Extraction 1
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Extraction of Flavonoids from Artificial Honey
Extraction 2
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Extraction of Flavonoids from Artificial Honey
Extraction 3
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Extraction of Flavonoids from Artificial Honey
Extraction 4
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Extraction of Flavonoids from Artificial Honey
Extraction 5
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Extraction of Flavonoids from Artificial Honey
Extraction 6
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Extraction of Flavonoids from Artificial Honey
Extraction 7
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Recovery Rate Test of Extraction Method
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Recovery Rate Test of Extraction Method
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Repeated Extraction of M110 
Manuka Honey Sample
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Repeated Extraction of M110 
Manuka Honey Sample
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Repeated Extraction of M110 
Manuka Honey Sample
Sample Name: CC 211108 C
Chromatograms
290.0nm - PDA 290.0 nm
A
U
0.00
0.50
1.00
1.50
2.00
2.50
3.00
340.0nm - PDA 340.0 nm
A
U
0.00
0.10
0.20
0.30
0.40
0.50
0.60
Minutes
0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00
Empower Node: Hplc-a Date Acquired: 2/18/2009 2:32:24 PM NZDTSystem Name: Waters 2007
Instrument Method Name: Symmetry MeOH 3 a
Empower 2 Software Build 2154 Software Revision Number
Project Name:    Chris Adams\BenReported by User: System
Report Method: Honey Flavonoid Chromatogram Date Printed:
3207 3/31/2009Report Method ID: 3207
5:33:48 PM NZPage: 1 of 1
Repeated Extraction of M110 
Manuka Honey Sample
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Repeated Extraction of M110 
Manuka Honey Sample
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Repeated Extraction of M110 
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